{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 1356589, "items": [{"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T06:02:06Z", "timestamp": 1574748126438}, "reference-count": 222, "publisher": "Informa UK Limited", "issue": "1", "funder": [{"DOI": "10.13039/100000054", "name": "National Cancer Institute", "doi-asserted-by": "publisher", "award": ["R35 CA197735", "K07 CA190673", "R01 CA151993"]}], "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Expert Review of Molecular Diagnostics"], "published-print": {"date-parts": [[2016, 1, 2]]}, "DOI": "10.1586/14737159.2016.1115346", "type": "journal-article", "created": {"date-parts": [[2015, 12, 4]], "date-time": "2015-12-04T16:41:20Z", "timestamp": 1449247280000}, "page": "11-23", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 38, "title": ["Integration of molecular pathology, epidemiology and social science for global precision medicine"], "prefix": "10.1586", "volume": "16", "author": [{"given": "Akihiro", "family": "Nishi", "sequence": "first", "affiliation": []}, {"suffix": "Jr", "given": "Danny A", "family": "Milner", "sequence": "additional", "affiliation": []}, {"given": "Edward L", "family": "Giovannucci", "sequence": "additional", "affiliation": []}, {"given": "Reiko", "family": "Nishihara", "sequence": "additional", "affiliation": []}, {"given": "Andy S", "family": "Tan", "sequence": "additional", "affiliation": []}, {"given": "Ichiro", "family": "Kawachi", "sequence": "additional", "affiliation": []}, {"given": "Shuji", "family": "Ogino", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2015, 12, 4]]}, "reference": [{"key": "CIT0001", "unstructured": "Papers of special note have been highlighted as:"}, {"key": "CIT0002", "unstructured": "\u2022 of interest"}, {"key": "CIT0003", "unstructured": "\u2022\u2022 of considerable interest"}, {"key": "CIT0004", "DOI": "10.1056/NEJMp1500523", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1001/jama.2015.3595", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1097/00001648-200009000-00011", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.2105/AJPH.2004.059204", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1007/s10654-006-9075-0", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1097/01.ede.0000222409.00878.37", "doi-asserted-by": "publisher"}, {"issue": "1", "key": "CIT0010", "first-page": "79", "volume": "3", "author": "Vanderweele TJ", "year": "2014", "journal-title": "Epidemiol Methods"}, {"key": "CIT0011", "DOI": "10.1093/ije/dyg070", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1158/1940-6207.CAPR-08-0070", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1371/journal.pmed.0050177", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1016/j.ehb.2013.12.002", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1097/EDE.0000000000000081", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "DOI": "10.1093/ije/dyv082", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "DOI": "10.1093/jnci/djq031", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "DOI": "10.1136/gut.2010.217182", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "DOI": "10.1093/aje/kws226", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "DOI": "10.2307/2086918", "doi-asserted-by": "publisher"}, {"key": "CIT0021", "author": "Berkman LF", "year": "2000", "volume-title": "Social epidemiology"}, {"key": "CIT0022", "DOI": "10.1093/ije/30.4.668", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "author": "Oaks JM", "year": "2006", "volume-title": "Methods in social epidemiology"}, {"key": "CIT0024", "DOI": "10.1146/annurev.publhealth.031308.100310", "doi-asserted-by": "publisher"}, {"key": "CIT0025", "author": "Galea S", "year": "2007", "volume-title": "Macrosocial determinants of population health"}, {"key": "CIT0026", "DOI": "10.1093/acprof:oso/9780195383874.001.0001", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "DOI": "10.1016/j.socscimed.2005.08.036", "doi-asserted-by": "publisher"}, {"key": "CIT0028", "DOI": "10.1136/bmj.b4471", "doi-asserted-by": "publisher"}, {"key": "CIT0029", "DOI": "10.1371/journal.pmed.1000316", "doi-asserted-by": "publisher"}, {"key": "CIT0030", "DOI": "10.1007/s10865-006-9056-5", "doi-asserted-by": "publisher"}, {"key": "CIT0031", "DOI": "10.1001/jama.294.22.2879", "doi-asserted-by": "publisher"}, {"key": "CIT0032", "author": "Nishi A", "year": "2015", "journal-title": "Soc Sci Med"}, {"key": "CIT0033", "author": "Nishi A", "year": "2015", "journal-title": "Nature"}, {"key": "CIT0034", "DOI": "10.15195/v2.a22", "doi-asserted-by": "publisher"}, {"key": "CIT0035", "DOI": "10.1056/NEJMp1506241", "doi-asserted-by": "publisher"}, {"key": "CIT0036", "DOI": "10.1136/jech.56.10.734", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "DOI": "10.1158/1055-9965.EPI-10-0056", "doi-asserted-by": "publisher"}, {"key": "CIT0038", "DOI": "10.1136/jech.56.10.728", "doi-asserted-by": "publisher"}, {"key": "CIT0039", "DOI": "10.1002/(SICI)1096-9896(199901)187:1<8::AID-PATH232>3.0.CO;2-Y", "doi-asserted-by": "publisher"}, {"key": "CIT0040", "DOI": "10.1038/nrc3967", "doi-asserted-by": "publisher"}, {"key": "CIT0041", "DOI": "10.1038/modpathol.2012.214", "doi-asserted-by": "publisher"}, {"key": "CIT0042", "author": "Ogino S", "journal-title": "Epidemiology"}, {"key": "CIT0043", "DOI": "10.1093/biomet/asq036", "doi-asserted-by": "publisher"}, {"key": "CIT0044", "DOI": "10.1198/016214504000000124", "doi-asserted-by": "publisher"}, {"key": "CIT0045", "DOI": "10.1002/cam4.456", "doi-asserted-by": "publisher"}, {"key": "CIT0046", "DOI": "10.1186/1471-2288-14-138", "doi-asserted-by": "publisher"}, {"key": "CIT0047", "DOI": "10.1093/aje/kws128", "doi-asserted-by": "publisher"}, {"key": "CIT0048", "DOI": "10.1002/sim.5902", "doi-asserted-by": "publisher"}, {"key": "CIT0049", "DOI": "10.1002/ijc.25714", "doi-asserted-by": "publisher"}, {"key": "CIT0050", "DOI": "10.1093/aje/kwv040", "doi-asserted-by": "publisher"}, {"key": "CIT0051", "DOI": "10.1093/aje/kws457", "doi-asserted-by": "publisher"}, {"key": "CIT0052", "author": "Nishihara R", "year": "2015", "journal-title": "Eur J Epidemiol"}, {"key": "CIT0053", "DOI": "10.1097/EDE.0000000000000031", "doi-asserted-by": "publisher"}, {"key": "CIT0054", "DOI": "10.1016/j.ypmed.2014.02.003", "doi-asserted-by": "publisher"}, {"key": "CIT0055", "DOI": "10.1093/ije/dyu162", "doi-asserted-by": "publisher"}, {"key": "CIT0056", "DOI": "10.1038/onc.2013.244", "doi-asserted-by": "publisher"}, {"key": "CIT0057", "DOI": "10.1001/jama.2013.281501", "doi-asserted-by": "publisher"}, {"key": "CIT0058", "DOI": "10.1001/jama.2013.280927", "doi-asserted-by": "publisher"}, {"key": "CIT0059", "DOI": "10.1017/S2045796014000559", "doi-asserted-by": "publisher"}, {"key": "CIT0060", "DOI": "10.1038/nrclinonc.2011.122", "doi-asserted-by": "publisher"}, {"key": "CIT0061", "DOI": "10.1136/gutjnl-2014-308852", "doi-asserted-by": "publisher"}, {"key": "CIT0062", "DOI": "10.1001/jamaoncol.2015.1377", "doi-asserted-by": "publisher"}, {"key": "CIT0063", "DOI": "10.1093/jnci/djv007", "doi-asserted-by": "publisher"}, {"key": "CIT0064", "DOI": "10.1136/gutjnl-2015-310101", "doi-asserted-by": "publisher"}, {"key": "CIT0065", "DOI": "10.1158/2326-6066.CIR-15-0084", "doi-asserted-by": "publisher"}, {"key": "CIT0066", "author": "Ito M", "year": "2015", "journal-title": "Int J Cancer"}, {"key": "CIT0067", "DOI": "10.1186/1479-5876-10-205", "doi-asserted-by": "publisher"}, {"key": "CIT0068", "DOI": "10.1002/path.4287", "doi-asserted-by": "publisher"}, {"key": "CIT0069", "DOI": "10.1038/nrdp.2015.65", "doi-asserted-by": "publisher"}, {"key": "CIT0070", "author": "Curtin K", "volume": "2011", "first-page": "902674", "year": "2011", "journal-title": "Patholog Res Int"}, {"key": "CIT0071", "DOI": "10.1371/journal.pone.0018571", "doi-asserted-by": "publisher"}, {"key": "CIT0072", "DOI": "10.1016/j.coph.2012.07.010", "doi-asserted-by": "publisher"}, {"issue": "1", "key": "CIT0073", "first-page": "77", "volume": "1825", "author": "Hughes LA", "year": "2012", "journal-title": "Biochimica Et Biophysica Acta"}, {"key": "CIT0074", "DOI": "10.1245/s10434-011-2176-3", "doi-asserted-by": "publisher"}, {"key": "CIT0075", "DOI": "10.1158/1055-9965.EPI-11-1168", "doi-asserted-by": "publisher"}, {"key": "CIT0076", "DOI": "10.1093/ije/dys055", "doi-asserted-by": "publisher"}, {"key": "CIT0077", "DOI": "10.1038/modpathol.2012.62", "doi-asserted-by": "publisher"}, {"key": "CIT0078", "DOI": "10.1038/ajg.2012.161", "doi-asserted-by": "publisher"}, {"key": "CIT0079", "DOI": "10.1016/j.annepidem.2012.03.001", "doi-asserted-by": "publisher"}, {"key": "CIT0080", "DOI": "10.5772/28146", "doi-asserted-by": "publisher"}, {"key": "CIT0081", "DOI": "10.1002/path.4085", "doi-asserted-by": "publisher"}, {"key": "CIT0082", "DOI": "10.1038/nrclinonc.2012.137", "doi-asserted-by": "publisher"}, {"key": "CIT0083", "DOI": "10.1158/1078-0432.CCR-11-3265", "doi-asserted-by": "publisher"}, {"key": "CIT0084", "DOI": "10.1158/2159-8290.CD-12-0424", "doi-asserted-by": "publisher"}, {"key": "CIT0085", "DOI": "10.1016/j.jmoldx.2012.06.007", "doi-asserted-by": "publisher"}, {"key": "CIT0086", "DOI": "10.1038/modpathol.2012.240", "doi-asserted-by": "publisher"}, {"key": "CIT0087", "DOI": "10.1007/s13668-012-0038-7", "doi-asserted-by": "publisher"}, {"key": "CIT0088", "DOI": "10.1158/1055-9965.EPI-12-1211", "doi-asserted-by": "publisher"}, {"key": "CIT0089", "DOI": "10.1158/0008-5472.CAN-12-3462", "doi-asserted-by": "publisher"}, {"key": "CIT0090", "DOI": "10.3748/wjg.v19.i20.3043", "doi-asserted-by": "publisher"}, {"key": "CIT0091", "DOI": "10.1159/000347166", "doi-asserted-by": "publisher"}, {"key": "CIT0092", "DOI": "10.1016/j.plipres.2013.08.005", "doi-asserted-by": "publisher"}, {"issue": "3", "key": "CIT0093", "first-page": "140", "volume": "4", "author": "Abbenhardt C", "year": "2013", "journal-title": "Int J Mol Epidemiol Genet"}, {"key": "CIT0094", "DOI": "10.1158/0008-5472.CAN-12-4306", "doi-asserted-by": "publisher"}, {"key": "CIT0095", "DOI": "10.1038/bjc.2013.430", "doi-asserted-by": "publisher"}, {"key": "CIT0096", "DOI": "10.1186/1750-9378-8-42", "doi-asserted-by": "publisher"}, {"key": "CIT0097", "DOI": "10.1158/1055-9965.EPI-13-0239", "doi-asserted-by": "publisher"}, {"key": "CIT0098", "DOI": "10.1016/j.prp.2013.08.007", "doi-asserted-by": "publisher"}, {"key": "CIT0099", "DOI": "10.1586/14737159.2013.811897", "doi-asserted-by": "publisher"}, {"key": "CIT0100", "DOI": "10.1038/bjc.2014.6", "doi-asserted-by": "publisher"}, {"key": "CIT0101", "DOI": "10.1016/j.canlet.2014.02.026", "doi-asserted-by": "publisher"}, {"key": "CIT0102", "DOI": "10.1038/ajg.2014.35", "doi-asserted-by": "publisher"}, {"key": "CIT0103", "DOI": "10.1186/1471-2407-14-371", "doi-asserted-by": "publisher"}, {"key": "CIT0104", "DOI": "10.1586/17474124.2014.924397", "doi-asserted-by": "publisher"}, {"key": "CIT0105", "DOI": "10.3748/wjg.v20.i20.6055", "doi-asserted-by": "publisher"}, {"key": "CIT0106", "DOI": "10.1002/cncr.28799", "doi-asserted-by": "publisher"}, {"key": "CIT0107", "DOI": "10.1158/1055-9965.EPI-13-1285", "doi-asserted-by": "publisher"}, {"key": "CIT0108", "DOI": "10.1007/s10620-014-3277-1", "doi-asserted-by": "publisher"}, {"key": "CIT0109", "DOI": "10.1016/j.canep.2014.07.003", "doi-asserted-by": "publisher"}, {"key": "CIT0111", "DOI": "10.1007/978-1-4939-0706-9_1", "doi-asserted-by": "publisher"}, {"key": "CIT0112", "DOI": "10.1136/gutjnl-2014-308260", "doi-asserted-by": "publisher"}, {"key": "CIT0113", "author": "Huser V", "volume": "7", "first-page": "275", "year": "2014", "journal-title": "Pharmgenomics Pers Med"}, {"key": "CIT0114", "DOI": "10.1186/s13000-014-0189-5", "doi-asserted-by": "publisher"}, {"key": "CIT0115", "DOI": "10.3390/genes5030821", "doi-asserted-by": "publisher"}, {"key": "CIT0116", "DOI": "10.1158/1055-9965.EPI-14-0541", "doi-asserted-by": "publisher"}, {"key": "CIT0117", "DOI": "10.1093/jnci/dju353", "doi-asserted-by": "publisher"}, {"key": "CIT0118", "DOI": "10.3389/fonc.2015.00019", "doi-asserted-by": "publisher"}, {"key": "CIT0119", "DOI": "10.3390/ijms16022472", "doi-asserted-by": "publisher"}, {"key": "CIT0120", "DOI": "10.1158/1055-9965.EPI-14-0756", "doi-asserted-by": "publisher"}, {"issue": "3", "key": "CIT0121", "first-page": "id1012", "volume": "1", "author": "Witvliet MI", "year": "2014", "journal-title": "Austin J Public Health Epidemiol"}, {"key": "CIT0122", "author": "Potter S", "year": "2014", "volume-title": "Body mass index 112 success secrets - 112 most asked questions on body mass index - what you need to know"}, {"key": "CIT0123", "DOI": "10.1016/j.neo.2015.02.001", "doi-asserted-by": "publisher"}, {"key": "CIT0124", "DOI": "10.1158/1055-9965.EPI-14-1161", "doi-asserted-by": "publisher"}, {"issue": "3", "key": "CIT0125", "first-page": "1040", "volume": "2", "author": "Gao C", "year": "2015", "journal-title": "Austin J Gastroenterol"}, {"key": "CIT0126", "DOI": "10.1155/2015/573814", "doi-asserted-by": "publisher"}, {"key": "CIT0127", "DOI": "10.1586/14737140.2015.1038248", "doi-asserted-by": "publisher"}, {"key": "CIT0128", "DOI": "10.1158/1055-9965.EPI-15-0094", "doi-asserted-by": "publisher"}, {"key": "CIT0129", "DOI": "10.1155/2015/367837", "doi-asserted-by": "publisher"}, {"key": "CIT0130", "author": "Miller KD", "year": "2015", "journal-title": "Abc-Clio"}, {"key": "CIT0131", "DOI": "10.1038/labinvest.2015.53", "doi-asserted-by": "publisher"}, {"key": "CIT0132", "DOI": "10.1007/978-3-319-09614-8_2", "doi-asserted-by": "publisher"}, {"key": "CIT0133", "author": "Kyriazis M", "year": "2015", "journal-title": "World J Transl Med"}, {"key": "CIT0134", "DOI": "10.1186/s13148-015-0110-4", "doi-asserted-by": "publisher"}, {"key": "CIT0135", "DOI": "10.2147/CMAR.S70358", "doi-asserted-by": "publisher"}, {"key": "CIT0136", "DOI": "10.1158/1055-9965.EPI-15-0601", "doi-asserted-by": "publisher"}, {"key": "CIT0137", "author": "Sylvetsky AC", "year": "2015", "journal-title": "World J Diabetes"}, {"issue": "11", "key": "CIT0138", "first-page": "CN06", "volume": "6", "author": "Ogino S", "year": "2013", "journal-title": "Cancer Prev Res (Phila)"}, {"key": "CIT0139", "DOI": "10.1093/aje/kwt239", "doi-asserted-by": "publisher"}, {"key": "CIT0140", "DOI": "10.1158/1055-9965.EPI-14-0848", "doi-asserted-by": "publisher"}, {"key": "CIT0141", "DOI": "10.1007/s10552-015-0596-2", "doi-asserted-by": "publisher"}, {"key": "CIT0142", "DOI": "10.1586/erm.12.46", "doi-asserted-by": "publisher"}, {"key": "CIT0143", "DOI": "10.1101/gr.126573.111", "doi-asserted-by": "publisher"}, {"key": "CIT0144", "DOI": "10.1158/0008-5472.CAN-13-1865", "doi-asserted-by": "publisher"}, {"key": "CIT0145", "DOI": "10.1016/j.amepre.2014.09.031", "doi-asserted-by": "publisher"}, {"key": "CIT0146", "author": "Ijspeert JE", "year": "2015", "journal-title": "Nat Rev Gastroenterol Hepatol"}, {"key": "CIT0147", "DOI": "10.1093/gastro/got022", "doi-asserted-by": "publisher"}, {"key": "CIT0148", "DOI": "10.1007/s13277-014-1845-9", "doi-asserted-by": "publisher"}, {"key": "CIT0149", "DOI": "10.1053/j.gastro.2014.12.035", "doi-asserted-by": "publisher"}, {"key": "CIT0150", "author": "Okugawa Y", "year": "2015", "journal-title": "Gastroenterology"}, {"key": "CIT0151", "DOI": "10.1053/j.gastro.2013.11.051", "doi-asserted-by": "publisher"}, {"key": "CIT0152", "DOI": "10.1038/onc.2010.89", "doi-asserted-by": "publisher"}, {"key": "CIT0153", "DOI": "10.1200/JCO.2008.20.8397", "doi-asserted-by": "publisher"}, {"key": "CIT0154", "DOI": "10.1016/S1470-2045(10)70130-3", "doi-asserted-by": "publisher"}, {"key": "CIT0155", "DOI": "10.1200/JCO.2014.60.0213", "doi-asserted-by": "publisher"}, {"key": "CIT0156", "DOI": "10.1056/NEJMoa067208", "doi-asserted-by": "publisher"}, {"key": "CIT0157", "DOI": "10.1001/jama.2013.6599", "doi-asserted-by": "publisher"}, {"key": "CIT0158", "DOI": "10.1093/jnci/djt331", "doi-asserted-by": "publisher"}, {"key": "CIT0159", "DOI": "10.1126/scitranslmed.3008481", "doi-asserted-by": "publisher"}, {"key": "CIT0160", "DOI": "10.1001/jama.2009.1112", "doi-asserted-by": "publisher"}, {"key": "CIT0161", "DOI": "10.1056/NEJMoa1207756", "doi-asserted-by": "publisher"}, {"key": "CIT0162", "DOI": "10.1200/JCO.2013.50.0322", "doi-asserted-by": "publisher"}, {"key": "CIT0163", "DOI": "10.3389/fonc.2014.00035", "doi-asserted-by": "publisher"}, {"issue": "2", "key": "CIT0164", "first-page": "12", "volume": "1", "author": "Amatu A", "year": "2013", "journal-title": "Annals Translational Med"}, {"key": "CIT0165", "DOI": "10.3109/0284186X.2014.990158", "doi-asserted-by": "publisher"}, {"key": "CIT0166", "DOI": "10.1158/1078-0432.CCR-13-2563", "doi-asserted-by": "publisher"}, {"key": "CIT0167", "author": "Guilgen G", "year": "2015", "journal-title": "Curr Colorectal Cancer Rep"}, {"key": "CIT0168", "DOI": "10.1200/JCO.2013.52.0080", "doi-asserted-by": "publisher"}, {"key": "CIT0169", "DOI": "10.7326/0003-4819-158-5-201303050-00003", "doi-asserted-by": "publisher"}, {"key": "CIT0170", "DOI": "10.1056/NEJMoa1301969", "doi-asserted-by": "publisher"}, {"key": "CIT0171", "DOI": "10.1053/j.gastro.2013.09.001", "doi-asserted-by": "publisher"}, {"key": "CIT0172", "DOI": "10.1038/ajg.2009.699", "doi-asserted-by": "publisher"}, {"key": "CIT0173", "DOI": "10.1016/j.bbrc.2014.08.002", "doi-asserted-by": "publisher"}, {"key": "CIT0174", "DOI": "10.1016/j.bbrc.2014.07.007", "doi-asserted-by": "publisher"}, {"key": "CIT0175", "DOI": "10.2353/jmoldx.2009.080125", "doi-asserted-by": "publisher"}, {"key": "CIT0176", "DOI": "10.3748/wjg.v20.i15.4230", "doi-asserted-by": "publisher"}, {"key": "CIT0177", "DOI": "10.1016/j.canlet.2008.03.022", "doi-asserted-by": "publisher"}, {"key": "CIT0178", "author": "Li X", "volume": "2014", "first-page": "236361", "year": "2014", "journal-title": "Biomed Res Int"}, {"key": "CIT0179", "DOI": "10.1093/jnci/djj468", "doi-asserted-by": "publisher"}, {"key": "CIT0180", "DOI": "10.1093/jnci/djq201", "doi-asserted-by": "publisher"}, {"key": "CIT0181", "DOI": "10.1093/aje/kws431", "doi-asserted-by": "publisher"}, {"key": "CIT0182", "DOI": "10.1002/ijc.24338", "doi-asserted-by": "publisher"}, {"key": "CIT0183", "DOI": "10.1158/1055-9965.EPI-09-0517", "doi-asserted-by": "publisher"}, {"key": "CIT0184", "DOI": "10.1016/j.ymgme.2009.09.010", "doi-asserted-by": "publisher"}, {"key": "CIT0185", "DOI": "10.1158/0008-5472.CAN-06-1535", "doi-asserted-by": "publisher"}, {"key": "CIT0186", "DOI": "10.1053/j.gastro.2015.06.047", "doi-asserted-by": "publisher"}, {"key": "CIT0187", "DOI": "10.1038/nrgastro.2011.173", "doi-asserted-by": "publisher"}, {"key": "CIT0188", "DOI": "10.3390/ijms140816365", "doi-asserted-by": "publisher"}, {"key": "CIT0189", "DOI": "10.1007/s11888-014-0208-7", "doi-asserted-by": "publisher"}, {"key": "CIT0190", "DOI": "10.3390/cancers5020676", "doi-asserted-by": "publisher"}, {"key": "CIT0191", "DOI": "10.1158/1078-0432.CCR-09-2594", "doi-asserted-by": "publisher"}, {"key": "CIT0192", "DOI": "10.1111/his.12564", "doi-asserted-by": "publisher"}, {"key": "CIT0193", "DOI": "10.1097/PAS.0b013e3181c17fe6", "doi-asserted-by": "publisher"}, {"key": "CIT0194", "DOI": "10.1158/1078-0432.CCR-14-0091", "doi-asserted-by": "publisher"}, {"key": "CIT0195", "DOI": "10.1309/AJCP6K0DZCNVCSCI", "doi-asserted-by": "publisher"}, {"key": "CIT0196", "DOI": "10.1007/s10552-008-9256-0", "doi-asserted-by": "publisher"}, {"key": "CIT0197", "DOI": "10.1093/jnci/djs356", "doi-asserted-by": "publisher"}, {"key": "CIT0198", "DOI": "10.1001/jama.2011.513", "doi-asserted-by": "publisher"}, {"key": "CIT0199", "DOI": "10.1158/0008-5472.CAN-12-2276", "doi-asserted-by": "publisher"}, {"key": "CIT0200", "DOI": "10.1016/j.hoc.2014.09.005", "doi-asserted-by": "publisher"}, {"key": "CIT0201", "DOI": "10.1016/j.socscimed.2011.12.033", "doi-asserted-by": "publisher"}, {"key": "CIT0202", "DOI": "10.1016/j.socscimed.2012.06.002", "doi-asserted-by": "publisher"}, {"key": "CIT0203", "DOI": "10.1158/0008-5472.CAN-10-3021", "doi-asserted-by": "publisher"}, {"key": "CIT0204", "DOI": "10.1158/1055-9965.EPI-14-0110", "doi-asserted-by": "publisher"}, {"key": "CIT0205", "DOI": "10.1007/s10552-013-0299-5", "doi-asserted-by": "publisher"}, {"key": "CIT0206", "DOI": "10.1002/ijc.28458", "doi-asserted-by": "publisher"}, {"key": "CIT0207", "DOI": "10.1158/1055-9965.EPI-15-0204", "doi-asserted-by": "publisher"}, {"key": "CIT0208", "DOI": "10.1093/jnci/dju237", "doi-asserted-by": "publisher"}, {"key": "CIT0209", "DOI": "10.18632/oncotarget.1599", "doi-asserted-by": "publisher"}, {"key": "CIT0210", "DOI": "10.1371/journal.pone.0007012", "doi-asserted-by": "publisher"}, {"key": "CIT0211", "DOI": "10.4161/epi.27644", "doi-asserted-by": "publisher"}, {"key": "CIT0212", "DOI": "10.1016/j.bbcan.2014.07.001", "doi-asserted-by": "publisher"}, {"issue": "1", "key": "CIT0213", "first-page": "40", "volume": "4", "author": "Vogtmann E", "year": "2013", "journal-title": "J Gastrointest Oncol"}, {"key": "CIT0214", "DOI": "10.1038/sj.bjc.6605540", "doi-asserted-by": "publisher"}, {"issue": "8", "key": "CIT0215", "doi-asserted-by": "crossref", "first-page": "796", "DOI": "10.1093/oxfordjournals.aje.a117718", "volume": "142", "author": "Gordon NH", "year": "1995", "journal-title": "Am J Epidemiol"}, {"key": "CIT0216", "DOI": "10.1093/pubmed/fdg072", "doi-asserted-by": "publisher"}, {"key": "CIT0217", "DOI": "10.1002/cncr.23243", "doi-asserted-by": "publisher"}, {"key": "CIT0218", "DOI": "10.1002/cncr.22618", "doi-asserted-by": "publisher"}, {"key": "CIT0219", "DOI": "10.1111/j.1524-4741.2009.00822.x", "doi-asserted-by": "publisher"}, {"key": "CIT0220", "DOI": "10.1016/j.amepre.2012.02.012", "doi-asserted-by": "publisher"}, {"key": "CIT0221", "DOI": "10.1126/science.1136099", "doi-asserted-by": "publisher"}, {"key": "CIT0222", "DOI": "10.1126/science.1205008", "doi-asserted-by": "publisher"}, {"key": "CIT0223", "DOI": "10.1093/aje/kwu256", "doi-asserted-by": "publisher"}], "container-title": ["Expert Review of Molecular Diagnostics"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1586/14737159.2016.1115346", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T01:02:58Z", "timestamp": 1498266178000}, "score": 40.686935, "issued": {"date-parts": [[2015, 12, 4]]}, "references-count": 222, "journal-issue": {"published-online": {"date-parts": [[2015, 11, 23]]}, "published-print": {"date-parts": [[2016, 1, 2]]}, "issue": "1"}, "alternative-id": ["10.1586/14737159.2016.1115346"], "URL": "http://dx.doi.org/10.1586/14737159.2016.1115346", "relation": {"cites": []}, "ISSN": ["1473-7159", "1744-8352"], "issn-type": [{"value": "1473-7159", "type": "print"}, {"value": "1744-8352", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=iero20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=iero20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:19:50Z", "timestamp": 1574720390743}, "reference-count": 98, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 11, 1]], "date-time": "2015-11-01T00:00:00Z", "timestamp": 1446336000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Social Science & Medicine"], "published-print": {"date-parts": [[2015, 11]]}, "DOI": "10.1016/j.socscimed.2015.08.015", "type": "journal-article", "created": {"date-parts": [[2015, 8, 14]], "date-time": "2015-08-14T09:59:38Z", "timestamp": 1439546378000}, "page": "132-137", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Evolution and social epidemiology"], "prefix": "10.1016", "volume": "145", "author": [{"ORCID": "http://orcid.org/0000-0003-1629-5985", "authenticated-orcid": false, "given": "Akihiro", "family": "Nishi", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Social Science & Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0277953615300678?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0277953615300678?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 29]], "date-time": "2019-08-29T10:54:33Z", "timestamp": 1567076073000}, "score": 36.399616, "issued": {"date-parts": [[2015, 11]]}, "references-count": 98, "alternative-id": ["S0277953615300678"], "URL": "http://dx.doi.org/10.1016/j.socscimed.2015.08.015", "ISSN": ["0277-9536"], "issn-type": [{"value": "0277-9536", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Evolution and social epidemiology", "name": "articletitle", "label": "Article Title"}, {"value": "Social Science & Medicine", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.socscimed.2015.08.015", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "simple-article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T12:21:36Z", "timestamp": 1574857296583}, "publisher-location": "Cham", "reference-count": 21, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319629407", "type": "print"}, {"value": "9783319629414", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2017, 8, 14]], "date-time": "2017-08-14T00:00:00Z", "timestamp": 1502668800000}, "delay-in-days": 0, "content-version": "unspecified"}, {"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2017, 8, 14]], "date-time": "2017-08-14T00:00:00Z", "timestamp": 1502668800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1007/978-3-319-62941-4_2", "type": "book-chapter", "created": {"date-parts": [[2017, 11, 11]], "date-time": "2017-11-11T08:54:30Z", "timestamp": 1510390470000}, "page": "15-17", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Lung Cancer Epidemiology and Demographics"], "prefix": "10.1007", "author": [{"given": "Ross A.", "family": "Miller", "sequence": "first", "affiliation": []}, {"given": "Philip T.", "family": "Cagle", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 8, 14]]}, "reference": [{"issue": "1", "key": "2_CR1", "doi-asserted-by": "publisher", "first-page": "7", "DOI": "10.3322/caac.21332", "volume": "66", "author": "RL Siegal", "year": "2016", "unstructured": "Siegal RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7\u201330.", "journal-title": "CA Cancer J Clin"}, {"issue": "5", "key": "2_CR2", "doi-asserted-by": "publisher", "first-page": "1133", "DOI": "10.1002/ijc.27711", "volume": "132", "author": "F Bray", "year": "2013", "unstructured": "Bray F, Ren JS, Masuyer E, Ferlay J. Estimates of global cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133\u201345.", "journal-title": "Int J Cancer"}, {"issue": "9972", "key": "2_CR3", "doi-asserted-by": "publisher", "first-page": "977", "DOI": "10.1016/S0140-6736(14)62038-9", "volume": "385", "author": "C Allemani", "year": "2015", "unstructured": "Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25,676,887 patients from 279 population based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977\u2013101.", "journal-title": "Lancet"}, {"issue": "1", "key": "2_CR4", "doi-asserted-by": "publisher", "first-page": "75", "DOI": "10.1038/nrc1784", "volume": "6", "author": "GA Colditz", "year": "2006", "unstructured": "Colditz GA, Sellers TA, Trapido E. Epidemiology\u2014identifying the causes and preventability of cancer? Nat Rev Cancer. 2006;6(1):75\u201383.", "journal-title": "Nat Rev Cancer"}, {"issue": "6", "key": "2_CR5", "doi-asserted-by": "publisher", "first-page": "1025", "DOI": "10.1158/1055-9965.EPI-13-1220", "volume": "23", "author": "LA Torre", "year": "2014", "unstructured": "Torre LA, Siegel RL, Ward EM, Jemal A. International variation in lung cancer mortality rates and trends among women. Cancer Epidemiol Biomark Prev. 2014;23(6):1025\u201336.", "journal-title": "Cancer Epidemiol Biomark Prev"}, {"issue": "3", "key": "2_CR6", "doi-asserted-by": "publisher", "first-page": "171", "DOI": "10.1016/j.lungcan.2012.08.008", "volume": "78", "author": "C Bosetti", "year": "2012", "unstructured": "Bosetti C, Malvezzi M, Rosso T, et al. Lung cancer mortality in European women: trends and predictions. Lung Cancer. 2012;78(3):171\u20138.", "journal-title": "Lung Cancer"}, {"issue": "8", "key": "2_CR7", "doi-asserted-by": "publisher", "first-page": "819", "DOI": "10.1097/JTO.0b013e31818020eb", "volume": "3", "author": "DR Youlden", "year": "2008", "unstructured": "Youlden DR, Cramb SM, Baade PD. The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol. 2008;3(8):819\u201331.", "journal-title": "J Thorac Oncol"}, {"issue": "9", "key": "2_CR8", "first-page": "1045", "volume": "8", "author": "WK Lam", "year": "2004", "unstructured": "Lam WK, White NW, Chan-Yeung MM. Lung cancer epidemiology and risk factors in Asia and Africa. Int J Tuberc Lung Dis. 2004;8(9):1045\u201357.", "journal-title": "Int J Tuberc Lung Dis"}, {"key": "2_CR9", "author": "M Eriksen", "year": "2012", "edition": "4", "unstructured": "Eriksen M, Mackay J, Ross H. The Tobacco Atlas. 4th ed. Atlanta: American Cancer Society; 2012.", "volume-title": "The Tobacco Atlas"}, {"issue": "4", "key": "2_CR10", "doi-asserted-by": "publisher", "first-page": "265", "DOI": "10.1159/000324601", "volume": "81", "author": "IM Adcock", "year": "2011", "unstructured": "Adcock IM, Caramori G, Barnes PJ. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011;81(4):265\u201384.", "journal-title": "Respiration"}, {"issue": "supplement", "key": "2_CR11", "doi-asserted-by": "publisher", "first-page": "21S", "DOI": "10.1378/chest.123.1_suppl.21S", "volume": "123", "author": "AJ Alberg", "year": "2003", "unstructured": "Alberg AJ, Semet JM. Epidemiology of lung cancer. Chest. 2003;123(supplement):21S\u201349S.", "journal-title": "Chest"}, {"key": "2_CR12", "author": "PT Cagle", "year": "2008", "unstructured": "Cagle PT, Allen TC. Genetic susceptibility to lung cancer. In: Zander D, Popper HH, Jaigrdar J, Haque A, Cagle PT, Barrios R, editors. Molecular pathology of lung diseases. New York: Springer; 2008.", "volume-title": "Molecular pathology of lung diseases"}, {"key": "2_CR13", "first-page": "413", "volume-title": "Pathology of the lung", "author": "PT Cagle", "year": "2005", "unstructured": "Cagle PT. Carcinoma of the lung. In: Churg AM, Myers JL, Tazelaar HD, Wright JL, editors. Pathology of the lung. 3rd ed. New York: Thieme Medical Publishers; 2005. p. 413\u201379.", "edition": "3rd"}, {"key": "2_CR14", "author": "Z Hrubec", "first-page": "501", "year": "1997", "unstructured": "Hrubec Z, McLaughlin JK. Former cigarette smoking and mortality among US veterans: a 26-year follow-up, 1954\u20131980. In: Burns DM, Garfinkel L, Samet JM, editors. Changes in cigarette-related disease risks and their implications for prevention and control. Bethesda: US Government Printing Office; 1997. p. 501\u201330.", "volume-title": "Changes in cigarette-related disease risks and their implications for prevention and control"}, {"key": "2_CR15", "unstructured": "US Department of Health and Human Services: The health benefits of smoking cessation. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. DHHS Publication No (CDC) 89\u20138416, 1990."}, {"issue": "8", "key": "2_CR16", "doi-asserted-by": "publisher", "first-page": "751", "DOI": "10.1016/S1470-2045(09)70213-X", "volume": "10", "author": "F Ghissassi El", "year": "2009", "unstructured": "El Ghissassi F, Baan R, Straif K, et al. A review of human carcinogens\u2013part D: radiation. Lancet Oncol. 2009;10(8):751\u20132.", "journal-title": "Lancet Oncol"}, {"issue": "9499", "key": "2_CR17", "doi-asserted-by": "publisher", "first-page": "1784", "DOI": "10.1016/S0140-6736(05)67725-2", "volume": "366", "author": "G Danaei", "year": "2005", "unstructured": "Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366(9499):1784\u201393.", "journal-title": "Lancet"}, {"key": "2_CR18", "author": "American Cancer Society", "year": "2015", "edition": "3", "unstructured": "American Cancer Society. Global cancer facts and figures. 3rd ed. Atlanta: American Cancer Society; 2015.", "volume-title": "Global cancer facts and figures"}, {"key": "2_CR19", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1186/1465-9921-12-31", "volume": "12", "author": "C Herr", "year": "2011", "unstructured": "Herr C, Greulich T, Koczulla RA, Meyer S, Zakharkina T, Branscheidt M, Eschmann R, Bals R. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res. 2011;12:31.", "journal-title": "Respir Res"}, {"issue": "3", "key": "2_CR20", "doi-asserted-by": "publisher", "first-page": "326", "DOI": "10.1513/pats.201009-061WR", "volume": "8", "author": "GD Kirk", "year": "2011", "unstructured": "Kirk GD, Merlo CA. Lung HIV study. HIV infection in the etiology of lung cancer: confounding, causality, and consequences. Proc Am Thorac Soc. 2011;8(3):326\u201332.", "journal-title": "Proc Am Thorac Soc"}, {"key": "2_CR21", "author": "LM Sholl", "first-page": "41", "year": "2016", "unstructured": "Sholl LM, Nishino M. Adenocarcinoma. In: Cagle PR, Allen TC, editors. Lung and pleural pathology. China: McGraw-Hill Education; 2016. p. 41\u201372.", "volume-title": "Lung and pleural pathology"}], "container-title": ["Precision Molecular Pathology of Lung Cancer", "Molecular Pathology Library"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-62941-4_2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 19]], "date-time": "2019-05-19T01:53:55Z", "timestamp": 1558230835000}, "score": 26.350203, "issued": {"date-parts": [[2017, 8, 14]]}, "ISBN": ["9783319629407", "9783319629414"], "references-count": 21, "URL": "http://dx.doi.org/10.1007/978-3-319-62941-4_2", "relation": {"cites": []}, "ISSN": ["1935-987X", "1935-9888"], "issn-type": [{"value": "1935-987X", "type": "print"}, {"value": "1935-9888", "type": "electronic"}], "assertion": [{"value": "14 August 2017", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ChapterHistory", "label": "Chapter History"}}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:06:32Z", "timestamp": 1574114792788}, "reference-count": 48, "publisher": "Elsevier BV", "issue": "7", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 10, 1]], "date-time": "2004-10-01T00:00:00Z", "timestamp": 1096588800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Social Science & Medicine"], "published-print": {"date-parts": [[2004, 10]]}, "DOI": "10.1016/j.socscimed.2004.01.028", "type": "journal-article", "created": {"date-parts": [[2004, 3, 13]], "date-time": "2004-03-13T10:12:36Z", "timestamp": 1079172756000}, "page": "1541-1546", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Audience, consequence, and journal selection in toxic-exposure epidemiology"], "prefix": "10.1016", "volume": "59", "author": [{"given": "David A", "family": "Rier", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Social Science & Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0277953604000334?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0277953604000334?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 14]], "date-time": "2019-02-14T17:28:17Z", "timestamp": 1550165297000}, "score": 24.644873, "issued": {"date-parts": [[2004, 10]]}, "references-count": 48, "journal-issue": {"published-print": {"date-parts": [[2004, 10]]}, "issue": "7"}, "alternative-id": ["S0277953604000334"], "URL": "http://dx.doi.org/10.1016/j.socscimed.2004.01.028", "ISSN": ["0277-9536"], "issn-type": [{"value": "0277-9536", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:27:51Z", "timestamp": 1574134071293}, "reference-count": 93, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1994, 9, 1]], "date-time": "1994-09-01T00:00:00Z", "timestamp": 778377600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Social Science & Medicine"], "published-print": {"date-parts": [[1994, 9]]}, "DOI": "10.1016/0277-9536(94)90023-x", "type": "journal-article", "created": {"date-parts": [[2002, 10, 9]], "date-time": "2002-10-09T17:30:04Z", "timestamp": 1034184604000}, "page": "671-686", "source": "Crossref", "is-referenced-by-count": 42, "title": ["Ethnography, epidemiology and infertility in Egypt"], "prefix": "10.1016", "volume": "39", "author": [{"given": "Marcia C.", "family": "Inhorn", "sequence": "first", "affiliation": []}, {"given": "Kimberly A.", "family": "Buss", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Social Science & Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:027795369490023X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:027795369490023X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 10]], "date-time": "2019-04-10T02:28:40Z", "timestamp": 1554863320000}, "score": 24.197723, "issued": {"date-parts": [[1994, 9]]}, "references-count": 93, "journal-issue": {"published-print": {"date-parts": [[1994, 9]]}, "issue": "5"}, "alternative-id": ["027795369490023X"], "URL": "http://dx.doi.org/10.1016/0277-9536(94)90023-x", "ISSN": ["0277-9536"], "issn-type": [{"value": "0277-9536", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T03:10:41Z", "timestamp": 1574824241007}, "reference-count": 199, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Advances In Anatomic Pathology"], "published-print": {"date-parts": [[2017, 11]]}, "DOI": "10.1097/pap.0000000000000166", "type": "journal-article", "created": {"date-parts": [[2017, 8, 17]], "date-time": "2017-08-17T18:37:17Z", "timestamp": 1502995037000}, "page": "336-353", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Surgical Pathology of Gastrointestinal Stromal Tumors"], "prefix": "10.1097", "volume": "24", "author": [{"given": "Gregory W.", "family": "Charville", "sequence": "first", "affiliation": []}, {"given": "Teri A.", "family": "Longacre", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Advances In Anatomic Pathology"], "language": "en", "link": [{"URL": "http://Insights.ovid.com/crossref?an=00125480-201711000-00002", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 2]], "date-time": "2019-10-02T14:25:24Z", "timestamp": 1570026324000}, "score": 23.71425, "subtitle": ["Practical Implications of Morphologic and Molecular Heterogeneity for Precision Medicine"], "issued": {"date-parts": [[2017, 11]]}, "references-count": 199, "journal-issue": {"issue": "6"}, "URL": "http://dx.doi.org/10.1097/pap.0000000000000166", "ISSN": ["1072-4109"], "issn-type": [{"value": "1072-4109", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T14:42:21Z", "timestamp": 1574865741329}, "reference-count": 103, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0", "start": {"date-parts": [[2017, 12, 1]], "date-time": "2017-12-01T00:00:00Z", "timestamp": 1512086400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["npj Precision Onc"], "published-print": {"date-parts": [[2017, 12]]}, "DOI": "10.1038/s41698-017-0042-x", "type": "journal-article", "created": {"date-parts": [[2017, 11, 30]], "date-time": "2017-11-30T10:35:11Z", "timestamp": 1512038111000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology"], "prefix": "10.1038", "volume": "1", "author": [{"given": "Shuji", "family": "Ogino", "sequence": "first", "affiliation": []}, {"given": "Iny", "family": "Jhun", "sequence": "additional", "affiliation": []}, {"given": "Douglas A.", "family": "Mata", "sequence": "additional", "affiliation": []}, {"given": "Thing Rinda", "family": "Soong", "sequence": "additional", "affiliation": []}, {"given": "Tsuyoshi", "family": "Hamada", "sequence": "additional", "affiliation": []}, {"given": "Li", "family": "Liu", "sequence": "additional", "affiliation": []}, {"given": "Reiko", "family": "Nishihara", "sequence": "additional", "affiliation": []}, {"given": "Marios", "family": "Giannakis", "sequence": "additional", "affiliation": []}, {"given": "Yin", "family": "Cao", "sequence": "additional", "affiliation": []}, {"given": "JoAnn E.", "family": "Manson", "sequence": "additional", "affiliation": []}, {"given": "Jonathan A.", "family": "Nowak", "sequence": "additional", "affiliation": []}, {"given": "Andrew T.", "family": "Chan", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 12, 6]]}, "reference": [{"key": "42_CR1", "doi-asserted-by": "crossref", "first-page": "1510", "DOI": "10.1158/0008-5472.CAN-16-2346", "volume": "77", "author": "A Spira", "year": "2017", "unstructured": "Spira, A. et al. Precancer atlas to drive precision prevention trials. Cancer Res. 77, 1510\u20131541 (2017).", "journal-title": "Cancer Res"}, {"key": "42_CR2", "doi-asserted-by": "crossref", "first-page": "djv309", "DOI": "10.1093/jnci/djw309", "volume": "108", "author": "FL Meyskens Jr.", "year": "2016", "unstructured": "Meyskens, F. L. Jr. et al. Cancer prevention: obstacles, challenges and the road ahead. J. Natl Cancer Inst. 108, djv309 (2016).", "journal-title": "J. Natl Cancer Inst."}, {"key": "42_CR3", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1093/carcin/bgv166", "volume": "37", "author": "BW Stewart", "year": "2016", "unstructured": "Stewart, B. W. et al. Cancer prevention as part of precision medicine: 'plenty to be done'. Carcinogenesis 37, 2\u20139 (2016).", "journal-title": "Carcinogenesis"}, {"key": "42_CR4", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1158/1940-6207.CAPR-15-0406", "volume": "9", "author": "TW Kensler", "year": "2016", "unstructured": "Kensler, T. W. et al. Transforming cancer prevention through precision medicine and immune-oncology. Cancer Prev. Res. 9, 2\u201310 (2016).", "journal-title": "Cancer Prev. Res."}, {"key": "42_CR5", "doi-asserted-by": "crossref", "first-page": "e124", "DOI": "10.1371/journal.pmed.0020124", "volume": "2", "author": "JP Ioannidis", "year": "2005", "unstructured": "Ioannidis, J. P. Why most published research findings are false. PLoS Med. 2, e124 (2005).", "journal-title": "PLoS Med."}, {"key": "42_CR6", "doi-asserted-by": "crossref", "first-page": "e1001747", "DOI": "10.1371/journal.pmed.1001747", "volume": "11", "author": "JP Ioannidis", "year": "2014", "unstructured": "Ioannidis, J. P. How to make more published research true. PLoS Med. 11, e1001747 (2014).", "journal-title": "PLoS Med"}, {"key": "42_CR7", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1038/modpathol.2012.214", "volume": "26", "author": "S Ogino", "year": "2013", "unstructured": "Ogino, S. et al. Molecular pathological epidemiology of epigenetics: Emerging integrative science to analyze environment, host, and disease. Mod. Pathol. 26, 465\u2013484 (2013).", "journal-title": "Mod. Pathol."}, {"key": "42_CR8", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1586/14737159.2016.1115346", "volume": "16", "author": "A Nishi", "year": "2016", "unstructured": "Nishi, A. et al. Integration of molecular pathology, epidemiology, and social science for global precision medicine. Expert Rev. Mol. Diagn. 16, 11\u201323 (2016).", "journal-title": "Expert Rev. Mol. Diagn."}, {"key": "42_CR9", "doi-asserted-by": "crossref", "first-page": "659", "DOI": "10.1093/aje/kws226", "volume": "176", "author": "S Ogino", "year": "2012", "unstructured": "Ogino, S. et al. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am. J. Epidemiol. 176, 659\u2013667 (2012).", "journal-title": "Am. J. Epidemiol."}, {"key": "42_CR10", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1093/jnci/djq031", "volume": "102", "author": "S Ogino", "year": "2010", "unstructured": "Ogino, S. & Stampfer, M. Lifestyle factors and microsatellite instability in colorectal cancer: The evolving field of molecular pathological epidemiology. J .Natl Cancer. Inst. 102, 365\u2013367 (2010).", "journal-title": "J .Natl Cancer. Inst."}, {"key": "42_CR11", "doi-asserted-by": "crossref", "first-page": "397", "DOI": "10.1136/gut.2010.217182", "volume": "60", "author": "S Ogino", "year": "2011", "unstructured": "Ogino, S., Chan, A. T., Fuchs, C. S. & Giovannucci, E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 60, 397\u2013411 (2011).", "journal-title": "Gut"}, {"key": "42_CR12", "doi-asserted-by": "crossref", "first-page": "602", "DOI": "10.1097/EDE.0000000000000471", "volume": "27", "author": "S Ogino", "year": "2016", "unstructured": "Ogino, S. et al. The role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine. Epidemiology 27, 602\u2013611 (2016).", "journal-title": "Epidemiology"}, {"key": "42_CR13", "first-page": "79", "volume": "3", "author": "TJ VanderWeele", "year": "2014", "unstructured": "VanderWeele, T. J. & Knol, M. J. Interactions and complexity: goals and limitations. Epidemiol. Meth. 3, 79\u201381 (2014).", "journal-title": "Epidemiol. Meth."}, {"key": "42_CR14", "doi-asserted-by": "crossref", "first-page": "1432", "DOI": "10.1002/cam4.456", "volume": "4", "author": "CB Begg", "year": "2015", "unstructured": "Begg, C. B. et al. Identifying etiologically distinct sub-types of cancer: a demonstration project involving breast cancer. Cancer Med. 4, 1432\u20131439 (2015).", "journal-title": "Cancer Med."}, {"key": "42_CR15", "doi-asserted-by": "crossref", "first-page": "782", "DOI": "10.1002/sim.6793", "volume": "35", "author": "M Wang", "year": "2016", "unstructured": "Wang, M. et al. Statistical methods for studying disease subtype heterogeneity. Stat. Med. 35, 782\u2013800 (2016).", "journal-title": "Stat. Med"}, {"key": "42_CR16", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1093/aje/kwv040", "volume": "182", "author": "M Wang", "year": "2015", "unstructured": "Wang, M., Kuchiba, A. & Ogino, S. A meta-regression method for studying etiologic heterogeneity across disease subtypes classified by multiple biomarkers. Am. J. Epidemiol. 182, 263\u2013270 (2015).", "journal-title": "Am. J. Epidemiol."}, {"key": "42_CR17", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1007/s10654-017-0253-z", "volume": "32", "author": "L Richiardi", "year": "2017", "unstructured": "Richiardi, L., Barone-Adesi, F. & Pearce, N. Cancer subtypes in aetiological research. Eur. J. Epidemiol. 32, 353\u2013361 (2017).", "journal-title": "Eur. J. Epidemiol."}, {"key": "42_CR18", "unstructured": "Zabor, E. C. & Begg, C. B. A comparison of statistical methods for the study of etiologic heterogeneity. Stat. Med. 36, 4050\u20134060 (2017).", "DOI": "10.1002/sim.7405", "doi-asserted-by": "crossref"}, {"key": "42_CR19", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.3390/molecules22010105", "volume": "22", "author": "T Rescigno", "year": "2017", "unstructured": "Rescigno, T., Micolucci, L., Tecce, M. F. & Capasso, A. Bioactive nutrients and nutrigenomics in age-related diseases. Molecules 22, 105 (2017).", "journal-title": "Molecules"}, {"key": "42_CR20", "doi-asserted-by": "crossref", "first-page": "902674", "DOI": "10.4061/2011/902674", "volume": "2011", "author": "K Curtin", "year": "2011", "unstructured": "Curtin, K., Slattery, M. L. & Samowitz, W. S. CpG island methylation in colorectal cancer: past, present and future. Pathol. Res. Int. 2011, 902674 (2011).", "journal-title": "Pathol. Res. Int."}, {"key": "42_CR21", "doi-asserted-by": "crossref", "first-page": "6055", "DOI": "10.3748/wjg.v20.i20.6055", "volume": "20", "author": "F Bishehsari", "year": "2014", "unstructured": "Bishehsari, F., Mahdavinia, M., Vacca, M., Malekzadeh, R. & Mariani-Costantini, R. Epidemiological transition of colorectal cancer in developing countries: Environmental factors, molecular pathways, and opportunities for prevention. World J. Gastroenterol. 20, 6055\u20136072 (2014).", "journal-title": "World J. Gastroenterol."}, {"key": "42_CR22", "first-page": "163", "volume": "1866", "author": "M Jiang", "year": "2017", "unstructured": "Jiang, M., Dai, J., Gu, D., Huang, Q. & Tian, L. Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials. BBA Rev. Cancer 1866, 163\u2013176 (2017).", "journal-title": "BBA Rev. Cancer"}, {"key": "42_CR23", "author": "J Martinez-Useros", "volume": "14", "year": "2016", "unstructured": "Martinez-Useros, J. & Garcia-Foncillas, J. Obesity and colorectal cancer: molecular features of adipose tissue. J. Transl. Med. 14, 21 (2016).", "journal-title": "J. Transl. Med.", "DOI": "10.1186/s12967-016-0772-5", "doi-asserted-by": "crossref"}, {"key": "42_CR24", "doi-asserted-by": "crossref", "first-page": "1229", "DOI": "10.1158/1055-9965.EPI-15-0094", "volume": "24", "author": "PT Campbell", "year": "2015", "unstructured": "Campbell, P. T. et al. Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype. Cancer Epidemiol. Biomarkers Prev. 24, 1229\u20131238 (2015).", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "42_CR25", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1080/17460441.2017.1271321", "volume": "12", "author": "A Serafino", "year": "2017", "unstructured": "Serafino, A. et al. Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases. Expert Opin. Drug Discov. 12, 169\u2013186 (2017).", "journal-title": "Expert Opin. Drug Discov."}, {"key": "42_CR26", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1016/j.drudis.2016.09.022", "volume": "22", "author": "H Patil", "year": "2017", "unstructured": "Patil, H. et al. Chasing the personalized medicine dream through biomarker validation in colorectal cancer. Drug Discov. Today 22, 111\u2013119 (2017).", "journal-title": "Drug Discov. Today"}, {"key": "42_CR27", "doi-asserted-by": "crossref", "first-page": "6266", "DOI": "10.1158/1078-0432.CCR-15-2765", "volume": "22", "author": "J Kuroiwa-Trzmielina", "year": "2016", "unstructured": "Kuroiwa-Trzmielina, J. et al. SNP rs16906252C>T is an expression and methylation quantitative trait locus associated with an increased risk of developing MGMT-methylated colorectal cancer. Clin. Cancer Res. 22, 6266\u20136277 (2016).", "journal-title": "Clin. Cancer Res."}, {"key": "42_CR28", "doi-asserted-by": "crossref", "first-page": "1152", "DOI": "10.1038/modpathol.2017.38", "volume": "30", "author": "ML Slattery", "year": "2017", "unstructured": "Slattery, M. L. et al. Infrequently expressed miRNAs in colorectal cancer tissue and tumor molecular phenotype. Mod. Pathol. 30, 1152\u20131169 (2017).", "journal-title": "Mod. Pathol."}, {"key": "42_CR29", "unstructured": "Alnabulsi, A. & Murray, G. I. Integrative analysis of the colorectal cancer proteome: potential clinical impact. Expert Rev. Proteomics (2017).", "DOI": "10.1080/14789450.2016.1233062", "doi-asserted-by": "crossref"}, {"key": "42_CR30", "doi-asserted-by": "crossref", "first-page": "1350", "DOI": "10.1093/aje/kwt239", "volume": "178", "author": "LH Kuller", "year": "2013", "unstructured": "Kuller, L. H., Bracken, M. B., Ogino, S., Prentice, R. L. & Tracy, R. P. The role of epidemiology in the era of molecular epidemiology and genomics: Summary of the 2013 AJE-sponsored society of epidemiologic research symposium. Am. J. Epidemiol. 178, 1350\u20131354 (2013).", "journal-title": "Am. J. Epidemiol."}, {"key": "42_CR31", "doi-asserted-by": "crossref", "first-page": "2613", "DOI": "10.1158/1055-9965.EPI-14-0848", "volume": "23", "author": "M Epplein", "year": "2014", "unstructured": "Epplein, M. et al. Challenges and opportunities in international molecular cancer prevention research: An ASPO molecular epidemiology and the environment and international cancer prevention interest groups report. Cancer Epidemiol. Biomarkers Prev. 23, 2613\u20132617 (2014).", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "42_CR32", "doi-asserted-by": "crossref", "first-page": "959", "DOI": "10.1007/s10552-015-0596-2", "volume": "26", "author": "S Ogino", "year": "2015", "unstructured": "Ogino, S. et al. Proceedings of the second international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control 26, 959\u2013972 (2015).", "journal-title": "Cancer Causes Control"}, {"key": "42_CR33", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1007/s10552-016-0845-z", "volume": "28", "author": "PT Campbell", "year": "2017", "unstructured": "Campbell, P. T. et al. Proceedings of the third international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control 28, 167\u2013176 (2017).", "journal-title": "Cancer Causes Control"}, {"key": "42_CR34", "doi-asserted-by": "crossref", "first-page": "2131", "DOI": "10.1056/NEJMoa067208", "volume": "356", "author": "AT Chan", "year": "2007", "unstructured": "Chan, A. T., Ogino, S. & Fuchs, C. S. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N. Engl J. Med. 356, 2131\u20132142 (2007).", "journal-title": "N. Engl J. Med."}, {"key": "42_CR35", "doi-asserted-by": "crossref", "first-page": "2563", "DOI": "10.1001/jama.2013.6599", "volume": "309", "author": "R Nishihara", "year": "2013", "unstructured": "Nishihara, R. et al. Aspirin use and risk of colorectal cancer according to BRAF mutation status. JAMA 309, 2563\u20132571 (2013).", "journal-title": "JAMA"}, {"key": "42_CR36", "doi-asserted-by": "crossref", "first-page": "879", "DOI": "10.1053/j.gastro.2016.07.030", "volume": "151", "author": "Y Cao", "year": "2016", "unstructured": "Cao, Y. et al. Regular aspirin use associates with lower risk of colorectal cancers with low numbers of tumor-infiltrating lymphocytes. Gastroenterology 151, 879\u2013892 (2016).", "journal-title": "Gastroenterology"}, {"key": "42_CR37", "doi-asserted-by": "crossref", "first-page": "1836", "DOI": "10.1200/JCO.2016.70.7547", "volume": "35", "author": "T Hamada", "year": "2017", "unstructured": "Hamada, T. et al. Aspirin use and colorectal cancer survival according to tumor CD274 (PD-L1) expression status. J. Clin. Oncol. 35, 1836\u20131844 (2017).", "journal-title": "J. Clin. Oncol."}, {"key": "42_CR38", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1007/s00535-016-1272-3", "volume": "52", "author": "T Hamada", "year": "2017", "unstructured": "Hamada, T., Keum, N., Nishihara, R. & Ogino, S. Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. J. Gastroenterol. 52, 265\u2013275 (2017).", "journal-title": "J. Gastroenterol"}, {"key": "42_CR39", "unstructured": "Strom, B. L. What is Pharmacoepidemiology? in Textbook of Pharmacoepidemiology (eds Strom, B.L., Kimmel, S.E. & Hennessy, S.) (John Wiley & Sons Ltd, 2013).", "DOI": "10.1002/9781118344828.ch01", "doi-asserted-by": "crossref"}, {"key": "42_CR40", "doi-asserted-by": "crossref", "first-page": "793", "DOI": "10.1056/NEJMp1500523", "volume": "372", "author": "FS Collins", "year": "2015", "unstructured": "Collins, F. S. & Varmus, H. A new initiative on precision medicine. N. Engl J. Med. 372, 793\u2013795 (2015).", "journal-title": "N. Engl J. Med."}, {"key": "42_CR41", "doi-asserted-by": "crossref", "first-page": "2949", "DOI": "10.1038/onc.2013.244", "volume": "33", "author": "S Ogino", "year": "2014", "unstructured": "Ogino, S. et al. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene 33, 2949\u20132955 (2014).", "journal-title": "Oncogene"}, {"key": "42_CR42", "doi-asserted-by": "crossref", "first-page": "16365", "DOI": "10.3390/ijms140816365", "volume": "14", "author": "D Colussi", "year": "2013", "unstructured": "Colussi, D., Brandi, G., Bazzoli, F. & Ricciardiello, L. Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int. J. Mol. Sci. 14, 16365\u201316385 (2013).", "journal-title": "Int. J. Mol. Sci."}, {"key": "42_CR43", "first-page": "269", "volume": "3", "author": "JM Kocarnik", "year": "2015", "unstructured": "Kocarnik, J. M., Shiovitz, S. & Phipps, A. I. Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol. Rep. 3, 269\u2013276 (2015).", "journal-title": "Gastroenterol. Rep."}, {"key": "42_CR44", "doi-asserted-by": "crossref", "first-page": "53959", "DOI": "10.18632/oncotarget.9796", "volume": "7", "author": "AV Kudryavtseva", "year": "2016", "unstructured": "Kudryavtseva, A. V. et al. Important molecular genetic markers of colorectal cancer. Oncotarget 7, 53959\u201353983 (2016).", "journal-title": "Oncotarget"}, {"key": "42_CR45", "doi-asserted-by": "crossref", "first-page": "1787", "DOI": "10.1200/JCO.2014.60.0213", "volume": "33", "author": "R Dienstmann", "year": "2015", "unstructured": "Dienstmann, R., Salazar, R. & Tabernero, J. Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients. J. Clin. Oncol. 33, 1787\u20131796 (2015).", "journal-title": "J. Clin. Oncol."}, {"key": "42_CR46", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1038/nrc.2016.126", "volume": "17", "author": "R Dienstmann", "year": "2017", "unstructured": "Dienstmann, R. et al. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer. Nat. Rev. Cancer 17, 79\u201392 (2017).", "journal-title": "Nat. Rev. Cancer"}, {"key": "42_CR47", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1053/j.gastro.2014.09.038", "volume": "148", "author": "AI Phipps", "year": "2015", "unstructured": "Phipps, A. I. et al. Association between molecular subtypes of colorectal cancer and patient survival. Gastroenterology 148, 77\u201387.e72 (2015).", "journal-title": "Gastroenterology"}, {"key": "42_CR48", "doi-asserted-by": "crossref", "first-page": "350", "DOI": "10.1002/path.2774", "volume": "222", "author": "K Nosho", "year": "2010", "unstructured": "Nosho, K. et al. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer and prognosis: cohort study and literature review. J. Pathol. 222, 350\u2013366 (2010).", "journal-title": "J. Pathol."}, {"key": "42_CR49", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1080/14712598.2017.1315405", "volume": "17", "author": "D Basile", "year": "2017", "unstructured": "Basile, D. et al. Immunotherapy for colorectal cancer: where are we heading? Expert Opin. Biol. Ther. 17, 709\u2013721 (2017).", "journal-title": "Expert Opin. Biol. Ther."}, {"key": "42_CR50", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1002/path.4287", "volume": "232", "author": "J Galon", "year": "2014", "unstructured": "Galon, J. et al. Towards the introduction of the Immunoscore in the classification of malignant tumors. J. Pathol. 232, 199\u2013209 (2014).", "journal-title": "J. Pathol."}, {"key": "42_CR51", "doi-asserted-by": "crossref", "first-page": "1088", "DOI": "10.1111/jcmm.12117", "volume": "17", "author": "G Caro Di", "year": "2013", "unstructured": "Di Caro, G., Marchesi, F., Laghi, L. & Grizzi, F. Immune cells: plastic players along colorectal cancer progression. J. Cell Mol. Med. 17, 1088\u20131095 (2013).", "journal-title": "J. Cell Mol. Med"}, {"key": "42_CR52", "doi-asserted-by": "crossref", "first-page": "698", "DOI": "10.1016/j.immuni.2016.02.025", "volume": "44", "author": "B Mlecnik", "year": "2016", "unstructured": "Mlecnik, B. et al. Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability. Immunity 44, 698\u2013711 (2016).", "journal-title": "Immunity"}, {"key": "42_CR53", "doi-asserted-by": "crossref", "first-page": "djw027", "DOI": "10.1093/jnci/djw027", "volume": "108", "author": "LS Rozek", "year": "2016", "unstructured": "Rozek, L. S. et al. Tumor-Infiltrating lymphocytes, Crohn's-Like lymphoid reaction, and survival from colorectal cancer. J. Natl Cancer Inst. 108, djw027 (2016).", "journal-title": "J. Natl Cancer Inst."}, {"key": "42_CR54", "doi-asserted-by": "crossref", "first-page": "847", "DOI": "10.1136/gutjnl-2011-300865", "volume": "61", "author": "M Yamauchi", "year": "2012", "unstructured": "Yamauchi, M. et al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61, 847\u2013854 (2012).", "journal-title": "Gut"}, {"key": "42_CR55", "doi-asserted-by": "crossref", "first-page": "794", "DOI": "10.1136/gutjnl-2012-302014", "volume": "61", "author": "M Yamauchi", "year": "2012", "unstructured": "Yamauchi, M. et al. Colorectal cancer: a tale of two sides or a continuum? Gut 61, 794\u2013797 (2012).", "journal-title": "Gut"}, {"key": "42_CR56", "doi-asserted-by": "crossref", "first-page": "e65479", "DOI": "10.1371/journal.pone.0065479", "volume": "8", "author": "C Rosty", "year": "2013", "unstructured": "Rosty, C. et al. PIK3CA activating mutation in colorectal carcinoma: Associations with molecular features and survival. PLoS One 8, e65479 (2013).", "journal-title": "PLoS One"}, {"key": "42_CR57", "doi-asserted-by": "crossref", "first-page": "1004", "DOI": "10.1038/bjc.2013.430", "volume": "109", "author": "JM Bae", "year": "2013", "unstructured": "Bae, J. M., Kim, J. H., Cho, N. Y., Kim, T. Y. & Kang, G. H. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location. Br. J. Cancer 109, 1004\u20131012 (2013).", "journal-title": "Br. J. Cancer"}, {"key": "42_CR58", "doi-asserted-by": "crossref", "first-page": "e200", "DOI": "10.1038/ctg.2016.53", "volume": "7", "author": "K Mima", "year": "2016", "unstructured": "Mima, K. et al. Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location. Clin. Transl. Gastroenterol. 7, e200 (2016).", "journal-title": "Clin. Transl. Gastroenterol."}, {"key": "42_CR59", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1038/nrc.2016.4", "volume": "16", "author": "DA Drew", "year": "2016", "unstructured": "Drew, D. A., Cao, Y. & Chan, A. T. Aspirin and colorectal cancer: the promise of precision chemoprevention. Nat. Rev. Cancer 16, 173\u2013186 (2016).", "journal-title": "Nat. Rev. Cancer"}, {"key": "42_CR60", "doi-asserted-by": "crossref", "first-page": "1419", "DOI": "10.1136/gutjnl-2014-308260", "volume": "64", "author": "P Li", "year": "2015", "unstructured": "Li, P. et al. Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis. Gut 64, 1419\u20131425 (2015).", "journal-title": "Gut"}, {"key": "42_CR61", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1007/s11888-014-0247-0", "volume": "10", "author": "K Herbert", "year": "2014", "unstructured": "Herbert, K., Kerr, R., Kerr, D. J. & Church, D. N. Are NSAIDs coming back to colorectal cancer therapy or not? Curr. Colorectal. Cancer Rep. 10, 363\u2013371 (2014).", "journal-title": "Curr. Colorectal. Cancer Rep."}, {"key": "42_CR62", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1053/j.seminoncol.2015.09.010", "volume": "43", "author": "A Umar", "year": "2016", "unstructured": "Umar, A., Steele, V. E., Menter, D. & Hawk, E. T. Mechanisms of non-steroidal anti-inflammatory drugs (NSAIDs) in cancer prevention. Semin. Oncol. 43, 67\u201377 (2016).", "journal-title": "Semin. Oncol."}, {"key": "42_CR63", "doi-asserted-by": "crossref", "first-page": "166", "DOI": "10.1093/gastro/got022", "volume": "1", "author": "MS Reimers", "year": "2013", "unstructured": "Reimers, M. S., Zeestraten, E. C., Kuppen, P. J., Liefers, G. J. & van de Velde, J. H. Biomarkers in precision therapy in colorectal cancer. Gastroenterol. Rep. 1, 166\u2013183 (2013).", "journal-title": "Gastroenterol. Rep."}, {"key": "42_CR64", "doi-asserted-by": "crossref", "first-page": "762", "DOI": "10.1001/jamaoncol.2015.6396", "volume": "2", "author": "Y Cao", "year": "2016", "unstructured": "Cao, Y. et al. Population-wide impact of long-term use of aspirin and the risk for cancer. JAMA Oncol. 2, 762\u2013769 (2016).", "journal-title": "JAMA Oncol"}, {"key": "42_CR65", "doi-asserted-by": "crossref", "first-page": "561", "DOI": "10.1038/nrclinonc.2012.137", "volume": "9", "author": "WK Chia", "year": "2012", "unstructured": "Chia, W. K., Ali, R. & Toh, H. C. Aspirin as adjuvant therapy for colorectal cancer-reinterpreting paradigms. Nat. Rev. Clin. Oncol. 9, 561\u2013570 (2012).", "journal-title": "Nat. Rev. Clin. Oncol."}, {"key": "42_CR66", "doi-asserted-by": "crossref", "first-page": "1087", "DOI": "10.1158/1078-0432.CCR-13-2563", "volume": "20", "author": "D Tougeron", "year": "2014", "unstructured": "Tougeron, D., Sha, D., Manthravadi, S. & Sinicrope, F. A. Aspirin and colorectal cancer: Back to the future. Clin Cancer Res. 20, 1087\u20131094 (2014).", "journal-title": "Clin Cancer Res."}, {"key": "42_CR67", "doi-asserted-by": "crossref", "first-page": "1852", "DOI": "10.1093/jnci/djt331", "volume": "105", "author": "H Nan", "year": "2013", "unstructured": "Nan, H. et al. Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations. J. Natl Cancer. Inst. 105, 1852\u20131861 (2013).", "journal-title": "J. Natl Cancer. Inst."}, {"key": "42_CR68", "doi-asserted-by": "crossref", "first-page": "649", "DOI": "10.1001/jama.2009.1112", "volume": "302", "author": "AT Chan", "year": "2009", "unstructured": "Chan, A. T., Ogino, S. & Fuchs, C. S. Aspirin use and survival after diagnosis of colorectal cancer. JAMA 302, 649\u2013658 (2009).", "journal-title": "JAMA"}, {"key": "42_CR69", "doi-asserted-by": "crossref", "first-page": "1808", "DOI": "10.1158/1940-6207.CAPR-11-0113", "volume": "4", "author": "JE Lee", "year": "2011", "unstructured": "Lee, J. E. et al. Statin use and colorectal cancer risk according to molecular subtypes in two large prospective cohort studies. Cancer Prev. Res. 4, 1808\u20131815 (2011).", "journal-title": "Cancer Prev. Res."}, {"key": "42_CR70", "doi-asserted-by": "crossref", "first-page": "3229", "DOI": "10.1200/JCO.2011.39.2670", "volume": "30", "author": "H Khalili", "year": "2012", "unstructured": "Khalili, H., Huang, E. S., Ogino, S., Fuchs, C. S. & Chan, A. T. A prospective study of bisphosphonate use and risk of colorectal cancer. J. Clin. Oncol. 30, 3229\u20133233 (2012).", "journal-title": "J. Clin. Oncol."}, {"key": "42_CR71", "doi-asserted-by": "crossref", "first-page": "1596", "DOI": "10.1056/NEJMoa1207756", "volume": "367", "author": "X Liao", "year": "2012", "unstructured": "Liao, X. et al. Aspirin use, tumor PIK3CA mutation status, and colorectal cancer survival. N. Engl. J. Med. 367, 1596\u20131606 (2012).", "journal-title": "N. Engl. J. Med."}, {"key": "42_CR72", "first-page": "233re232", "volume": "6", "author": "SP Fink", "year": "2014", "unstructured": "Fink, S. P. et al. Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD). Sci. Transl. Med. 6, 233re232 (2014).", "journal-title": "Sci. Transl. Med."}, {"key": "42_CR73", "doi-asserted-by": "crossref", "first-page": "1836", "DOI": "10.1093/annonc/mdw264", "volume": "27", "author": "Z Mei", "year": "2016", "unstructured": "Mei, Z., Duan, C., Li, C., Cui, L. & Ogino, S. Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis. Ann. Oncol. 27, 1836\u20131848 (2016).", "journal-title": "Ann. Oncol."}, {"key": "42_CR74", "doi-asserted-by": "crossref", "first-page": "594", "DOI": "10.1016/S1470-2045(10)70209-6", "volume": "12", "author": "W Roock De", "year": "2011", "unstructured": "De Roock, W., Vriendt, V. D., Normanno, N., Ciardiello, F. & Tejpar, S. KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer. Lancet Oncol. 12, 594\u2013603 (2011).", "journal-title": "Lancet Oncol"}, {"key": "42_CR75", "doi-asserted-by": "crossref", "first-page": "2257", "DOI": "10.1158/1078-0432.CCR-11-2410", "volume": "18", "author": "X Liao", "year": "2012", "unstructured": "Liao, X. et al. Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review. Clin. Cancer Res. 18, 2257\u20132268 (2012).", "journal-title": "Clin. Cancer Res."}, {"key": "42_CR76", "doi-asserted-by": "crossref", "first-page": "2153", "DOI": "10.1038/bjc.2013.212", "volume": "108", "author": "V Eklof", "year": "2013", "unstructured": "Eklof, V. et al. The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer. Br. J. Cancer 108, 2153\u20132163 (2013).", "journal-title": "Br. J. Cancer"}, {"key": "42_CR77", "doi-asserted-by": "crossref", "first-page": "371", "DOI": "10.1002/cam4.370", "volume": "4", "author": "G Manceau", "year": "2015", "unstructured": "Manceau, G. et al. PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer. Cancer Med. 4, 371\u2013382 (2015).", "journal-title": "Cancer Med"}, {"key": "42_CR78", "doi-asserted-by": "crossref", "first-page": "1038", "DOI": "10.2119/molmed.2015.00220", "volume": "21", "author": "F Vogelaar", "year": "2015", "unstructured": "Vogelaar, F. et al. The prognostic value of microsatellite Instability, KRAS, BRAF and PIK3CA mutations in stage II colon cancer patients. Mol. Med. 21, 1038\u20131046 (2015).", "journal-title": "Mol. Med."}, {"key": "42_CR79", "doi-asserted-by": "crossref", "first-page": "1789", "DOI": "10.1093/jnci/djt298", "volume": "105", "author": "S Ogino", "year": "2013", "unstructured": "Ogino, S. et al. Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial. J. Natl Cancer Inst. 105, 1789\u20131798 (2013).", "journal-title": "J. Natl Cancer Inst."}, {"key": "42_CR80", "doi-asserted-by": "crossref", "first-page": "4297", "DOI": "10.1200/JCO.2013.50.0322", "volume": "31", "author": "E Domingo", "year": "2013", "unstructured": "Domingo, E. et al. Evaluation of PIK3CA mutation as a predictor of benefit from NSAID therapy in colorectal cancer. J. Clin. Oncol. 31, 4297\u20134305 (2013).", "journal-title": "J. Clin. Oncol."}, {"key": "42_CR81", "doi-asserted-by": "crossref", "first-page": "732", "DOI": "10.1001/jamainternmed.2014.511", "volume": "174", "author": "MS Reimers", "year": "2014", "unstructured": "Reimers, M. S. et al. Expression of HLA Class I antigen, aspirin use, and survival after a diagnosis of colon cancer. JAMA Intern. Med. 174, 732\u2013739 (2014).", "journal-title": "JAMA Intern. Med."}, {"key": "42_CR82", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.3109/0284186X.2014.990158", "volume": "54", "author": "N Kothari", "year": "2015", "unstructured": "Kothari, N. et al. Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation. Acta Oncol. 54, 487\u2013492 (2015).", "journal-title": "Acta Oncol"}, {"key": "42_CR83", "doi-asserted-by": "crossref", "first-page": "e91", "DOI": "10.1038/ctg.2017.18", "volume": "8", "author": "RT Gray", "year": "2017", "unstructured": "Gray, R. T. et al. Evaluation of PTGS2 expression, PIK3CA mutation, aspirin use and colon cancer survival in a population-based cohort study. Clin. Transl. Gastroenterol. 8, e91 (2017).", "journal-title": "Clin. Transl. Gastroenterol."}, {"key": "42_CR84", "doi-asserted-by": "crossref", "first-page": "317", "DOI": "10.1016/j.clon.2015.11.008", "volume": "28", "author": "L Paleari", "year": "2016", "unstructured": "Paleari, L. et al. PIK3CA mutation, aspirin use after diagnosis and survival of colorectal cancer. A systematic review and meta-analysis of epidemiological studies. Clin. Oncol. 28, 317\u2013326 (2016).", "journal-title": "Clin. Oncol."}, {"key": "42_CR85", "doi-asserted-by": "crossref", "first-page": "208", "DOI": "10.1158/1940-6207.CAPR-16-0175", "volume": "10", "author": "TJ Zumwalt", "year": "2017", "unstructured": "Zumwalt, T. J. et al. Aspirin-induced chemoprevention and response kinetics are enhanced by PIK3CA mutations in colorectal cancer cells. Cancer Prev. Res. 10, 208\u2013218 (2017).", "journal-title": "Cancer Prev. Res."}, {"key": "42_CR86", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1007/s10549-016-3729-8", "volume": "156", "author": "SB Turturro", "year": "2016", "unstructured": "Turturro, S. B., Najor, M. S., Ruby, C. E., Cobleigh, M. A. & Abukhdeir, A. M. Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin. Breast Cancer Res. Treat. 156, 33\u201343 (2016).", "journal-title": "Breast Cancer Res. Treat."}, {"key": "42_CR87", "author": "R Ali", "volume": "12", "year": "2011", "unstructured": "Ali, R., Toh, H. C. & Chia, W. K. The utility of aspirin in Dukes C and high risk Dukes B colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial. Trials 12, 261 (2011).", "journal-title": "Trials"}, {"key": "42_CR88", "doi-asserted-by": "crossref", "first-page": "36", "DOI": "10.1053/j.gastro.2016.10.015", "volume": "152", "author": "B Jung", "year": "2017", "unstructured": "Jung, B., Staudacher, J. J. & Beauchamp, D. Transforming growth factor beta superfamily signaling in development of colorectal cancer. Gastroenterology 152, 36\u201352 (2017).", "journal-title": "Gastroenterology"}, {"key": "42_CR89", "doi-asserted-by": "crossref", "first-page": "17468", "DOI": "10.1073/pnas.0406142101", "volume": "101", "author": "M Yan", "year": "2004", "unstructured": "Yan, M. et al. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers. Proc. Natl Acad. Sci. USA 101, 17468\u201317473 (2004).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "42_CR90", "doi-asserted-by": "crossref", "first-page": "12098", "DOI": "10.1073/pnas.0603235103", "volume": "103", "author": "SJ Myung", "year": "2006", "unstructured": "Myung, S. J. et al. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proc. Natl Acad. Sci. USA 103, 12098\u201312102 (2006).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "42_CR91", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1136/gutjnl-2015-309996", "volume": "66", "author": "HK Roy", "year": "2017", "unstructured": "Roy, H. K. et al. Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin. Gut 66, 285\u2013292 (2017).", "journal-title": "Gut"}, {"key": "42_CR92", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1038/nrclinonc.2016.162", "volume": "14", "author": "JP O'Connor", "year": "2017", "unstructured": "O'Connor, J. P. et al. Imaging biomarker roadmap for cancer studies. Nat. Rev. Clin. Oncol. 14, 169\u2013186 (2017).", "journal-title": "Nat. Rev. Clin. Oncol."}, {"key": "42_CR93", "doi-asserted-by": "crossref", "first-page": "1133", "DOI": "10.1001/jama.2015.1815", "volume": "313", "author": "H Nan", "year": "2015", "unstructured": "Nan, H. et al. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA 313, 1133\u20131142 (2015).", "journal-title": "JAMA"}, {"key": "42_CR94", "doi-asserted-by": "crossref", "first-page": "625", "DOI": "10.1038/nrclinonc.2013.169", "volume": "10", "author": "N Gronich", "year": "2013", "unstructured": "Gronich, N. & Rennert, G. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates. Nat. Rev. Clin. Oncol. 10, 625\u2013642 (2013).", "journal-title": "Nat. Rev. Clin. Oncol."}, {"key": "42_CR95", "doi-asserted-by": "crossref", "first-page": "1540", "DOI": "10.1093/jnci/djr307", "volume": "103", "author": "K Ng", "year": "2011", "unstructured": "Ng, K. et al. Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803. J. Natl Cancer Inst. 103, 1540\u20131551 (2011).", "journal-title": "J. Natl Cancer Inst."}, {"key": "42_CR96", "doi-asserted-by": "crossref", "first-page": "732", "DOI": "10.1038/nrclinonc.2015.169", "volume": "12", "author": "F Bertolini", "year": "2015", "unstructured": "Bertolini, F., Sukhatme, V. P. & Bouche, G. Drug repurposing in oncology--patient and health systems opportunities. Nat. Rev. Clin. Oncol. 12, 732\u2013742 (2015).", "journal-title": "Nat. Rev. Clin. Oncol."}, {"key": "42_CR97", "doi-asserted-by": "crossref", "first-page": "986", "DOI": "10.1056/NEJMsb1609101", "volume": "376", "author": "KM Emmons", "year": "2017", "unstructured": "Emmons, K. M. & Colditz, G. A. Realizing the potential of cancer prevention-the role of implementation science. N. Engl J. Med. 376, 986\u2013990 (2017).", "journal-title": "N. Engl J. Med"}, {"key": "42_CR98", "doi-asserted-by": "crossref", "first-page": "843", "DOI": "10.1038/ni.3754", "volume": "18", "author": "L Zitvogel", "year": "2017", "unstructured": "Zitvogel, L., Pietrocola, F. & Kroemer, G. Nutrition, inflammation and cancer. Nat. Immunol. 18, 843\u2013850 (2017).", "journal-title": "Nat. Immunol."}, {"key": "42_CR99", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1038/nrmicro.2016.17", "volume": "14", "author": "P Spanogiannopoulos", "year": "2016", "unstructured": "Spanogiannopoulos, P., Bess, E. N., Carmody, R. N. & Turnbaugh, P. J. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat. Rev. Microbiol. 14, 273\u2013287 (2016).", "journal-title": "Nat. Rev. Microbiol."}, {"key": "42_CR100", "unstructured": "Cao, Y. et al. Long-term use of antibiotics and risk of colorectal adenoma. Gut (2018).", "DOI": "10.1158/1538-7445.CRC16-A24", "doi-asserted-by": "crossref"}, {"key": "42_CR101", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1126/science.aan6733", "volume": "357", "author": "DT Le", "year": "2017", "unstructured": "Le, D. T. et al. Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357, 409\u2013413 (2017).", "journal-title": "Science"}, {"key": "42_CR102", "doi-asserted-by": "crossref", "first-page": "1036", "DOI": "10.1126/science.1136099", "volume": "316", "author": "S Wuchty", "year": "2007", "unstructured": "Wuchty, S., Jones, B. F. & Uzzi, B. The increasing dominance of teams in production of knowledge. Science 316, 1036\u20131039 (2007).", "journal-title": "Science"}, {"key": "42_CR103", "doi-asserted-by": "crossref", "first-page": "684", "DOI": "10.1038/nature18315", "volume": "534", "author": "L Bromham", "year": "2016", "unstructured": "Bromham, L., Dinnage, R. & Hua, X. Interdisciplinary research has consistently lower funding success. Nature 534, 684\u2013687 (2016).", "journal-title": "Nature"}], "container-title": ["npj Precision Oncology"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/s41698-017-0042-x.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41698-017-0042-x", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41698-017-0042-x.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 7]], "date-time": "2019-10-07T04:30:44Z", "timestamp": 1570422644000}, "score": 23.564009, "issued": {"date-parts": [[2017, 12]]}, "references-count": 103, "journal-issue": {"published-print": {"date-parts": [[2017, 12]]}, "issue": "1"}, "alternative-id": ["42"], "URL": "http://dx.doi.org/10.1038/s41698-017-0042-x", "relation": {"cites": []}, "ISSN": ["2397-768X"], "issn-type": [{"value": "2397-768X", "type": "electronic"}], "article-number": "40"}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:10:19Z", "timestamp": 1574719819643}, "publisher-location": "New York, NY", "reference-count": 142, "publisher": "Springer New York", "isbn-type": [{"value": "9781493928859", "type": "print"}, {"value": "9781493928866", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2015]]}, "DOI": "10.1007/978-1-4939-2886-6_16", "type": "book-chapter", "created": {"date-parts": [[2015, 8, 12]], "date-time": "2015-08-12T08:51:12Z", "timestamp": 1439369472000}, "page": "271-289", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Molecular Pathology of Breast Cancer Metastasis"], "prefix": "10.1007", "author": [{"given": "Mohammed A.", "family": "Aleskandarany", "sequence": "first", "affiliation": []}, {"given": "Ian O.", "family": "Ellis", "sequence": "additional", "affiliation": []}, {"given": "Emad A.", "family": "Rakha", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 8, 13]]}, "reference": [{"issue": "1", "key": "16_CR1", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1016/S0092-8674(00)81683-9", "volume": "100", "author": "D Hanahan", "year": "2000", "unstructured": "Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57\u201370.", "journal-title": "Cell"}, {"issue": "12", "key": "16_CR2", "doi-asserted-by": "publisher", "first-page": "1668", "DOI": "10.1016/S0959-8049(03)00273-9", "volume": "39", "author": "GW Sledge", "year": "2003", "unstructured": "Sledge GW, Miller KD. Exploiting the hallmarks of cancer: the future conquest of breast cancer. Eur J Cancer. 2003;39(12):1668\u201375.", "journal-title": "Eur J Cancer"}, {"issue": "6", "key": "16_CR3", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.1007/s001090050128", "volume": "75", "author": "MW Beckmann", "year": "1997", "unstructured": "Beckmann MW, Niederacher D, Schn\u00fcrch HG, Gusterson BA, Bender HG. Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med. 1997;75(6):429\u201339.", "journal-title": "J Mol Med"}, {"issue": "6", "key": "16_CR4", "doi-asserted-by": "publisher", "first-page": "453", "DOI": "10.1038/nrc1098", "volume": "3", "author": "IJ Fidler", "year": "2003", "unstructured": "Fidler IJ. The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer. 2003;3(6):453\u20138.", "journal-title": "Nat Rev Cancer"}, {"key": "16_CR5", "unstructured": "Weinberg RA. Mechanisms of malignant progression. Carcinogenesis. 2008;29(6):1092\u20131095. PubMed PMID: 18453542. Epub 2008/05/06. eng.", "DOI": "10.1093/carcin/bgn104", "doi-asserted-by": "crossref"}, {"key": "16_CR6", "unstructured": "Rabbani SA, Mazar AP. Evaluating distant metastases in breast cancer: from biology to outcomes. Cancer Metastasis Rev. 2007;26(3\u20134):663\u2013674. PubMed PMID: 17823779. Epub 2007/09/08. eng.", "DOI": "10.1007/s10555-007-9085-8", "doi-asserted-by": "crossref"}, {"key": "16_CR7", "unstructured": "Nicolini A, Giardino R, Carpi A, Ferrari P, Anselmi L, Colosimo S, et al. Metastatic breast cancer: an updating. Biomed Pharmacother. 2006;60(9):548\u2013556. PubMed PMID: 16950593. Epub 2006/09/05. eng.", "DOI": "10.1016/j.biopha.2006.07.086", "doi-asserted-by": "crossref"}, {"key": "16_CR8", "unstructured": "Weigelt B, Peterse JL, van \u2018t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5(8):591\u2013602. PubMed PMID: 16056258. Epub 2005/08/02. eng.", "DOI": "10.1038/nrc1670", "doi-asserted-by": "crossref"}, {"key": "16_CR9", "unstructured": "Duffy MJ, McGowan PM, Gallagher WM. Cancer invasion and metastasis: changing views. J Pathol. 2008;214(3):283\u2013293. PubMed PMID: 18095256. Epub 2007/12/21. eng.", "DOI": "10.1002/path.2282", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "16_CR10", "doi-asserted-by": "publisher", "first-page": "170", "DOI": "10.1093/jnci/djp482", "volume": "102", "author": "BA Virnig", "year": "2010", "unstructured": "Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170\u20138.", "journal-title": "J Natl Cancer Inst"}, {"key": "16_CR11", "unstructured": "Christofori G. New signals from the invasive front. Nature. 2006;441(7092):444\u2013450. PubMed PMID: 16724056. Epub 2006/05/26. eng.", "DOI": "10.1038/nature04872", "doi-asserted-by": "crossref"}, {"key": "16_CR12", "unstructured": "Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127(4):679\u2013695. PubMed PMID: 17110329. Epub 2006/11/18. eng.", "DOI": "10.1016/j.cell.2006.11.001", "doi-asserted-by": "crossref"}, {"key": "16_CR13", "unstructured": "Shchors K, Evan G. Tumor angiogenesis: cause or consequence of cancer? Cancer Res. 2007;67(15):7059\u20137061. PubMed PMID: 17671171. Epub 2007/08/03. eng.", "DOI": "10.1158/0008-5472.CAN-07-2053", "doi-asserted-by": "crossref"}, {"key": "16_CR14", "unstructured": "Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2(6):442\u2013454. PubMed PMID: 12189386. Epub 2002/08/22. eng.", "DOI": "10.1038/nrc822", "doi-asserted-by": "crossref"}, {"issue": "5", "key": "16_CR15", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1038/nrg2101", "volume": "8", "author": "DX Nguyen", "year": "2007", "unstructured": "Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet. 2007;8(5):341\u201352.", "journal-title": "Nat Rev Genet"}, {"key": "16_CR16", "unstructured": "Schmidt S, Friedl P. Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms. Cell Tissue Res. 2010;339(1):83\u201392. PubMed PMID: 19921267. Epub 2009/11/19. eng.", "DOI": "10.1007/s00441-009-0892-9", "doi-asserted-by": "crossref"}, {"key": "16_CR17", "unstructured": "Knust E. Regulation of epithelial cell shape and polarity by cell-cell adhesion (Review). Mol Membr Biol. 2002;19(2):113\u2013120. PubMed PMID: 12126229. Epub 2002/07/20. eng.", "DOI": "10.1080/09687680210137219", "doi-asserted-by": "crossref"}, {"key": "16_CR18", "unstructured": "Friedl P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol. 2004;16(1):14\u201323. PubMed PMID: 15037300. Epub 2004/03/24. eng.", "DOI": "10.1016/j.ceb.2003.11.001", "doi-asserted-by": "crossref"}, {"key": "16_CR19", "unstructured": "Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7(2):131\u2013142. PubMed PMID: 16493418. Epub 2006/02/24. eng.", "DOI": "10.1038/nrm1835", "doi-asserted-by": "crossref"}, {"key": "16_CR20", "unstructured": "Moustakas A, Heldin CH. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007;98(10):1512\u20131520. PubMed PMID: 17645776. Epub 2007/07/25. eng.", "DOI": "10.1111/j.1349-7006.2007.00550.x", "doi-asserted-by": "crossref"}, {"key": "16_CR21", "unstructured": "Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. 2006 20060222 DCOM- 20060317(1471-0072 (Print)). eng."}, {"key": "16_CR22", "unstructured": "Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, et al. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010;101(2):293\u2013239. PubMed PMID: 19961486. Epub 2009/12/08. eng.", "DOI": "10.1111/j.1349-7006.2009.01419.x", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "16_CR23", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1007/s10911-010-9184-y", "volume": "15", "author": "R Cardiff", "year": "2010", "unstructured": "Cardiff R. The Pathology of EMT in Mouse Mammary Tumorigenesis. J Mammary Gland Biol Neoplasia. 2010;15(2):225\u201333.", "journal-title": "J Mammary Gland Biol Neoplasia"}, {"key": "16_CR24", "unstructured": "Tomaskovic-Crook E, Thompson EW, Thiery JP. Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res. 2009;11(6):213. PubMed PMID: 19909494. Epub 2009/11/17. eng.", "DOI": "10.1186/bcr2416", "doi-asserted-by": "crossref"}, {"key": "16_CR25", "unstructured": "Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9(4):265\u2013273. PubMed PMID: 19262571. Epub 2009/03/06. eng.", "DOI": "10.1038/nrc2620", "doi-asserted-by": "crossref"}, {"key": "16_CR26", "unstructured": "Barak V, Goike H, Panaretakis KW, Einarsson R. Clinical utility of cytokeratins as tumor markers. Clin Biochem. 2004;37(7):529\u2013540. PubMed PMID: 15234234. Epub 2004/07/06. eng.", "DOI": "10.1016/j.clinbiochem.2004.05.009", "doi-asserted-by": "crossref"}, {"key": "16_CR27", "unstructured": "Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol. 2008;129(6):705\u2013733. PubMed PMID: 18461349. Epub 2008/05/08. eng.", "DOI": "10.1007/s00418-008-0435-6", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "16_CR28", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1016/0092-8674(82)90400-7", "volume": "31", "author": "R Moll", "year": "1982", "unstructured": "Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31(1):11\u201324.", "journal-title": "Cell"}, {"key": "16_CR29", "unstructured": "Wu Y, Zhou BP. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai). 2008;40(7):643\u2013650. PubMed PMID: 18604456. Epub 2008/07/08. eng.", "DOI": "10.1111/j.1745-7270.2008.00443.x", "doi-asserted-by": "crossref"}, {"key": "16_CR30", "unstructured": "Xue C, Plieth D, Venkov C, Xu C, Neilson EG. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res. 2003;63(12):3386\u20133394. PubMed PMID: 12810675. Epub 2003/06/18. eng."}, {"issue": "14", "key": "16_CR31", "doi-asserted-by": "publisher", "first-page": "5996", "DOI": "10.1158/0008-5472.CAN-05-0699", "volume": "65", "author": "D Tarin", "year": "2005", "unstructured": "Tarin D. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 2005;65(14):5996\u20136001.", "journal-title": "Cancer Res"}, {"key": "16_CR32", "unstructured": "Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell. 2006;9(4):261\u2013272. PubMed PMID: 16616332. Epub 2006/04/18. eng.", "DOI": "10.1016/j.ccr.2006.03.010", "doi-asserted-by": "crossref"}, {"issue": "11", "key": "16_CR33", "doi-asserted-by": "publisher", "first-page": "1287", "DOI": "10.1038/ncb1973", "volume": "11", "author": "S Giampieri", "year": "2009", "unstructured": "Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E. Localized and reversible TGF[beta] signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol. 2009;11(11):1287\u201396.", "journal-title": "Nat Cell Biol"}, {"key": "16_CR34", "unstructured": "Tse JC, Kalluri R. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem. 2007;101(4):816-29. PubMed PMID: 17243120. Epub 2007/01/24. eng.", "DOI": "10.1002/jcb.21215", "doi-asserted-by": "crossref"}, {"key": "16_CR35", "unstructured": "Wendt MK, Smith JA, Schiemann WP. Transforming growth factor-beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene. 2010;29(49):6485\u20136498. PubMed PMID: 20802523. Epub 2010/08/31. eng.", "DOI": "10.1038/onc.2010.377", "doi-asserted-by": "crossref"}, {"key": "16_CR36", "unstructured": "Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117(7):927\u2013939. PubMed PMID: 15210113. Epub 2004/06/24. eng.", "DOI": "10.1016/j.cell.2004.06.006", "doi-asserted-by": "crossref"}, {"key": "16_CR37", "unstructured": "Lamouille S, Derynck R. Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-beta-induced epithelial-mesenchymal transition. Cells Tissues Organs. 2011;193(1\u20132):8\u201322. PubMed PMID: 21041997. Epub 2010/11/03. eng.", "DOI": "10.1159/000320172", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "16_CR38", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1002/path.2508", "volume": "218", "author": "A Albasri", "year": "2009", "unstructured": "Albasri A, Seth R, Jackson D, Benhasouna A, Crook S, Nateri AS, et al. C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer. J Pathol. 2009;218(1):57\u201365.", "journal-title": "J Pathol"}, {"key": "16_CR39", "unstructured": "Moyret-Lalle C, Ruiz E, Puisieux A. Epithelial-mesenchymal transition transcription factors and miRNAs: \u201cPlastic surgeons\u201d of breast cancer. World J Clin Oncol. 2014;5(3):311\u2013322. PubMed PMID: 25114847. Pubmed Central PMCID: PMC4127603. Epub 2014/08/13. eng.", "DOI": "10.5306/wjco.v5.i3.311", "doi-asserted-by": "crossref"}, {"key": "16_CR40", "unstructured": "Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol. 2004;48(5\u20136):365\u2013375. PubMed PMID: 15349812. Epub 2004/09/07. eng.", "DOI": "10.1387/ijdb.041794hp", "doi-asserted-by": "crossref"}, {"key": "16_CR41", "unstructured": "Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci. 2004;1014:155\u2013163. PubMed PMID: 15153430. Epub 2004/05/22. eng.", "DOI": "10.1196/annals.1294.016", "doi-asserted-by": "crossref"}, {"issue": "S1", "key": "16_CR42", "doi-asserted-by": "publisher", "first-page": "S1", "DOI": "10.1002/path.2770", "volume": "222", "author": "M Aleskandarany", "year": "2010", "unstructured": "Aleskandarany M, Green A, Rakha E, Powe D, Ellis I. Epithelial mesenchymal transition in invasive breast carcinoma: molecular pathways and relation to molecular subtypes. J Pathol. 2010;222(S1):S1\u201351.", "journal-title": "J Pathol"}, {"key": "16_CR43", "unstructured": "Yoder BJ, Wilkinson EJ, Massoll NA. Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast. Breast J. 2007;13(2):172\u2013179. PubMed PMID: 17319859.", "DOI": "10.1111/j.1524-4741.2007.00393.x", "doi-asserted-by": "crossref"}, {"issue": "5", "key": "16_CR44", "doi-asserted-by": "publisher", "first-page": "615", "DOI": "10.1136/jcp.2007.053991", "volume": "61", "author": "B Mahler-Araujo", "year": "2008", "unstructured": "Mahler-Araujo B, Savage K, Parry S, Reis-Filho JS. Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype. J Clin Pathol. 2008;61(5):615\u201320.", "journal-title": "J Clin Pathol"}, {"key": "16_CR45", "unstructured": "Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 2008;68(4):989\u2013997. PubMed PMID: 18281472. Epub 2008/02/19. eng.", "DOI": "10.1158/0008-5472.CAN-07-2017", "doi-asserted-by": "crossref"}, {"key": "16_CR46", "unstructured": "Aleskandarany MA, Negm OH, Green AR, Ahmed MA, Nolan CC, Tighe PJ, et al. Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study. Breast Cancer Res Treat. 2014;145(2):339\u2013348. PubMed PMID: 24771047. Epub 2014/04/29. eng.", "DOI": "10.1007/s10549-014-2927-5", "doi-asserted-by": "crossref"}, {"key": "16_CR47", "unstructured": "Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125(Pt 23):5591\u20135596. PubMed PMID: 23420197. Epub 2013/02/20. eng.", "DOI": "10.1242/jcs.116392", "doi-asserted-by": "crossref"}, {"key": "16_CR48", "unstructured": "Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006 05//print;6(5):392\u2013401.", "DOI": "10.1038/nrc1877", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "16_CR49", "doi-asserted-by": "publisher", "first-page": "283", "DOI": "10.1002/path.4298", "volume": "232", "author": "LE Drake", "year": "2014", "unstructured": "Drake LE, Macleod KF. Tumour suppressor gene function in carcinoma-associated fibroblasts: from tumour cells via EMT and back again? J Pathol. 2014;232(3):283\u20138.", "journal-title": "J Pathol"}, {"key": "16_CR50", "unstructured": "Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nature Genet. 2002;32(3):355\u2013357. PubMed PMID: 12379854. Epub 2002/10/16. eng.", "DOI": "10.1038/ng1013", "doi-asserted-by": "crossref"}, {"key": "16_CR51", "unstructured": "Phan-Lai V, Florczyk SJ, Kievit FM, Wang K, Gad E, Disis ML, et al. Three-dimensional scaffolds to evaluate tumor associated fibroblast-mediated suppression of breast tumor specific T cells. Biomacromolecules. 2013;14(5):1330\u20131337. PubMed PMID: 23517456. Pubmed Central PMCID: PMC3664178. Epub 2013/03/23. eng.", "DOI": "10.1021/bm301928u", "doi-asserted-by": "crossref"}, {"key": "16_CR52", "unstructured": "Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton. Cancer cell. 2006;9(4):261\u2013272.", "DOI": "10.1016/j.ccr.2006.03.010", "doi-asserted-by": "crossref"}, {"key": "16_CR53", "unstructured": "Fridman WH, Pag\u00e8s F, Saut\u00e8s-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298\u2013306.", "DOI": "10.1038/nrc3245", "doi-asserted-by": "crossref"}, {"key": "16_CR54", "unstructured": "Schoenborn JR, Wilson CB. Regulation of interferon\u2010\u03b3 during innate and adaptive immune responses. In: Frederick WA, editor. Advances in immunology 96: Academic Press; 2007. p. 41\u2013101.", "DOI": "10.1016/S0065-2776(07)96002-2", "doi-asserted-by": "crossref"}, {"key": "16_CR55", "unstructured": "Hsieh CS, Lee HM, Lio CW. Selection of regulatory T cells in the thymus. Nat Rev Immunol. 2012;12(3):157\u2013167. PubMed PMID: 22322317. Epub 2012/02/11. eng.", "DOI": "10.1038/nri3155", "doi-asserted-by": "crossref"}, {"key": "16_CR56", "unstructured": "Jaberipour M, Habibagahi M, Hosseini A, Habibabad SR, Talei A, Ghaderi A. Increased CTLA-4 and FOXP3 transcripts in peripheral blood mononuclear cells of patients with breast cancer. Pathol Oncol Res. 2010;16(4):547\u2013551. PubMed PMID: 20306312. Epub 2010/03/23. eng.", "DOI": "10.1007/s12253-010-9256-8", "doi-asserted-by": "crossref"}, {"key": "16_CR57", "unstructured": "Campbell DJ, Koch MA. Treg cells: patrolling a dangerous neighborhood. 2011.", "DOI": "10.1038/nm.2433", "doi-asserted-by": "crossref"}, {"key": "16_CR58", "unstructured": "Mahmoud SM, Lee AH, Paish EC, Macmillan RD, Ellis IO, Green AR. The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Breast Cancer Res Treat. 2012;132(2):545\u2013553. PubMed PMID: 21671016. Epub 2011/06/15. eng.", "DOI": "10.1007/s10549-011-1620-1", "doi-asserted-by": "crossref"}, {"key": "16_CR59", "unstructured": "Andre F, Dieci MV, Dubsky P, Sotiriou C, Curigliano G, Denkert C, et al. Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer. Clin Cancer Res. 2013;19(1):28\u201333. PubMed PMID: 23258741. Epub 2012/12/22. eng.", "DOI": "10.1158/1078-0432.CCR-11-2701", "doi-asserted-by": "crossref"}, {"issue": "10", "key": "16_CR60", "doi-asserted-by": "publisher", "first-page": "3505", "DOI": "10.1158/0008-5472.CAN-10-4316", "volume": "71", "author": "PB Olkhanud", "year": "2011", "unstructured": "Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K, et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+\u00a0T cells to T-regulatory cells. Cancer Res. 2011;71(10):3505\u201315.", "journal-title": "Cancer Res"}, {"key": "16_CR61", "unstructured": "Joimel U, Gest C, Soria J, Pritchard LL, Alexandre J, Laurent M, et al. Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate. BMC Cancer. 2010;10:375. PubMed PMID: 20637124. Pubmed Central PMCID: PMC2918575. Epub 2010/07/20. eng.", "DOI": "10.1186/1471-2407-10-375", "doi-asserted-by": "crossref"}, {"key": "16_CR62", "unstructured": "Pollard JW. Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol. 2008;84(3):623\u2013630. PubMed PMID: 18467655. Pubmed Central PMCID: PMC2516896. Epub 2008/05/10. eng.", "DOI": "10.1189/jlb.1107762", "doi-asserted-by": "crossref"}, {"key": "16_CR63", "unstructured": "Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113(7):1040\u20131050. PubMed PMID: 15057311. Pubmed Central PMCID: PMC379325. Epub 2004/04/02. eng.", "DOI": "10.1172/JCI200420465", "doi-asserted-by": "crossref"}, {"key": "16_CR64", "unstructured": "Cheung KJ, Ewald AJ. Illuminating breast cancer invasion: diverse roles for cell\u2013cell interactions. Curr Opin Cell Biol. 2014;30(0):99\u2013111."}, {"key": "16_CR65", "unstructured": "Cekic C, Day YJ, Sag D, Linden J. Myeloid expression of Adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment. Cancer Res. 2014. PubMed PMID: 25377469. Epub 2014/11/08. Eng.", "DOI": "10.1158/0008-5472.CAN-13-3583", "doi-asserted-by": "crossref"}, {"key": "16_CR66", "unstructured": "Kozlowska A, Mackiewicz J, Mackiewicz A. Therapeutic gene modified cell based cancer vaccines. Gene. 2013;525(2):200\u2013207. PubMed PMID: 23566846. Epub 2013/04/10. eng.", "DOI": "10.1016/j.gene.2013.03.056", "doi-asserted-by": "crossref"}, {"key": "16_CR67", "unstructured": "Lochter A, Bissell MJ. Involvement of extracellular matrix constituents in breast cancer. Semin Cancer Biol. 1995;6(3):165\u2013173.", "DOI": "10.1006/scbi.1995.0017", "doi-asserted-by": "crossref"}, {"key": "16_CR68", "unstructured": "Fu H, Moss J, Shore I, Slade MJ, Coombes RC, Coombes RC. Ultrastructural localization of laminin and type IV collagen in normal human breast. 2002 20020530 DCOM- 20021107(0191-3123 (Print)). eng."}, {"key": "16_CR69", "unstructured": "Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196(4):395\u2013406. PubMed PMID: 22351925. Pubmed Central PMCID: PMC3283993. Epub 2012/02/22. eng.", "DOI": "10.1083/jcb.201102147", "doi-asserted-by": "crossref"}, {"key": "16_CR70", "unstructured": "Gehler S, Ponik SM, Riching KM, Keely PJ. Bi-directional signaling: extracellular matrix and integrin regulation of breast tumor progression. Critical reviews in eukaryotic gene expression.\u00a02013;23(2):139\u201357. PubMed PMID: 23582036. Epub 2013/04/16. eng.", "DOI": "10.1615/CritRevEukarGeneExpr.2013006647", "doi-asserted-by": "crossref"}, {"key": "16_CR71", "unstructured": "Pouliot N, Kusuma N. Laminin-511: a multi-functional adhesion protein regulating cell migration, tumor invasion and metastasis. Cell Adhes Migr. 2013;7(1):142\u2013149. PubMed PMID: 23076212. Pubmed Central PMCID: PMC3544778. Epub 2012/10/19. eng.", "DOI": "10.4161/cam.22125", "doi-asserted-by": "crossref"}, {"key": "16_CR72", "unstructured": "Gritsenko PG, Ilina O, Friedl P. Interstitial guidance of cancer invasion. J Pathol. 2012;226(2):185\u2013199. PubMed PMID: 22006671. Epub 2011/10/19. eng.", "DOI": "10.1002/path.3031", "doi-asserted-by": "crossref"}, {"key": "16_CR73", "unstructured": "Oskarsson T. Extracellular matrix components in breast cancer progression and metastasis. Breast (Edinburgh, Scotland). 2013;22 Suppl 2:S66\u201372. PubMed PMID: 24074795. Epub 2013/10/01. eng.", "DOI": "10.1016/j.breast.2013.07.012", "doi-asserted-by": "crossref"}, {"key": "16_CR74", "unstructured": "Rothberg JM, Sameni M, Moin K, Sloane BF. Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment. Biochim et Biophys Acta. 2012;1824(1):123\u2013132. PubMed PMID: 21854877. Pubmed Central PMCID: PMC3232330. Epub 2011/08/23. eng.", "DOI": "10.1016/j.bbapap.2011.07.025", "doi-asserted-by": "crossref"}, {"key": "16_CR75", "unstructured": "Tang L, Han X. The urokinase plasminogen activator system in breast cancer invasion and metastasis. Biomed Pharmacother. 2013;67(2):179\u2013182. PubMed PMID: 23201006. Epub 2012/12/04. eng.", "DOI": "10.1016/j.biopha.2012.10.003", "doi-asserted-by": "crossref"}, {"key": "16_CR76", "unstructured": "Agrawal AK, Ekonjo GB, Teterycz E, Zyoeko D, Grzebieniak Z, Milan M, et al. Cysteine peptidases and their inhibitors in breast and genital cancer. Folia Histochem et Cytobiologica/Pol Acad Sci Pol Histochem Cytochemical Soc. 2010;48(3):323\u2013327. PubMed PMID: 21071333. Epub 2010/11/13. eng.", "DOI": "10.2478/v10042-10-0067-2", "doi-asserted-by": "crossref"}, {"key": "16_CR77", "unstructured": "Dian D, Heublein S, Wiest I, Barthell L, Friese K, Jeschke U. Significance of the tumor protease cathepsin D for the biology of breast cancer. Histol Histopathology. 2014;29(4):433\u2013438. PubMed PMID: 24265119. Epub 2013/11/23. eng."}, {"key": "16_CR78", "unstructured": "Lebeau A, Nerlich AG, Sauer U, Lichtinghagen R, Lohrs U. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas. Anticancer Res. 1999;19(5B):4257\u20134264. PubMed PMID: 10628384. Epub 2000/01/11. eng."}, {"key": "16_CR79", "unstructured": "Roy DM, Walsh LA. Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors. Breast Cancer (Dove Med Press). 2014;6:81\u201391. PubMed PMID: 25114586. Pubmed Central PMCID: PMC4090043. Epub 2014/08/13. eng.", "DOI": "10.2147/BCTT.S46020", "doi-asserted-by": "crossref"}, {"key": "16_CR80", "unstructured": "Davies KJ. The complex interaction of matrix metalloproteinases in the migration of cancer cells through breast tissue stroma. Int J Breast Cancer. 2014;2014:839094. PubMed PMID: 24800085. Pubmed Central PMCID: PMC3985306. Epub 2014/05/07. eng."}, {"key": "16_CR81", "unstructured": "Velinov N, Poptodorov G, Gabrovski N, Gabrovski S. The role of matrixmetalloproteinases in the tumor growth and metastasis. Khirurgiia. 2010 (1):44\u201349. PubMed PMID: 21972705. Epub 2010/01/01. bul.", "DOI": "10.4236/jsip.2010.11005", "doi-asserted-by": "crossref"}, {"key": "16_CR82", "unstructured": "Friedl P, Wolf K. Proteolytic interstitial cell migration: a five-step process. Cancer Metastasis Rev. 2009;28(1\u20132):129\u2013135. PubMed PMID: 19153672. Epub 2009/01/21. eng.", "DOI": "10.1007/s10555-008-9174-3", "doi-asserted-by": "crossref"}, {"key": "16_CR83", "unstructured": "Stylli SS, Kaye AH, Lock P. Invadopodia: at the cutting edge of tumour invasion. J Clin Neurosci Official J Neurosurg Soc Australas. 2008;15(7):725\u2013737. PubMed PMID: 18468901. Epub 2008/05/13. eng.", "DOI": "10.1016/j.jocn.2008.03.003", "doi-asserted-by": "crossref"}, {"key": "16_CR84", "first-page": "6", "volume": "2014", "author": "KJ Davies", "year": "2014", "unstructured": "Davies KJ. Methods of cell propulsion through the local stroma in breast cancer. Int J Breast Cancer. 2014;2014:6.", "journal-title": "Int J Breast Cancer"}, {"key": "16_CR85", "unstructured": "Rakha EA, Martin S, Lee AH, Morgan D, Pharoah PD, Hodi Z, et al. The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Cancer. 2012;118(15):3670\u20133680. PubMed PMID: 22180017. Epub 2011/12/20. eng.", "DOI": "10.1002/cncr.26711", "doi-asserted-by": "crossref"}, {"key": "16_CR86", "unstructured": "Mohammed RA, Martin SG, Mahmmod AM, Macmillan RD, Green AR, Paish EC, et al. Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up. J Pathol. 2010 Oct 14. PubMed PMID: 21132836.", "DOI": "10.1002/path.2810", "doi-asserted-by": "crossref"}, {"key": "16_CR87", "unstructured": "Gujam FJ, Going JJ, Edwards J, Mohammed ZM, McMillan DC. The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer. Crit Rev Oncol/Hematol. 2014;89(2):231\u2013241. PubMed PMID: 24075309. Epub 2013/10/01. eng.", "DOI": "10.1016/j.critrevonc.2013.08.014", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "16_CR88", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1111/j.1365-2559.2008.03169.x", "volume": "55", "author": "RA Mohammed", "year": "2009", "unstructured": "Mohammed RA, Ellis IO, Lee AH, Martin SG. Vascular invasion in breast cancer; an overview of recent prognostic developments and molecular pathophysiological mechanisms. Histopathology. 2009;55(1):1\u20139.", "journal-title": "Histopathology"}, {"key": "16_CR89", "unstructured": "Gujam FJ, Going JJ, Mohammed ZM, Orange C, Edwards J, McMillan DC. Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer. BMC Cancer. 2014;14:676. PubMed PMID: 25234410. Pubmed Central PMCID: PMC4177173. Epub 2014/09/23. eng.", "DOI": "10.1186/1471-2407-14-676", "doi-asserted-by": "crossref"}, {"key": "16_CR90", "unstructured": "Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, Achen MG. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer. 2014;14(3):159\u2013172.", "DOI": "10.1038/nrc3677", "doi-asserted-by": "crossref"}, {"key": "16_CR91", "unstructured": "Tammela T, Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell. 2010;140(4):460\u2013476. PubMed PMID: 20178740. Epub 2010/02/25. eng.", "DOI": "10.1016/j.cell.2010.01.045", "doi-asserted-by": "crossref"}, {"key": "16_CR92", "unstructured": "Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol. 2011;27:563\u2013584. PubMed PMID: 21756109. Epub 2011/07/16. eng.", "DOI": "10.1146/annurev-cellbio-092910-154002", "doi-asserted-by": "crossref"}, {"key": "16_CR93", "unstructured": "Shayan R, Inder R, Karnezis T, Caesar C, Paavonen K, Ashton MW, et al. Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis. Clin Exp Metastasis. 2013;30(3):345\u2013356. PubMed PMID: 23124573. Epub 2012/11/06. eng.", "DOI": "10.1007/s10585-012-9541-x", "doi-asserted-by": "crossref"}, {"key": "16_CR94", "unstructured": "Ji RC. Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: new insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev. 2006;25(4):677\u2013694. PubMed PMID: 17160713. Epub 2006/12/13. eng.", "DOI": "10.1007/s10555-006-9026-y", "doi-asserted-by": "crossref"}, {"issue": "6", "key": "16_CR95", "doi-asserted-by": "publisher", "first-page": "526", "DOI": "10.1016/j.ccr.2007.04.020", "volume": "11", "author": "JD Shields", "year": "2007", "unstructured": "Shields JD, Fleury ME, Yong C, Tomei AA, Randolph GJ, Swartz MA. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell. 2007;11(6):526\u201338.", "journal-title": "Cancer Cell"}, {"key": "16_CR96", "unstructured": "Ugras S, Stempel M, Patil S, Morrow M. Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement. Ann Surg Oncol. 2014 2014/11/01;21(12):3780\u20133786. English.", "DOI": "10.1245/s10434-014-3851-y", "doi-asserted-by": "crossref"}, {"key": "16_CR97", "unstructured": "Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u2013352.", "DOI": "10.1038/nature10983", "doi-asserted-by": "crossref"}, {"key": "16_CR98", "unstructured": "Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res: BCR. 2010;12(5):R68. PubMed PMID: 20813035. Pubmed Central PMCID: PMC3096954. Epub 2010/09/04. eng.", "DOI": "10.1186/bcr2635", "doi-asserted-by": "crossref"}, {"key": "16_CR99", "unstructured": "Holm-Rasmussen EV, Jensen MB, Balslev E, Kroman N, Tvedskov TF. Reduced risk of axillary lymphatic spread in triple-negative breast cancer. Breast Cancer Res Treat. 2015;149(1):229\u2013236. PubMed PMID: 25488719. Epub 2014/12/10. eng.", "DOI": "10.1007/s10549-014-3225-y", "doi-asserted-by": "crossref"}, {"key": "16_CR100", "unstructured": "Wan L, Pantel K, Kang Y. Tumor metastasis: moving new biological insights into the clinic. Nat Med. 2013;19(11):1450\u20131464. PubMed PMID: 24202397. Epub 2013/11/10. eng.", "DOI": "10.1038/nm.3391", "doi-asserted-by": "crossref"}, {"key": "16_CR101", "unstructured": "Douma S, van Laar T, Zevenhoven J, Meuwissen R, van Garderen E, Peeper DS. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature. 2004;430(7003):1034\u20131039.", "DOI": "10.1038/nature02765", "doi-asserted-by": "crossref"}, {"key": "16_CR102", "unstructured": "Nierodzik ML, Karpatkin S. Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell. 2006;10(5):355\u2013362. PubMed PMID: 17097558. Epub 2006/11/14. eng.", "DOI": "10.1016/j.ccr.2006.10.002", "doi-asserted-by": "crossref"}, {"key": "16_CR103", "unstructured": "Chao MP, Weissman IL, Majeti R. The CD47-SIRPalpha pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol. 2012;24(2):225\u2013232. PubMed PMID: 22310103. Pubmed Central PMCID: PMC3319521. Epub 2012/02/09. eng.", "DOI": "10.1016/j.coi.2012.01.010", "doi-asserted-by": "crossref"}, {"key": "16_CR104", "unstructured": "Hiratsuka S, Goel S, Kamoun WS, Maru Y, Fukumura D, Duda DG, et al. Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation. Proc Natl Acad Sci USA. 2011;108(9):3725\u20133730. PubMed PMID: 21321210. Pubmed Central PMCID: PMC3048115. Epub 2011/02/16. eng.", "DOI": "10.1073/pnas.1100446108", "doi-asserted-by": "crossref"}, {"key": "16_CR105", "unstructured": "Bendas G, Borsig L. Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol. 2012;2012:676731. PubMed PMID: 22505933. Pubmed Central PMCID: PMC3296185. Epub 2012/04/17. eng.", "DOI": "10.1155/2012/676731", "doi-asserted-by": "crossref"}, {"key": "16_CR106", "unstructured": "Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10(1):9\u201322. PubMed PMID: 20029421. Epub 2009/12/24. eng.", "DOI": "10.1038/nrc2748", "doi-asserted-by": "crossref"}, {"key": "16_CR107", "unstructured": "Takayama S, Ishii S, Ikeda T, Masamura S, Doi M, Kitajima M. The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression. Anticancer Res. 2005;25(1A):79\u201383. PubMed PMID: 15816522. Epub 2005/04/09. eng."}, {"key": "16_CR108", "unstructured": "Sloan EK, Pouliot N, Stanley KL, Chia J, Moseley JM, Hards DK, et al. Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Res. 2006;8(2):R20. PubMed PMID: 16608535. Pubmed Central PMCID: PMC1557720. Epub 2006/04/13. eng.", "DOI": "10.1186/bcr1398", "doi-asserted-by": "crossref"}, {"key": "16_CR109", "unstructured": "Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G, et al. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell. 2006;126(3):489\u2013502. PubMed PMID: 16901783. Epub 2006/08/12. eng.", "DOI": "10.1016/j.cell.2006.05.047", "doi-asserted-by": "crossref"}, {"key": "16_CR110", "unstructured": "Yoon SO, Shin S, Lipscomb EA. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling. Cancer Res. 2006;66(5):2732\u20132739. PubMed PMID: 16510594. Epub 2006/03/03. eng.", "DOI": "10.1158/0008-5472.CAN-05-2941", "doi-asserted-by": "crossref"}, {"key": "16_CR111", "unstructured": "Lee YT. Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol. 1983;23(3):175\u2013180. PubMed PMID: 6345937. Epub 1983/07/01. eng.", "DOI": "10.1002/jso.2930230311", "doi-asserted-by": "crossref"}, {"key": "16_CR112", "unstructured": "Lu X, Kang Y. Organotropism of breast cancer metastasis. J Mammary Gland Biol Neoplasia. 2007;12(2\u20133):153\u2013162. PubMed PMID: 17566854. Epub 2007/06/15. eng.", "DOI": "10.1007/s10911-007-9047-3", "doi-asserted-by": "crossref"}, {"key": "16_CR113", "unstructured": "Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410(6824):50\u201356. PubMed PMID: 11242036. Epub 2001/03/10. eng.", "DOI": "10.1038/35065016", "doi-asserted-by": "crossref"}, {"key": "16_CR114", "unstructured": "Mukherjee D, Zhao J. The Role of chemokine receptor CXCR4 in breast cancer metastasis. Am J Cancer Res. 2013;3(1):46\u201357. PubMed PMID: 23359227. Pubmed Central PMCID: PMC3555200. Epub 2013/01/30. eng."}, {"issue": "8", "key": "16_CR115", "doi-asserted-by": "publisher", "first-page": "895", "DOI": "10.1038/nm1469", "volume": "12", "author": "PS Steeg", "year": "2006", "unstructured": "Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12(8):895\u2013904.", "journal-title": "Nat Med"}, {"key": "16_CR116", "unstructured": "Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3(6):537\u2013549. PubMed PMID: 12842083. Epub 2003/07/05. eng.", "DOI": "10.1016/S1535-6108(03)00132-6", "doi-asserted-by": "crossref"}, {"issue": "20", "key": "16_CR117", "doi-asserted-by": "publisher", "first-page": "6213s", "DOI": "10.1158/1078-0432.CCR-06-1007", "volume": "12", "author": "TA Guise", "year": "2006", "unstructured": "Guise TA, Mohammad KS, Clines G, Stebbins EG, Wong DH, Higgins LS, et al. Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases. Clin Cancer Res. 2006;12(20):6213s\u20136s.", "journal-title": "Clin Cancer Res"}, {"issue": "1", "key": "16_CR118", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1038/sj.cr.7290266", "volume": "15", "author": "JJ Yin", "year": "2005", "unstructured": "Yin JJ, Pollock CB, Kelly K. Mechanisms of cancer metastasis to the bone. Cell Res. 2005;15(1):57\u201362.", "journal-title": "Cell Res"}, {"issue": "24", "key": "16_CR119", "doi-asserted-by": "publisher", "first-page": "21352", "DOI": "10.1074/jbc.M111663200", "volume": "277", "author": "SL Dallas", "year": "2002", "unstructured": "Dallas SL, Rosser JL, Mundy GR, Bonewald LF. Proteolysis of latent transforming growth factor-\u03b2 (TGF-\u03b2)-binding Protein-1 by osteoclasts: a cellular mechanism for release of TGF-\u03b2 from bone matrix. J Biol Chem. 2002;277(24):21352\u201360.", "journal-title": "J Biol Chem"}, {"key": "16_CR120", "unstructured": "Brackstone M, Townson J, Chambers A. Tumour dormancy in breast cancer: an update. Breast Cancer Res. 2007;9(3):208. PubMed PMID. doi:\n                  10.1186/bcr1677\n                  \n                .", "DOI": "10.1186/bcr1677", "doi-asserted-by": "publisher"}, {"key": "16_CR121", "unstructured": "Wikman H, Vessella R, Pantel K. Cancer micrometastasis and tumour dormancy. APMIS. 2008;116(7\u20138):754\u2013770. PubMed PMID: 18834417. Epub 2008/10/07. eng.", "DOI": "10.1111/j.1600-0463.2008.01033.x", "doi-asserted-by": "crossref"}, {"key": "16_CR122", "unstructured": "Holmgren L, O\u2019Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1(2):149\u2013153. PubMed PMID: 7585012. Epub 1995/02/01. eng.", "DOI": "10.1038/nm0295-149", "doi-asserted-by": "crossref"}, {"key": "16_CR123", "unstructured": "Townson JL, Chambers AF. Dormancy of solitary metastatic cells. Cell Cycle. 2006;5(16):1744\u20131750. PubMed PMID: 16861927. Epub 2006/07/25. eng.", "DOI": "10.4161/cc.5.16.2864", "doi-asserted-by": "crossref"}, {"issue": "6900", "key": "16_CR124", "doi-asserted-by": "publisher", "first-page": "823", "DOI": "10.1038/418823a", "volume": "418", "author": "R Bernards", "year": "2002", "unstructured": "Bernards R, Weinberg RA. Metastasis genes: a progression puzzle. Nature. 2002;418(6900):823.", "journal-title": "Nature"}, {"key": "16_CR125", "unstructured": "Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van\u2019t Veer LJ. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA. 2003;100(26):15901\u201315905. PubMed PMID: 14665696.", "DOI": "10.1073/pnas.2634067100", "doi-asserted-by": "crossref"}, {"issue": "10", "key": "16_CR126", "doi-asserted-by": "publisher", "first-page": "5974", "DOI": "10.1073/pnas.0931261100", "volume": "100", "author": "XJ Ma", "year": "2003", "unstructured": "Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA. 2003;100(10):5974\u20139.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR127", "unstructured": "Weigelt B, van\u2019t Veer LJ. Hard-wired genotype in metastatic breast cancer. Cell Cycle. 2004;3(6):756\u2013757. PubMed PMID: 15153810. Epub 2004/05/22. eng.", "DOI": "10.4161/cc.3.6.923", "doi-asserted-by": "crossref"}, {"key": "16_CR128", "unstructured": "Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28(20):3271\u20133277. PubMed PMID: 20498394. Epub 2010/05/26. eng.", "DOI": "10.1200/JCO.2009.25.9820", "doi-asserted-by": "crossref"}, {"issue": "7", "key": "16_CR129", "doi-asserted-by": "publisher", "first-page": "2302", "DOI": "10.1158/1078-0432.CCR-08-2132", "volume": "15", "author": "EA Rakha", "year": "2009", "unstructured": "Rakha EA, Elsheikh SE, Aleskandarany MA, Habashi HO, Green AR, Powe DG, et al. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res. 2009;15(7):2302\u201310.", "journal-title": "Clin Cancer Res"}, {"key": "16_CR130", "unstructured": "Yaman S, Gumuskaya B, Ozkan C, Aksoy S, Guler G, Altundag K. Lymphatic and capillary invasion patterns in triple negative breast cancer. Am Surg. 2012;78(11):1238\u20131242. PubMed PMID: 23089442. Epub 2012/10/24. eng."}, {"key": "16_CR131", "unstructured": "Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol. 2011;24(2):157\u2013167.", "DOI": "10.1038/modpathol.2010.200", "doi-asserted-by": "crossref"}, {"key": "16_CR132", "unstructured": "Rodenhiser DI, Andrews Jd, Vandenberg TA, Chambers AF. Gene signatures of breast cancer progression and metastasis. Breast Cancer Res. 2011 20111115 DCOM- 20140325(1465-542X (Electronic)). eng.", "DOI": "10.1186/bcr2791", "doi-asserted-by": "crossref"}, {"key": "16_CR133", "unstructured": "van de Vijver MJ, He YD, van\u2019t Veer LJ, Dai H, Hart AAM, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347(25):1999\u20132009. PubMed PMID: ISI:000179874500003.", "DOI": "10.1056/NEJMoa021967", "doi-asserted-by": "crossref"}, {"key": "16_CR134", "unstructured": "Buyse M, Loi S, van\u2019t Veer L, Viale G, Delorenzi M, Glas AM, et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst. 2006;98(17):1183\u20131192.", "DOI": "10.1093/jnci/djj329", "doi-asserted-by": "crossref"}, {"key": "16_CR135", "unstructured": "Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 2005;365(9460):671\u2013679. PubMed PMID: 15721472."}, {"issue": "4", "key": "16_CR136", "doi-asserted-by": "publisher", "first-page": "262", "DOI": "10.1093/jnci/djj052", "volume": "98", "author": "C Sotiriou", "year": "2006", "unstructured": "Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst. 2006;98(4):262\u201372.", "journal-title": "J Natl Cancer Inst"}, {"issue": "27", "key": "16_CR137", "doi-asserted-by": "publisher", "first-page": "2817", "DOI": "10.1056/NEJMoa041588", "volume": "351", "author": "S Paik", "year": "2004", "unstructured": "Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817\u201326.", "journal-title": "N Engl J Med"}, {"issue": "5", "key": "16_CR138", "doi-asserted-by": "publisher", "first-page": "721", "DOI": "10.1200/JCO.2007.15.1068", "volume": "26", "author": "JA Sparano", "year": "2008", "unstructured": "Sparano JA, Paik S. Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol. 2008;26(5):721\u20138.", "journal-title": "J Clin Oncol"}, {"key": "16_CR139", "unstructured": "Ross JS, Hatzis C, Symmans WF, Pusztai L, Hortobagyi GN. Commercialized multigene predictors of clinical outcome for breast cancer. Oncologist. 2008;13(5):477\u2013493. PubMed PMID: 18515733. Epub 2008/06/03. eng.", "DOI": "10.1634/theoncologist.2007-0248", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "16_CR140", "doi-asserted-by": "publisher", "first-page": "R65", "DOI": "10.1186/bcr2124", "volume": "10", "author": "P Wirapati", "year": "2008", "unstructured": "Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, et al. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res. 2008;10(4):R65.", "journal-title": "Breast Cancer Res"}, {"key": "16_CR141", "doi-asserted-by": "publisher", "first-page": "394", "DOI": "10.1186/1471-2164-9-394", "volume": "9", "author": "B Haibe-Kains", "year": "2008", "unstructured": "Haibe-Kains B, Desmedt C, Piette F, Buyse M, Cardoso F, Van\u2019t Veer L, et al. Comparison of prognostic gene expression signatures for breast cancer. BMC Genom. 2008;9:394.", "journal-title": "BMC Genom"}, {"key": "16_CR142", "unstructured": "Mefford D, Mefford J. Stromal genes add prognostic information to proliferation and histoclinical markers: a basis for the next generation of breast cancer gene signatures. PloS One. 2012;7(6):e37646. PubMed PMID: 22719844. Pubmed Central PMCID: PMC3377707. Epub 2012/06/22. eng.", "DOI": "10.1371/journal.pone.0037646", "doi-asserted-by": "crossref"}], "container-title": ["Molecular Pathology Library", "Precision Molecular Pathology of Breast Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4939-2886-6_16", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T16:34:20Z", "timestamp": 1559234060000}, "score": 23.331406, "issued": {"date-parts": [[2015]]}, "ISBN": ["9781493928859", "9781493928866"], "references-count": 142, "URL": "http://dx.doi.org/10.1007/978-1-4939-2886-6_16", "relation": {"cites": []}, "ISSN": ["1935-987X", "1935-9888"], "issn-type": [{"value": "1935-987X", "type": "print"}, {"value": "1935-9888", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:10:21Z", "timestamp": 1574719821642}, "publisher-location": "New York, NY", "reference-count": 55, "publisher": "Springer New York", "isbn-type": [{"value": "9781493928859", "type": "print"}, {"value": "9781493928866", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2015]]}, "DOI": "10.1007/978-1-4939-2886-6_8", "type": "book-chapter", "created": {"date-parts": [[2015, 8, 12]], "date-time": "2015-08-12T08:51:12Z", "timestamp": 1439369472000}, "page": "107-118", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Molecular Pathology of Hormone Regulation in Breast Cancer: Hormone Receptor Evaluation and Therapeutic Implications"], "prefix": "10.1007", "author": [{"given": "Emad A.", "family": "Rakha", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 8, 13]]}, "reference": [{"issue": "5", "key": "8_CR1", "doi-asserted-by": "publisher", "first-page": "213", "DOI": "10.1186/bcr921", "volume": "6", "author": "SE Hankinson", "year": "2004", "unstructured": "Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 2004;6(5):213\u20138.", "journal-title": "Breast Cancer Res"}, {"issue": "1", "key": "8_CR2", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1023/B:JOMG.0000023584.01750.16", "volume": "9", "author": "E Anderson", "year": "2004", "unstructured": "Anderson E, Clarke RB. Steroid receptors and cell cycle in normal mammary epithelium. J Mammary Gland Biol Neoplasia. 2004;9(1):3\u201313.", "journal-title": "J Mammary Gland Biol Neoplasia"}, {"issue": "7299", "key": "8_CR3", "doi-asserted-by": "publisher", "first-page": "798", "DOI": "10.1038/nature09027", "volume": "465", "author": "ML Asselin-Labat", "year": "2010", "unstructured": "Asselin-Labat ML, et al. Control of mammary stem cell function by steroid hormone signalling. Nature. 2010;465(7299):798\u2013802.", "journal-title": "Nature"}, {"issue": "10", "key": "8_CR4", "doi-asserted-by": "publisher", "first-page": "4562", "DOI": "10.1210/en.2003-0567", "volume": "144", "author": "J Frasor", "year": "2003", "unstructured": "Frasor J, et al. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology. 2003;144(10):4562\u201374.", "journal-title": "Endocrinology"}, {"issue": "12", "key": "8_CR5", "first-page": "4669", "volume": "37", "author": "WA Knight", "year": "1977", "unstructured": "Knight WA, et al. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977;37(12):4669\u201371.", "journal-title": "Cancer Res"}, {"issue": "10", "key": "8_CR6", "doi-asserted-by": "publisher", "first-page": "1545", "DOI": "10.1016/j.ejca.2007.01.003", "volume": "43", "author": "RW Blamey", "year": "2007", "unstructured": "Blamey RW, et al. Reading the prognosis of the individual with breast cancer. Eur J Cancer. 2007;43(10):1545\u20137.", "journal-title": "Eur J Cancer"}, {"key": "8_CR7", "unstructured": "Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet, 2005;365(9472):1687\u20131717.", "DOI": "10.1016/S0140-6736(05)66544-0", "doi-asserted-by": "crossref"}, {"issue": "12", "key": "8_CR8", "doi-asserted-by": "publisher", "first-page": "1531", "DOI": "10.1200/JCO.2010.30.3677", "volume": "29", "author": "JM Bartlett", "year": "2011", "unstructured": "Bartlett JM, et al. Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial. J Clin Oncol. 2011;29(12):1531\u20138.", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "8_CR9", "doi-asserted-by": "publisher", "first-page": "e88238", "DOI": "10.1371/journal.pone.0088238", "volume": "9", "author": "M Al-Mubarak", "year": "2014", "unstructured": "Al-Mubarak M, et al. Extended adjuvant tamoxifen for early breast cancer: a meta-analysis. PLoS one. 2014;9(2):e88238.", "journal-title": "PLoS one"}, {"issue": "1\u20133", "key": "8_CR10", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1023/A:1006133418245", "volume": "52", "author": "SG Hilsenbeck", "year": "1998", "unstructured": "Hilsenbeck SG, et al. Time-dependence of hazard ratios for prognostic factors in primary breast cancer. Breast Cancer Res Treat. 1998;52(1\u20133):227\u201337.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "12", "key": "8_CR11", "doi-asserted-by": "publisher", "first-page": "1545", "DOI": "10.1038/modpathol.3800229", "volume": "17", "author": "SK Mohsin", "year": "2004", "unstructured": "Mohsin SK, et al. Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Mod Pathol. 2004;17(12):1545\u201354.", "journal-title": "Mod Pathol"}, {"issue": "10", "key": "8_CR12", "doi-asserted-by": "publisher", "first-page": "1973", "DOI": "10.1200/JCO.2003.09.099", "volume": "21", "author": "VJ Bardou", "year": "2003", "unstructured": "Bardou VJ, et al. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol. 2003;21(10):1973.", "journal-title": "J Clin Oncol"}, {"issue": "30", "key": "8_CR13", "doi-asserted-by": "publisher", "first-page": "4772", "DOI": "10.1200/JCO.2007.12.2747", "volume": "25", "author": "EA Rakha", "year": "2007", "unstructured": "Rakha EA, et al. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. J Clin Oncol. 2007;25(30):4772\u20138.", "journal-title": "J Clin Oncol"}, {"issue": "17", "key": "8_CR14", "doi-asserted-by": "publisher", "first-page": "1254", "DOI": "10.1093/jnci/dji249", "volume": "97", "author": "G Arpino", "year": "2005", "unstructured": "Arpino G, et al. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst. 2005;97(17):1254\u201361.", "journal-title": "J Natl Cancer Inst"}, {"issue": "15", "key": "8_CR15", "doi-asserted-by": "publisher", "first-page": "4614", "DOI": "10.1158/1078-0432.CCR-06-0248", "volume": "12", "author": "M Stendahl", "year": "2006", "unstructured": "Stendahl M, et al. High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients. Clin Cancer Res. 2006;12(15):4614\u20138.", "journal-title": "Clin Cancer Res"}, {"issue": "1", "key": "8_CR16", "doi-asserted-by": "publisher", "first-page": "53", "DOI": "10.1007/s10549-009-0318-0", "volume": "119", "author": "S Liu", "year": "2010", "unstructured": "Liu S, et al. Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients. Breast Cancer Res Treat. 2010;119(1):53\u201361.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "14", "key": "8_CR17", "doi-asserted-by": "publisher", "first-page": "8418", "DOI": "10.1073/pnas.0932692100", "volume": "100", "author": "T Sorlie", "year": "2003", "unstructured": "Sorlie T, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100(14):8418\u201323.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "3", "key": "8_CR18", "doi-asserted-by": "publisher", "first-page": "276", "DOI": "10.1634/theoncologist.2010-0302", "volume": "16", "author": "JP Thakkar", "year": "2011", "unstructured": "Thakkar JP, Mehta DG. A review of an unfavorable subset of breast cancer: estrogen receptor positive progesterone receptor negative. Oncologist. 2011;16(3):276\u201385.", "journal-title": "Oncologist"}, {"issue": "6 Suppl", "key": "8_CR19", "doi-asserted-by": "publisher", "first-page": "2934", "DOI": "10.1002/1097-0142(197706)39:6<2934::AID-CNCR2820390680>3.0.CO;2-P", "volume": "39", "author": "WL McGuire", "year": "1977", "unstructured": "McGuire WL, et al. Current status of estrogen and progesterone receptors in breast cancer. Cancer. 1977;39(6 Suppl):2934\u201347.", "journal-title": "Cancer"}, {"issue": "S1", "key": "8_CR20", "first-page": "S22", "volume": "228", "author": "E Rakha", "year": "2012", "unstructured": "Rakha E, et al. Oestrogen receptor negative progesterone receptor positive phenotype in breast cancer is a technical artefact. J Path. 2012;228(S1):S22.", "journal-title": "J Path"}, {"issue": "27", "key": "8_CR21", "doi-asserted-by": "publisher", "first-page": "4129", "DOI": "10.1200/JCO.2009.26.4200", "volume": "28", "author": "V Belle Van", "year": "2010", "unstructured": "Van Belle V, et al. Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5\u00a0years after breast cancer diagnosis. J Clin Oncol. 2010;28(27):4129\u201334.", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "8_CR22", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1007/s10549-010-0746-x", "volume": "120", "author": "EA Rakha", "year": "2010", "unstructured": "Rakha EA, Reis-Filho JS, Ellis IO. Combinatorial biomarker expression in breast cancer. Breast Cancer Res Treat. 2010;120(2):293\u2013308.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "16", "key": "8_CR23", "doi-asserted-by": "publisher", "first-page": "2784", "DOI": "10.1200/JCO.2009.25.6529", "volume": "28", "author": "ME Hammond", "year": "2010", "unstructured": "Hammond ME, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784\u201395.", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "8_CR24", "first-page": "547", "volume": "56", "author": "EV Jensen", "year": "1967", "unstructured": "Jensen EV, et al. Estrogen-receptor interactions in target tissues. Arch Anat Microsc Morphol Exp. 1967;56(3):547\u201369.", "journal-title": "Arch Anat Microsc Morphol Exp"}, {"issue": "24 Pt 1", "key": "8_CR25", "first-page": "6572", "volume": "47", "author": "SM Thorpe", "year": "1987", "unstructured": "Thorpe SM. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method. Cancer Res. 1987;47(24 Pt 1):6572\u20135.", "journal-title": "Cancer Res"}, {"issue": "27", "key": "8_CR26", "doi-asserted-by": "publisher", "first-page": "3715", "DOI": "10.1200/JCO.2011.37.3704", "volume": "29", "author": "JM Bartlett", "year": "2011", "unstructured": "Bartlett JM, Rea D, Rimm DL. Quantification of hormone receptors to guide adjuvant therapy choice in early breast cancer: better methods required for improved utility. J Clin Oncol. 2011;29(27):3715\u20136.", "journal-title": "J Clin Oncol"}, {"issue": "Suppl 2", "key": "8_CR27", "doi-asserted-by": "publisher", "first-page": "S52", "DOI": "10.1038/modpathol.2010.55", "volume": "23", "author": "DC Allred", "year": "2010", "unstructured": "Allred DC. Issues and updates: evaluating estrogen receptor-alpha, progesterone receptor, and HER2 in breast cancer. Mod Pathol. 2010;23(Suppl 2):S52\u20139.", "journal-title": "Mod Pathol"}, {"issue": "36", "key": "8_CR28", "doi-asserted-by": "publisher", "first-page": "5637", "DOI": "10.1200/JCO.2005.05.4155", "volume": "24", "author": "MC Cheang", "year": "2006", "unstructured": "Cheang MC, et al. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. J Clin Oncol. 2006;24(36):5637\u201344.", "journal-title": "J Clin Oncol"}, {"issue": "10", "key": "8_CR29", "doi-asserted-by": "publisher", "first-page": "684", "DOI": "10.1016/j.clon.2012.04.005", "volume": "24", "author": "S Nofech-Mozes", "year": "2012", "unstructured": "Nofech-Mozes S, et al. Cancer care Ontario guideline recommendations for hormone receptor testing in breast cancer. Clin Oncol (R Coll Radiol). 2012;24(10):684\u201396.", "journal-title": "Clin Oncol (R Coll Radiol)"}, {"issue": "8", "key": "8_CR30", "doi-asserted-by": "publisher", "first-page": "634", "DOI": "10.1136/jcp.53.8.634", "volume": "53", "author": "R Leake", "year": "2000", "unstructured": "Leake R, et al. Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK receptor group, UK NEQAS, The Scottish breast cancer pathology group, and the receptor and biomarker study group of the EORTC. J Clin Pathol. 2000;53(8):634\u20135.", "journal-title": "J Clin Pathol"}, {"issue": "9", "key": "8_CR31", "doi-asserted-by": "publisher", "first-page": "688", "DOI": "10.1136/jcp.53.9.688", "volume": "53", "author": "A Rhodes", "year": "2000", "unstructured": "Rhodes A, et al. Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol. 2000;53(9):688\u201396.", "journal-title": "J Clin Pathol"}, {"issue": "15", "key": "8_CR32", "doi-asserted-by": "publisher", "first-page": "2473", "DOI": "10.1200/JCO.2007.13.6424", "volume": "26", "author": "SS Badve", "year": "2008", "unstructured": "Badve SS, et al. Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. J Clin Oncol. 2008;26(15):2473\u201381.", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "8_CR33", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1136/jcp.2006.036665", "volume": "60", "author": "Z Hodi", "year": "2007", "unstructured": "Hodi Z, et al. The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast. J Clin Pathol. 2007;60(3):299\u2013302.", "journal-title": "J Clin Pathol"}, {"issue": "7", "key": "8_CR34", "doi-asserted-by": "publisher", "first-page": "573", "DOI": "10.1136/jclinpath-2013-201978", "volume": "67", "author": "AH Lee", "year": "2014", "unstructured": "Lee AH, et al. The effect of delay in fixation on HER2 expression in invasive carcinoma of the breast assessed with immunohistochemistry and in situ hybridisation. J Clin Pathol. 2014;67(7):573\u20135.", "journal-title": "J Clin Pathol"}, {"issue": "2", "key": "8_CR35", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1136/jclinpath-2014-202571", "volume": "68", "author": "EA Rakha", "year": "2015", "unstructured": "Rakha EA, et al. Updated UK recommendations for HER2 assessment in breast cancer. J Clin Pathol. 2015;68(2):93\u20139.", "journal-title": "J Clin Pathol"}, {"issue": "3", "key": "8_CR36", "first-page": "138", "volume": "8", "author": "W Remmele", "year": "1987", "unstructured": "Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 1987;8(3):138\u201340.", "journal-title": "Pathologe"}, {"issue": "5", "key": "8_CR37", "doi-asserted-by": "crossref", "first-page": "1474", "DOI": "10.1200/JCO.1999.17.5.1474", "volume": "17", "author": "JM Harvey", "year": "1999", "unstructured": "Harvey JM, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999;17(5):1474\u201381.", "journal-title": "J Clin Oncol"}, {"key": "8_CR38", "unstructured": "Rakha EA, et al. Low-estrogen receptor-positive breast cancer: the impact of tissue sampling, choice of antibody, and molecular subtyping. J Clin Oncol, 2012;30(23):2929\u201330; author reply 2931.", "DOI": "10.1200/JCO.2012.43.2831", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "8_CR39", "doi-asserted-by": "publisher", "first-page": "346", "DOI": "10.1111/j.1365-2559.2008.03075.x", "volume": "53", "author": "S Shousha", "year": "2008", "unstructured": "Shousha S. Oestrogen receptor status of breast carcinoma: Allred/H score conversion table. Histopathology. 2008;53(3):346\u20137.", "journal-title": "Histopathology"}, {"key": "8_CR40", "unstructured": "Tamoxifen for early breast cancer. Cochrane Database Syst Rev, 2001;1:CD000486."}, {"key": "8_CR41", "unstructured": "Burstein HJ et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. J Clin Oncol, 2014;32(21):2255\u201369.", "DOI": "10.1200/JCO.2013.54.2258", "doi-asserted-by": "crossref"}, {"issue": "22", "key": "8_CR42", "doi-asserted-by": "publisher", "first-page": "1609", "DOI": "10.1056/NEJM199811263392207", "volume": "339", "author": "CK Osborne", "year": "1998", "unstructured": "Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998;339(22):1609\u201318.", "journal-title": "N Engl J Med"}, {"issue": "4", "key": "8_CR43", "doi-asserted-by": "publisher", "first-page": "732", "DOI": "10.1200/JCO.2005.05.145", "volume": "23", "author": "MPHM Jansen", "year": "2005", "unstructured": "Jansen MPHM, et al. Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling. J Clin Oncol. 2005;23(4):732.", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "8_CR44", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1007/s10549-008-9939-y", "volume": "113", "author": "M Kok", "year": "2009", "unstructured": "Kok M, et al. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat. 2009;113(2):275\u201383.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "6", "key": "8_CR45", "doi-asserted-by": "publisher", "first-page": "1744", "DOI": "10.1158/1078-0432.CCR-07-1833", "volume": "14", "author": "M Chanrion", "year": "2008", "unstructured": "Chanrion M, et al. A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer. Clin Cancer Res. 2008;14(6):1744.", "journal-title": "Clin Cancer Res"}, {"issue": "11 Pt 2", "key": "8_CR46", "first-page": "4299", "volume": "38", "author": "JC Allegra", "year": "1978", "unstructured": "Allegra JC, et al. An association between steroid hormone receptors and response to cytotoxic chemotherapy in patients with metastatic breast cancer. Cancer Res. 1978;38(11 Pt 2):4299\u2013304.", "journal-title": "Cancer Res"}, {"issue": "14", "key": "8_CR47", "doi-asserted-by": "publisher", "first-page": "1658", "DOI": "10.1001/jama.295.14.1658", "volume": "295", "author": "DA Berry", "year": "2006", "unstructured": "Berry DA, et al. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA. 2006;295(14):1658\u201367.", "journal-title": "JAMA"}, {"issue": "1", "key": "8_CR48", "doi-asserted-by": "publisher", "first-page": "137", "DOI": "10.1007/s10549-008-9912-9", "volume": "113", "author": "B Thurlimann", "year": "2009", "unstructured": "Thurlimann B, et al. Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group trial 11\u201393. Breast Cancer Res Treat. 2009;113(1):137\u201344.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "27", "key": "8_CR49", "doi-asserted-by": "publisher", "first-page": "2817", "DOI": "10.1056/NEJMoa041588", "volume": "351", "author": "S Paik", "year": "2004", "unstructured": "Paik S, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817\u201326.", "journal-title": "N Engl J Med"}, {"key": "8_CR50", "unstructured": "Early Breast Cancer Trialists\u2019 Collaborative, G., et al., Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet, 2011;378(9793):771\u2013784.", "DOI": "10.1016/S0140-6736(11)60993-8", "doi-asserted-by": "crossref"}, {"issue": "6", "key": "8_CR51", "doi-asserted-by": "publisher", "first-page": "1090", "DOI": "10.1093/annonc/mdn005", "volume": "19", "author": "M Untch", "year": "2008", "unstructured": "Untch M, et al. Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial. Ann Oncol. 2008;19(6):1090\u20136.", "journal-title": "Ann Oncol"}, {"issue": "2", "key": "8_CR52", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1007/s10549-008-0223-y", "volume": "116", "author": "M Colleoni", "year": "2009", "unstructured": "Colleoni M, et al. Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy. Breast Cancer Res Treat. 2009;116(2):359\u201369.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "18", "key": "8_CR53", "doi-asserted-by": "crossref", "first-page": "3808", "DOI": "10.1200/JCO.2001.19.18.3808", "volume": "19", "author": "MJ Ellis", "year": "2001", "unstructured": "Ellis MJ, et al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J Clin Oncol. 2001;19(18):3808\u201316.", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "8_CR54", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1111/j.1075-122X.2004.21320.x", "volume": "10", "author": "AU Buzdar", "year": "2004", "unstructured": "Buzdar AU, Vergote I, Sainsbury R. The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women. Breast J. 2004;10(3):211\u20137.", "journal-title": "Breast J"}, {"key": "8_CR55", "unstructured": "Immunocytochemistry. Improving immunocytochemistry for over 25\u00a0years. UK NEQAS ICC and ISH for Immunocytochemistry and In Situ Hybridisation 2013, Run 103/32. (\n                  http://www.ukneqasicc.ucl.ac.uk/Run_103_Journal.pdf\n                  \n                )."}], "container-title": ["Molecular Pathology Library", "Precision Molecular Pathology of Breast Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4939-2886-6_8", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T16:17:28Z", "timestamp": 1559233048000}, "score": 23.297285, "issued": {"date-parts": [[2015]]}, "ISBN": ["9781493928859", "9781493928866"], "references-count": 55, "URL": "http://dx.doi.org/10.1007/978-1-4939-2886-6_8", "relation": {"cites": []}, "ISSN": ["1935-987X", "1935-9888"], "issn-type": [{"value": "1935-987X", "type": "print"}, {"value": "1935-9888", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T05:56:59Z", "timestamp": 1574834219698}, "publisher-location": "Cham", "reference-count": 48, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319621449", "type": "print"}, {"value": "9783319621463", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2017, 9, 13]], "date-time": "2017-09-13T00:00:00Z", "timestamp": 1505260800000}, "delay-in-days": 0, "content-version": "unspecified"}, {"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2017, 9, 13]], "date-time": "2017-09-13T00:00:00Z", "timestamp": 1505260800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1007/978-3-319-62146-3_7", "type": "book-chapter", "created": {"date-parts": [[2017, 9, 12]], "date-time": "2017-09-12T09:54:23Z", "timestamp": 1505210063000}, "page": "141-154", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Essential Thrombocythemia"], "prefix": "10.1007", "author": [{"given": "April A.", "family": "Ewton", "sequence": "first", "affiliation": []}, {"given": "Rachel E.", "family": "Donohue", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 9, 13]]}, "reference": [{"key": "7_CR1", "unstructured": "Thiel J, Kvasnicka HM, Orazi A, et al. Essential thrombocythaemia. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. p. 48\u201350."}, {"key": "7_CR2", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1007/BF01891529", "volume": "293", "author": "E Epstein", "year": "1934", "unstructured": "Epstein E, Goedel A. Hamorrhagischethrombo-zythamiebeivascularerschrumpfmilz (hemorrhagic thrombocythemia with a vascular, sclerotic spleen). Virchows Arch A Pathol Anat Histopathol. 1934;293:233\u201348.", "journal-title": "Virchows Arch A Pathol Anat Histopathol"}, {"issue": "20", "key": "7_CR3", "doi-asserted-by": "publisher", "first-page": "2391", "DOI": "10.1182/blood-2016-03-643544", "volume": "127", "author": "DA Arber", "year": "2016", "unstructured": "Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405. doi:\n10.1182/blood-2016-03-643544\n\n.", "journal-title": "Blood"}, {"issue": "3", "key": "7_CR4", "doi-asserted-by": "publisher", "first-page": "382", "DOI": "10.1111/bjh.14061", "volume": "174", "author": "SA Srour", "year": "2016", "unstructured": "Srour SA, Devesa SS, Morton LM, et al. Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the united states, 2001\u201312. Br J Haematol. 2016;174(3):382\u201396. doi:\n10.1111/bjh.14061\n\n.", "journal-title": "Br J Haematol"}, {"key": "7_CR5", "unstructured": "Mesa RA, Miller CB, Thyne M, et al. Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: findings from the MPN landmark survey. Cancer. 2016. doi:\n10.1002/cncr.30325\n\n.", "DOI": "10.1002/cncr.30325", "doi-asserted-by": "publisher"}, {"issue": "21", "key": "7_CR6", "doi-asserted-by": "publisher", "first-page": "5710", "DOI": "10.1182/blood-2010-07-293761", "volume": "117", "author": "J Thiele", "year": "2011", "unstructured": "Thiele J, Kvasnicka HM, Mullauer L, et al. Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification. Blood. 2011;117(21):5710\u20138. doi:\n10.1182/blood-2010-07-293761\n\n.", "journal-title": "Blood"}, {"issue": "23", "key": "7_CR7", "doi-asserted-by": "publisher", "first-page": "3179", "DOI": "10.1200/JCO.2010.34.5298", "volume": "29", "author": "T Barbui", "year": "2011", "unstructured": "Barbui T, Thiele J, Passamonti F, et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. J Clin Oncol. 2011;29(23):3179\u201384. doi:\n10.1200/JCO.2010.34.5298\n\n.", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "7_CR8", "doi-asserted-by": "publisher", "first-page": "1126", "DOI": "10.1038/leu.2015.360", "volume": "30", "author": "H Gisslinger", "year": "2016", "unstructured": "Gisslinger H, Jeryczynski G, Gisslinger B, et al. Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria. Leukemia. 2016;30(5):1126\u201332. doi:\n10.1038/leu.2015.360\n\n.", "journal-title": "Leukemia"}, {"issue": "9", "key": "7_CR9", "doi-asserted-by": "publisher", "first-page": "1193", "DOI": "10.1038/modpathol.2012.87.", "volume": "25", "author": "U Gianelli", "year": "2012", "unstructured": "Gianelli U, Vener C, Bossi A, et al. The European consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis. Mod Pathol Off J US Can Acad Pathol Inc. 2012;25(9):1193\u2013202. doi:\n10.1038/modpathol.2012.87.", "journal-title": "Mod Pathol Off J US Can Acad Pathol Inc"}, {"key": "7_CR10", "doi-asserted-by": "publisher", "first-page": "1325", "DOI": "10.1182/blood-2015-11-681932", "volume": "127", "author": "I Chachoua", "year": "2016", "unstructured": "Chachoua I, Pecquet C, El-Khoury M, et al. Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants. Blood. 2016;127:1325\u201335. doi:\n10.1182/blood-2015-11-681932\n\n.", "journal-title": "Blood"}, {"issue": "9464", "key": "7_CR11", "doi-asserted-by": "publisher", "first-page": "1054", "DOI": "10.1016/S0140-6736(05)71142-9", "volume": "365", "author": "EJ Baxter", "year": "2005", "unstructured": "Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365(9464):1054\u201361. doi:\n10.1016/S0140-6736(05)71142-9\n\n.", "journal-title": "Lancet"}, {"issue": "7037", "key": "7_CR12", "doi-asserted-by": "publisher", "first-page": "1144", "DOI": "10.1038/nature03546", "volume": "434", "author": "C James", "year": "2005", "unstructured": "James C, Ugo V, Le Couedic J-P, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434(7037):1144\u20138. doi:\n10.1038/nature03546\n\n.", "journal-title": "Nature"}, {"issue": "17", "key": "7_CR13", "doi-asserted-by": "publisher", "first-page": "1779", "DOI": "10.1056/NEJMoa051113", "volume": "352", "author": "R Kralovics", "year": "2005", "unstructured": "Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352(17):1779\u201390. doi:\n10.1056/NEJMoa051113\n\n.", "journal-title": "N Engl J Med"}, {"key": "7_CR14", "doi-asserted-by": "publisher", "first-page": "387", "DOI": "10.1016/j.ccr.2005.03.023", "volume": "4", "author": "RL Levine", "year": "2005", "unstructured": "Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;4:387\u201397. doi:\n10.1016/j.ccr.2005.03.023\n\n.", "journal-title": "Cancer Cell"}, {"issue": "8", "key": "7_CR15", "doi-asserted-by": "publisher", "DOI": "10.1038/bcj.2015.64", "volume": "5", "author": "T Barbui", "year": "2015", "unstructured": "Barbui T, Thiele J, Vannucchi AM, et al. Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis. Blood Cancer J. 2015;5(8):e337. doi:\n10.1038/bcj.2015.64\n\n.", "journal-title": "Blood Cancer J"}, {"key": "7_CR16", "doi-asserted-by": "publisher", "first-page": "2435", "DOI": "10.1182/blood-2006-04-018259", "volume": "108", "author": "LM Scott", "year": "2006", "unstructured": "Scott LM, Scott MA, Campbell PJ, et al. Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. Blood. 2006;108:2435\u20137. doi:\n10.1182/blood-2006-04-018259\n\n.", "journal-title": "Blood"}, {"key": "7_CR17", "doi-asserted-by": "publisher", "first-page": "3676", "DOI": "10.1182/blood-2005-09-3826", "volume": "107", "author": "F Passamonti", "year": "2006", "unstructured": "Passamonti F, Rumi E, Daniela P, et al. Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders. Blood. 2006;107:3676\u201382. doi:\n10.1182/blood-2005-09-3826\n\n.", "journal-title": "Blood"}, {"issue": "10", "key": "7_CR18", "doi-asserted-by": "publisher", "first-page": "1186", "DOI": "10.1016/j.exphem.2009.07.005", "volume": "37", "author": "K Hussein", "year": "2009", "unstructured": "Hussein K, Bock O, Theophile K, von Neuhoff N, et al. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis. Exp Hematol. 2009;37(10):1186\u20131193.e7. doi:\n10.1016/j.exphem.2009.07.005\n\n.", "journal-title": "Exp Hematol"}, {"issue": "1", "key": "7_CR19", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.3324/haematol.11653", "volume": "93", "author": "E Antonioli", "year": "2008", "unstructured": "Antonioli E, Guglielmelli P, Poli G, et al. Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia. Haematologica. 2008;93(1):41\u20138. doi:\n10.3324/haematol.11653\n\n.", "journal-title": "Haematologica"}, {"issue": "9", "key": "7_CR20", "doi-asserted-by": "crossref", "first-page": "2074", "DOI": "10.1038/sj.leu.2404724", "volume": "21", "author": "A Tefferi", "year": "2007", "unstructured": "Tefferi A, Strand JJ, Lasho TL, et al. Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera. Leukemia. 2007;21(9):2074\u20135.", "journal-title": "Leukemia"}, {"issue": "3", "key": "7_CR21", "doi-asserted-by": "publisher", "first-page": "840", "DOI": "10.1182/blood-2006-12-064287", "volume": "110", "author": "AM Vannucchi", "year": "2007", "unstructured": "Vannucchi AM, Antonioli E, Guglielmelli P, et al. Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. Blood. 2007;110(3):840\u20136. doi:\n10.1182/blood-2006-12-064287\n\n.", "journal-title": "Blood"}, {"issue": "25", "key": "7_CR22", "doi-asserted-by": "publisher", "first-page": "2391", "DOI": "10.1056/NEJMoa1312542", "volume": "369", "author": "J Nangalia", "year": "2013", "unstructured": "Nangalia J, Massie CE, Baxter EJ, et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. NEJM. 2013;369(25):2391\u2013405. doi:\n10.1056/NEJMoa1312542\n\n.", "journal-title": "NEJM"}, {"issue": "25", "key": "7_CR23", "doi-asserted-by": "publisher", "first-page": "2379", "DOI": "10.1056/NEJMoa1311347", "volume": "369", "author": "T Klampfl", "year": "2013", "unstructured": "Klampfl T, Gisslinger H, Harutyunyan AS, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013;369(25):2379\u201390. doi:\n10.1056/NEJMoa1311347\n\n.", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "7_CR24", "doi-asserted-by": "publisher", "first-page": "431", "DOI": "10.1038/leu.2015.277", "volume": "30", "author": "D Pietra", "year": "2016", "unstructured": "Pietra D, Rumi E, Ferretti VV, Di Buduo CA, et al. Differential clinical effects of different mutations subtypes in CALR-mutant myeloproliferative neoplasms. Leukemia. 2016;30(2):431\u20138. doi:\n10.1038/leu.2015.277\n\n.", "journal-title": "Leukemia"}, {"issue": "6", "key": "7_CR25", "doi-asserted-by": "publisher", "first-page": "1344", "DOI": "10.1038/leu.2015.87", "volume": "29", "author": "F Palandri", "year": "2015", "unstructured": "Palandri F, Latagliata R, Polverelli N, et al. Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis. Leukemia. 2015;29(6):1344\u20139. doi:\n10.1038/leu.2015.87\n\n.", "journal-title": "Leukemia"}, {"issue": "7", "key": "7_CR26", "doi-asserted-by": "publisher", "first-page": "681", "DOI": "10.1002/ajh.24377", "volume": "91", "author": "G Rotunno", "year": "2016", "unstructured": "Rotunno G, Pacilli A, Artusi V, et al. Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: a study on 359 patients of the AGIMM group. Am J Hematol. 2016;91(7):681\u20136. doi:\n10.1002/ajh.24377\n\n.", "journal-title": "Am J Hematol"}, {"issue": "3", "key": "7_CR27", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1182/blood-2015-07-661835", "volume": "127", "author": "JD Milosevic Feenstra", "year": "2016", "unstructured": "Milosevic Feenstra JD, Nivarthi H, Gisslinger H, et al. Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms. Blood. 2016;127(3):325\u201332. doi:\n10.1182/blood-2015-07-661835\n\n.", "journal-title": "Blood"}, {"key": "7_CR28", "doi-asserted-by": "publisher", "first-page": "988", "DOI": "10.1182/blood-2010-02-270108", "volume": "116", "author": "O ST", "year": "2010", "unstructured": "ST O, Simonds EF, Jones C, et al. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood. 2010;116:988\u201392. doi:\n10.1182/blood-2010-02-270108\n\n.", "journal-title": "Blood"}, {"issue": "14", "key": "7_CR29", "doi-asserted-by": "publisher", "first-page": "2220", "DOI": "10.1182/blood-2013-11-537167", "volume": "123", "author": "P Lundberg", "year": "2014", "unstructured": "Lundberg P, Karow A, Nienhold R, et al. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood. 2014;123(14):2220\u20138. doi:\n10.1182/blood-2013-11-537167\n\n.", "journal-title": "Blood"}, {"issue": "5", "key": "7_CR30", "doi-asserted-by": "publisher", "first-page": "905", "DOI": "10.1038/leu.2009.47", "volume": "23", "author": "A Tefferi", "year": "2009", "unstructured": "Tefferi A, Pardanani A, Lim KH, et al. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia. 2009;23(5):905\u201311. doi:\n10.1038/leu.2009.47\n\n.", "journal-title": "Leukemia"}, {"key": "7_CR31", "unstructured": "Delic S, Rose D, Kern W, et al. Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera. Br J Haematol. 2016. doi:\n10.1111/bjh.14269\n\n.", "DOI": "10.1111/bjh.14269", "doi-asserted-by": "publisher"}, {"key": "7_CR32", "doi-asserted-by": "publisher", "first-page": "2199", "DOI": "10.1182/blood-2008-03-143602", "volume": "112", "author": "O Landgren", "year": "2008", "unstructured": "Landgren O, Goldin L, Kristinsson S, et al. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden. Blood. 2008;112:2199\u2013204. doi:\n10.1182/blood-2008-03-143602\n\n.", "journal-title": "Blood"}, {"key": "7_CR33", "doi-asserted-by": "publisher", "first-page": "450", "DOI": "10.1038/ng.341", "volume": "41", "author": "D Olcaydu", "year": "2009", "unstructured": "Olcaydu D, Harutyunyan A, Jager R, et al. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat Genet. 2009;41:450\u20134. doi:\n10.1038/ng.341\n\n.", "journal-title": "Nat Genet"}, {"key": "7_CR34", "doi-asserted-by": "publisher", "first-page": "2785", "DOI": "10.1182/blood-2007-06-095703", "volume": "111", "author": "A Pardanani", "year": "2008", "unstructured": "Pardanani A, Fridley BL, Lasho TL, et al. Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders. Blood. 2008;111:2785\u20139. doi:\n10.1182/blood-2007-06-095703\n\n.", "journal-title": "Blood"}, {"key": "7_CR35", "doi-asserted-by": "publisher", "first-page": "1121", "DOI": "10.1182/blood-2015-06-652941", "volume": "128", "author": "DA Hinds", "year": "2016", "unstructured": "Hinds DA, Barnholt KE, Mesa RA, et al. Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. Blood. 2016;128:1121\u20138. doi:\n10.1182/blood-2015-06-652941\n\n.", "journal-title": "Blood"}, {"key": "7_CR36", "doi-asserted-by": "publisher", "first-page": "6691", "DOI": "10.1038/ncomms7691", "volume": "6", "author": "W Tapper", "year": "2015", "unstructured": "Tapper W, Jones AV, Kralovics R, et al. Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms. Nat Commun. 2015;6:6691. doi:\n10.1038/ncomms7691\n\n.", "journal-title": "Nat Commun"}, {"key": "7_CR37", "doi-asserted-by": "publisher", "first-page": "e369", "DOI": "10.1038/bcj.2015.94", "volume": "5", "author": "T Barbui", "year": "2015", "unstructured": "Barbui T, Vannucchi AM, Buxhofer-Ausch V, et al. Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia. Blood Cancer J. 2015;5:e369. doi:\n10.1038/bcj.2015.94\n\n.", "journal-title": "Blood Cancer J"}, {"issue": "4", "key": "7_CR38", "doi-asserted-by": "publisher", "first-page": "390", "DOI": "10.1002/ajh.24293", "volume": "91", "author": "M Haider", "year": "2016", "unstructured": "Haider M, Gangat N, Lasho T, et al. Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET-thrombosis) in 585 mayo clinic patients. Am J Hematol. 2016;91(4):390\u20134. doi:\n10.1002/ajh.24293\n\n.", "journal-title": "Am J Hematol"}, {"key": "7_CR39", "doi-asserted-by": "publisher", "first-page": "2507", "DOI": "10.1182/blood-2014-05-579136", "volume": "124", "author": "A Tefferi", "year": "2014", "unstructured": "Tefferi A, Guglielmelli P, Larson DR, et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood. 2014;124:2507\u201313. doi:\n10.1182/blood-2014-05-579136\n\n.", "journal-title": "Blood"}, {"key": "7_CR40", "doi-asserted-by": "publisher", "first-page": "e366", "DOI": "10.1038/bcj.2015.95", "volume": "5", "author": "S Cerquozzi", "year": "2015", "unstructured": "Cerquozzi S, Tefferi A. Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J. 2015;5:e366. doi:\n10.1038/bcj.2015.95\n\n.", "journal-title": "Blood Cancer J"}, {"issue": "2", "key": "7_CR41", "doi-asserted-by": "publisher", "first-page": "162", "DOI": "10.1002/ajh.23895.", "volume": "90", "author": "A Tefferi", "year": "2015", "unstructured": "Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management. Am J Hematol. 2015;90(2):162\u201373. doi:\n10.1002/ajh.23895.", "journal-title": "Am J Hematol"}, {"key": "7_CR42", "doi-asserted-by": "publisher", "first-page": "893", "DOI": "10.1182/blood-2012-07-44201", "volume": "122", "author": "A Quint\u00e1s-Cardama", "year": "2013", "unstructured": "Quint\u00e1s-Cardama A, Abdel-Wahab O, Manshouri T, et al. Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon \u03b1-2a. Blood. 2013;122:893\u2013901. doi:\n10.1182/blood-2012-07-44201\n\n.", "journal-title": "Blood"}, {"issue": "2", "key": "7_CR43", "doi-asserted-by": "publisher", "first-page": "188", "DOI": "10.1056/NEJMc1401255", "volume": "371", "author": "B Cassinat", "year": "2014", "unstructured": "Cassinat B, Verger E, Kiladjian JJ. Interferon alfa therapy in CALR-mutated essential thrombocythemia. N Engl J Med. 2014;371(2):188\u20139. doi:\n10.1056/NEJMc1401255\n\n.", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "7_CR44", "doi-asserted-by": "publisher", "first-page": "114", "DOI": "10.1056/NEJMoa035572", "volume": "350", "author": "R Landolfi", "year": "2004", "unstructured": "Landolfi R, Marchioli R, Kutti J, et al. Efficacy and safety of low-dose aspirin in polycythemia vera. N Engl J Med. 2004;350(2):114\u201324. doi:\n10.1056/NEJMoa035572\n\n.", "journal-title": "N Engl J Med"}, {"issue": "10", "key": "7_CR45", "doi-asserted-by": "publisher", "first-page": "1720", "DOI": "10.1182/blood-2012-07-443770", "volume": "121", "author": "H Gisslinger", "year": "2013", "unstructured": "Gisslinger H, Gotic M, Holowiecki J, et al. Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial. Blood. 2013;121(10):1720\u20138. doi:\n10.1182/blood-2012-07-443770\n\n.", "journal-title": "Blood"}, {"key": "7_CR46", "doi-asserted-by": "crossref", "first-page": "184", "DOI": "10.1182/blood-2014-03-562538", "volume": "124", "author": "S Verstovsek", "year": "2014", "unstructured": "Verstovsek S, Passamonti F, Rambaldi A, et al. Long-term results from a phase II open-label study of ruxolitinib in patients with essential thrombocythemia refractory to or intolerant of hydroxyurea. Blood. 2014;124:184.", "journal-title": "Blood"}, {"key": "7_CR47", "unstructured": "Tefferi A, Wassie EA, Lasho TL, et al. Calreticulin mutations and long-term survival in essential thrombocythemia. Leukemia. 2014;(12):2300\u20133. doi:\n10.1038/leu.2014.148\n\n.", "DOI": "10.1038/leu.2014.148", "doi-asserted-by": "publisher"}, {"key": "7_CR48", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1177/2040620713489144", "volume": "4", "author": "AV Jones", "year": "2013", "unstructured": "Jones AV, Cross NC. Inherited predisposition to myeloproliferative neoplasms. Ther Adv Hematol. 2013;4:237\u201353.", "journal-title": "Ther Adv Hematol"}], "container-title": ["Molecular Pathology Library", "Precision Molecular Pathology of Myeloid Neoplasms"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-62146-3_7", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 9, 27]], "date-time": "2017-09-27T11:46:03Z", "timestamp": 1506512763000}, "score": 23.270538, "issued": {"date-parts": [[2017, 9, 13]]}, "ISBN": ["9783319621449", "9783319621463"], "references-count": 48, "URL": "http://dx.doi.org/10.1007/978-3-319-62146-3_7", "relation": {"cites": []}, "ISSN": ["1935-987X", "1935-9888"], "issn-type": [{"value": "1935-987X", "type": "print"}, {"value": "1935-9888", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T10:57:25Z", "timestamp": 1574852245400}, "publisher-location": "Cham", "reference-count": 71, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319579832", "type": "print"}, {"value": "9783319579856", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2017, 1, 1]], "date-time": "2017-01-01T00:00:00Z", "timestamp": 1483228800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2017]]}, "DOI": "10.1007/978-3-319-57985-6_9", "type": "book-chapter", "created": {"date-parts": [[2017, 10, 28]], "date-time": "2017-10-28T12:04:39Z", "timestamp": 1509192279000}, "page": "169-186", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Hereditary Endometrial Carcinoma"], "prefix": "10.1007", "author": [{"given": "Anne M.", "family": "Mills", "sequence": "first", "affiliation": []}, {"given": "Teri A.", "family": "Longacre", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 10, 29]]}, "reference": [{"issue": "2", "key": "9_CR1", "doi-asserted-by": "crossref", "first-page": "214", "DOI": "10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L", "volume": "81", "author": "M Aarnio", "year": "1999", "unstructured": "Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer J Int Cancer. 1999;81(2):214\u20138 (Epub 03 Apr 1999).", "journal-title": "Int J Cancer J Int Cancer"}, {"issue": "2", "key": "9_CR2", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1007/s10689-013-9615-1", "volume": "12", "author": "E Barrow", "year": "2013", "unstructured": "Barrow E, Hill J, Evans DG. Cancer risk in Lynch syndrome. Fam Cancer. 2013;12(2):229\u201340 (Epub 23 Apr 2013).", "journal-title": "Fam Cancer"}, {"issue": "2", "key": "9_CR3", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1111/j.1399-0004.2008.01125.x", "volume": "75", "author": "E Barrow", "year": "2009", "unstructured": "Barrow E, Robinson L, Alduaij W, Shenton A, Clancy T, Lalloo F, et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet. 2009;75(2):141\u20139 (Epub 14 Feb 2009).", "journal-title": "Clin Genet"}, {"issue": "1", "key": "9_CR4", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1111/j.1399-0004.2009.01230.x", "volume": "76", "author": "HT Lynch", "year": "2009", "unstructured": "Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet. 2009;76(1):1\u201318 (Epub 08 Aug 2009).", "journal-title": "Clin Genet"}, {"issue": "6", "key": "9_CR5", "doi-asserted-by": "crossref", "first-page": "491", "DOI": "10.1136/jmg.2004.024299", "volume": "42", "author": "F Quehenberger", "year": "2005", "unstructured": "Quehenberger F, Vasen HF, van Houwelingen HC. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet. 2005;42(6):491\u20136 (Epub 07 June 2005).", "journal-title": "J Med Genet"}, {"issue": "4", "key": "9_CR6", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1200/JCO.2014.57.8088", "volume": "33", "author": "SW Broeke ten", "year": "2015", "unstructured": "ten Broeke SW, Brohet RM, Tops CM, van der Klift HM, Velthuizen ME, Bernstein I, et al. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk. J Clin Oncol: Off J Am Soc Clin Oncol. 2015;33(4):319\u201325 (Epub 17 Dec 2014).", "journal-title": "J Clin Oncol: Off J Am Soc Clin Oncol"}, {"issue": "1", "key": "9_CR7", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1016/S1470-2045(10)70265-5", "volume": "12", "author": "MJ Kempers", "year": "2011", "unstructured": "Kempers MJ, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, Rahner N, et al. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol. 2011;12(1):49\u201355 (Epub 15 Dec 2010).", "journal-title": "Lancet Oncol"}, {"issue": "2", "key": "9_CR8", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1007/s10689-012-9591-x", "volume": "12", "author": "MJ Ligtenberg", "year": "2013", "unstructured": "Ligtenberg MJ, Kuiper RP, Geurts van Kessel A, Hoogerbrugge N. EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients. Fam Cancer. 2013;12(2):169\u201374 (Epub 25 Dec 2012).", "journal-title": "Fam Cancer"}, {"issue": "1", "key": "9_CR9", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1016/j.jmoldx.2010.11.011", "volume": "13", "author": "K Rumilla", "year": "2011", "unstructured": "Rumilla K, Schowalter KV, Lindor NM, Thomas BC, Mensink KA, Gallinger S, et al. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. J Mol Diagn (JMD). 2011;13(1):93\u20139 (Epub 14 Jan 2011).", "journal-title": "J Mol Diagn (JMD)"}, {"issue": "8", "key": "9_CR10", "doi-asserted-by": "crossref", "first-page": "737", "DOI": "10.1002/gcc.20678", "volume": "48", "author": "RC Niessen", "year": "2009", "unstructured": "Niessen RC, Hofstra RM, Westers H, Ligtenberg MJ, Kooi K, Jager PO, et al. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosom Cancer. 2009;48(8):737\u201344 (Epub 21 May 2009).", "journal-title": "Genes Chromosom Cancer"}, {"issue": "12", "key": "9_CR11", "doi-asserted-by": "crossref", "first-page": "789", "DOI": "10.1136/jmedgenet-2014-102552", "volume": "51", "author": "K Newton", "year": "2014", "unstructured": "Newton K, Jorgensen NM, Wallace AJ, Buchanan DD, Lalloo F, McMahon RF, et al. Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC). J Med Genet. 2014;51(12):789\u201396 (Epub 05 Oct 2014).", "journal-title": "J Med Genet"}, {"issue": "3", "key": "9_CR12", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1097/PGP.0b013e318231fc51", "volume": "31", "author": "LM Peterson", "year": "2012", "unstructured": "Peterson LM, Kipp BR, Halling KC, Kerr SE, Smith DI, Distad TJ, et al. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis. Int J Gynecol Pathol: Off J Int Soc Gynecol Pathol. 2012;31(3):195\u2013205 (Epub 14 Apr 2012).", "journal-title": "Int J Gynecol Pathol: Off J Int Soc Gynecol Pathol"}, {"issue": "22", "key": "9_CR13", "doi-asserted-by": "crossref", "first-page": "2304", "DOI": "10.1001/jama.2011.743", "volume": "305", "author": "V Bonadona", "year": "2011", "unstructured": "Bonadona V, Bonaiti B, Olschwang S, Grandjouan S, Huiart L, Longy M, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011;305(22):2304\u201310 (Epub 07 June 2011).", "journal-title": "JAMA"}, {"issue": "15", "key": "9_CR14", "doi-asserted-by": "crossref", "first-page": "7810", "DOI": "10.1158/0008-5472.CAN-06-1114", "volume": "66", "author": "H Hampel", "year": "2006", "unstructured": "Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D, et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Can Res. 2006;66(15):7810\u20137 (Epub 04 Aug 2006).", "journal-title": "Can Res"}, {"issue": "18", "key": "9_CR15", "doi-asserted-by": "crossref", "first-page": "1851", "DOI": "10.1056/NEJMoa043146", "volume": "352", "author": "H Hampel", "year": "2005", "unstructured": "Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Medicine. 2005;352(18):1851\u201360 (Epub 06 May 2005).", "journal-title": "N Engl J Medicine"}, {"issue": "2", "key": "9_CR16", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1016/j.gastro.2005.05.011", "volume": "129", "author": "H Hampel", "year": "2005", "unstructured": "Hampel H, Stephens JA, Pukkala E, Sankila R, Aaltonen LA, Mecklin JP, et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology. 2005;129(2):415\u201321 (Epub 09 Aug 2005).", "journal-title": "Gastroenterology"}, {"issue": "3", "key": "9_CR17", "doi-asserted-by": "crossref", "first-page": "677", "DOI": "10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#", "volume": "71", "author": "P Watson", "year": "1993", "unstructured": "Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer. 1993;71(3):677\u201385 (Epub 01 Feb 1993.", "journal-title": "Cancer"}, {"issue": "24", "key": "9_CR18", "doi-asserted-by": "crossref", "first-page": "3932", "DOI": "10.1002/cncr.28933", "volume": "120", "author": "SE Ferguson", "year": "2014", "unstructured": "Ferguson SE, Aronson M, Pollett A, Eiriksson LR, Oza AM, Gallinger S, et al. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. Cancer. 2014;120(24):3932\u20139 (Epub 02 Aug 2014).", "journal-title": "Cancer"}, {"issue": "11", "key": "9_CR19", "doi-asserted-by": "crossref", "first-page": "1501", "DOI": "10.1097/PAS.0000000000000321", "volume": "38", "author": "AM Mills", "year": "2014", "unstructured": "Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J Surg Pathol. 2014;38(11):1501\u20139 (Epub 18 Sep 2014).", "journal-title": "Am J Surg Pathol"}, {"issue": "4", "key": "9_CR20", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1097/PAP.0b013e31825c6b76", "volume": "19", "author": "BA Clarke", "year": "2012", "unstructured": "Clarke BA, Cooper K. Identifying Lynch syndrome in patients with endometrial carcinoma: shortcomings of morphologic and clinical schemas. Adv Anat Pathol. 2012;19(4):231\u20138 (Epub 14 June 2012).", "journal-title": "Adv Anat Pathol"}, {"issue": "35", "key": "9_CR21", "doi-asserted-by": "crossref", "first-page": "5783", "DOI": "10.1200/JCO.2008.17.5950", "volume": "26", "author": "H Hampel", "year": "2008", "unstructured": "Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol: Off J Am Soc Clin Oncol. 2008;26(35):5783\u20138 (Epub 24 Sep 2008).", "journal-title": "J Clin Oncol: Off J Am Soc Clin Oncol"}, {"issue": "4", "key": "9_CR22", "doi-asserted-by": "crossref", "first-page": "e35", "DOI": "10.1097/PAS.0000000000000608", "volume": "40", "author": "AM Mills", "year": "2016", "unstructured": "Mills AM, Longacre TA. Lynch syndrome screening in the gynecologic tract: current state of the art. Am J Surg Pathol. 2016;40(4):e35\u201344 (Epub 13 Feb 2016).", "journal-title": "Am J Surg Pathol"}, {"issue": "6", "key": "9_CR23", "doi-asserted-by": "crossref", "first-page": "925", "DOI": "10.1097/PAS.0b013e318197a046", "volume": "33", "author": "K Garg", "year": "2009", "unstructured": "Garg K, Leitao MM Jr, Kauff ND, Hansen J, Kosarin K, Shia J, et al. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Am J Surg Pathol. 2009;33(6):925\u201333 (Epub 25 Feb 2009).", "journal-title": "Am J Surg Pathol"}, {"key": "9_CR24", "unstructured": "Mills A, Sloan E, Thomas M, et al. Clinicopathologic comparison of lynch syndrome-associated and lynch-like endometrial carcinomas identified on universal screening. Am J Surg Pathol. 2015 (In Press).", "DOI": "10.1097/PAS.0000000000000544", "doi-asserted-by": "crossref"}, {"issue": "6", "key": "9_CR25", "doi-asserted-by": "crossref", "first-page": "793", "DOI": "10.1097/PAS.0000000000000177", "volume": "38", "author": "JT Rabban", "year": "2014", "unstructured": "Rabban JT, Calkins SM, Karnezis AN, Grenert JP, Blanco A, Crawford B, et al. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Am J Surg Pathol. 2014;38(6):793\u2013800 (Epub 08 Feb 2014).", "journal-title": "Am J Surg Pathol"}, {"issue": "1", "key": "9_CR26", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1002/cncr.21560", "volume": "106", "author": "RR Broaddus", "year": "2006", "unstructured": "Broaddus RR, Lynch HT, Chen LM, Daniels MS, Conrad P, Munsell MF, et al. Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma. Cancer. 2006;106(1):87\u201394 (Epub 03 Dec 2005).", "journal-title": "Cancer"}, {"issue": "1", "key": "9_CR27", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1177/1066896909332117", "volume": "18", "author": "ML Carcangiu", "year": "2010", "unstructured": "Carcangiu ML, Radice P, Casalini P, Bertario L, Merola M, Sala P. Lynch syndrome-related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types. Int J Surg Pathol. 2010;18(1):21\u20136 (Epub 16 May 2009).", "journal-title": "Int J Surg Pathol"}, {"issue": "3", "key": "9_CR28", "doi-asserted-by": "crossref", "first-page": "1386", "DOI": "10.1111/j.1525-1438.2006.00535.x", "volume": "16", "author": "LH Honore", "year": "2006", "unstructured": "Honore LH, Hanson J, Andrew SE. Microsatellite instability in endometrioid endometrial carcinoma: correlation with clinically relevant pathologic variables. Int J Gynecol Cancer: Off J Int Gynecol Cancer Soc. 2006;16(3):1386\u201392 (Epub 29 June 2006).", "journal-title": "Int J Gynecol Cancer: Off J Int Gynecol Cancer Soc"}, {"issue": "1", "key": "9_CR29", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1016/j.humpath.2007.05.022", "volume": "39", "author": "J Shia", "year": "2008", "unstructured": "Shia J, Black D, Hummer AJ, Boyd J, Soslow RA. Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer. Hum Pathol. 2008;39(1):116\u201325 (Epub 24 Oct 2007).", "journal-title": "Hum Pathol"}, {"key": "9_CR30", "unstructured": "Tafe LJ, Garg K, Chew I, Tornos C, Soslow RA. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms. Mod Pathol: Off J US Can Acad Pathol Inc. 2010;23(6):781\u20139 (Epub 23 Mar 2010)", "DOI": "10.1038/modpathol.2010.41", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "9_CR31", "first-page": "155", "volume": "40", "author": "AM Mills", "year": "2016", "unstructured": "Mills AM, Sloan EA, Thomas M, Modesitt SC, Stoler MH, Atkins KA, et al. Clinicopathologic comparison of Lynch syndrome-associated and \u201cLynch-like\u201d endometrial carcinomas identified on universal screening using mismatch repair protein immunohistochemistry. Am J Surg Pathol. 2016;40(2):155\u201365 (Epub 03 Nov 2015).", "journal-title": "Am J Surg Pathol"}, {"issue": "8", "key": "9_CR32", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1136/jcp.2009.064949", "volume": "62", "author": "K Garg", "year": "2009", "unstructured": "Garg K, Soslow RA. Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma. J Clin Pathol. 2009;62(8):679\u201384 (Epub 30 July 2009).", "journal-title": "J Clin Pathol"}, {"issue": "3", "key": "9_CR33", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1002/1096-9896(2000)9999:9999<::AID-PATH701>3.0.CO;2-2", "volume": "192", "author": "WJ Leeuw de", "year": "2000", "unstructured": "de Leeuw WJ, Dierssen J, Vasen HF, Wijnen JT, Kenter GG, Meijers-Heijboer H, et al. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients. J Pathol. 2000;192(3):328\u201335 (Epub 31 Oct 2000).", "journal-title": "J Pathol"}, {"issue": "2", "key": "9_CR34", "doi-asserted-by": "crossref", "first-page": "306", "DOI": "10.1016/j.ygyno.2015.01.541", "volume": "137", "author": "MK McConechy", "year": "2015", "unstructured": "McConechy MK, Talhouk A, Li-Chang HH, Leung S, Huntsman DG, Gilks CB, et al. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas. Gynecol Oncol. 2015;137(2):306\u201310 (Epub 01 Feb 2015).", "journal-title": "Gynecol Oncol"}, {"issue": "5", "key": "9_CR35", "doi-asserted-by": "crossref", "first-page": "744", "DOI": "10.1097/01.pas.0000213428.61374.06", "volume": "31", "author": "I Modica", "year": "2007", "unstructured": "Modica I, Soslow RA, Black D, Tornos C, Kauff N, Shia J. Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma. Am J Surg Pathol. 2007;31(5):744\u201351 (Epub 27 Apr 2007).", "journal-title": "Am J Surg Pathol"}, {"issue": "3", "key": "9_CR36", "doi-asserted-by": "crossref", "first-page": "681", "DOI": "10.1002/cncr.26323", "volume": "118", "author": "P Ryan", "year": "2012", "unstructured": "Ryan P, Mulligan AM, Aronson M, Ferguson SE, Bapat B, Semotiuk K, et al. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries. Cancer. 2012;118(3):681\u20138 (Epub 02 July 2011).", "journal-title": "Cancer"}, {"issue": "2", "key": "9_CR37", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/j.path.2016.01.004", "volume": "9", "author": "AM Mills", "year": "2016", "unstructured": "Mills AM, Longacre TA. Lynch syndrome: female genital tract cancer diagnosis and screening. Surg Pathol Clin. 2016;9(2):201\u201314 (Epub 01 June 2016).", "journal-title": "Surg Pathol Clin"}, {"key": "9_CR38", "unstructured": "Mojtahed A, Schrijver I, Ford JM, Longacre TA, Pai RK. A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas. Mod Pathol: Off J US Can Acad Pathol Inc. 2011;24(7):1004\u201314 (Epub 19 Apr 2011)", "DOI": "10.1038/modpathol.2011.55", "doi-asserted-by": "crossref"}, {"issue": "11", "key": "9_CR39", "doi-asserted-by": "crossref", "first-page": "1639", "DOI": "10.1097/PAS.0b013e3181b15aa2", "volume": "33", "author": "J Shia", "year": "2009", "unstructured": "Shia J, Tang LH, Vakiani E, Guillem JG, Stadler ZK, Soslow RA, et al. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol. 2009;33(11):1639\u201345 (Epub 25 Aug 2009).", "journal-title": "Am J Surg Pathol"}, {"issue": "12", "key": "9_CR40", "doi-asserted-by": "crossref", "first-page": "1902", "DOI": "10.1097/PAS.0b013e318237c6ab", "volume": "35", "author": "CE Hagen", "year": "2011", "unstructured": "Hagen CE, Lefferts J, Hornick JL, Srivastava A. \u201cNull pattern\u201d of immunoreactivity in a Lynch syndrome-associated colon cancer due to germline MSH2 mutation and somatic MLH1 hypermethylation. Am J Surg Pathol. 2011;35(12):1902\u20135 (Epub 10 Nov 2011).", "journal-title": "Am J Surg Pathol"}, {"issue": "8", "key": "9_CR41", "doi-asserted-by": "crossref", "first-page": "1114", "DOI": "10.1097/PAS.0000000000000425", "volume": "39", "author": "B Dudley", "year": "2015", "unstructured": "Dudley B, Brand RE, Thull D, Bahary N, Nikiforova MN, Pai RK. Germline MLH1 mutations are frequently identified in Lynch syndrome patients with colorectal and endometrial carcinoma demonstrating isolated loss of PMS2 immunohistochemical expression. Am J Surg Pathol. 2015;39(8):1114\u201320 (Epub 15 Apr 2015).", "journal-title": "Am J Surg Pathol"}, {"issue": "7", "key": "9_CR42", "doi-asserted-by": "crossref", "first-page": "993", "DOI": "10.1097/PAS.0000000000000415", "volume": "39", "author": "RK Pai", "year": "2015", "unstructured": "Pai RK, Plesec TP, Abdul-Karim FW, Yang B, Marquard J, Shadrach B, et al. Abrupt loss of MLH1 and PMS2 expression in endometrial carcinoma: molecular and morphologic analysis of 6 cases. Am J Surg Pathol. 2015;39(7):993\u20139 (Epub 19 Mar 2015).", "journal-title": "Am J Surg Pathol"}, {"issue": "6", "key": "9_CR43", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1097/PAS.0000000000000606", "volume": "40", "author": "A Kato", "year": "2016", "unstructured": "Kato A, Sato N, Sugawara T, Takahashi K, Kito M, Makino K, et al. Isolated Loss of PMS2 immunohistochemical expression is frequently caused by heterogenous MLH1 promoter hypermethylation in lynch syndrome screening for endometrial cancer patients. Am J Surg Pathol. 2016;40(6):770\u20136 (Epub 06 Feb 2016).", "journal-title": "Am J Surg Pathol"}, {"issue": "22", "key": "9_CR44", "first-page": "5248", "volume": "58", "author": "CR Boland", "year": "1998", "unstructured": "Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Can Res. 1998;58(22):5248\u201357 (Epub 21 Nov 1998).", "journal-title": "Can Res"}, {"issue": "3", "key": "9_CR45", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1136/jmedgenet-2011-100714", "volume": "49", "author": "MT Parsons", "year": "2012", "unstructured": "Parsons MT, Buchanan DD, Thompson B, Young JP, Spurdle AB. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. J Med Genet. 2012;49(3):151\u20137 (Epub 01 Mar 2012).", "journal-title": "J Med Genet"}, {"issue": "1", "key": "9_CR46", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1093/carcin/bgv154", "volume": "37", "author": "Q Liu", "year": "2016", "unstructured": "Liu Q, Hesson LB, Nunez AC, Packham D, Williams R, Ward RL, et al. A cryptic paracentric inversion of MSH2 exons 2-6 causes Lynch syndrome. Carcinogenesis. 2016;37(1):10\u20137 (Epub 27 Oct 2015).", "journal-title": "Carcinogenesis"}, {"issue": "2", "key": "9_CR47", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1007/s10689-013-9688-x", "volume": "13", "author": "J Rhees", "year": "2014", "unstructured": "Rhees J, Arnold M, Boland CR. Inversion of exons 1-7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population. Fam Cancer. 2014;13(2):219\u201325 (Epub 12 Oct 2013).", "journal-title": "Fam Cancer"}, {"key": "9_CR48", "first-page": "183", "volume": "7", "author": "DD Buchanan", "year": "2014", "unstructured": "Buchanan DD, Rosty C, Clendenning M, Spurdle AB, Win AK. Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome). Appl Clin Genet. 2014;7:183\u201393 (Epub 21 Oct 2014).", "journal-title": "Appl Clin Genet."}, {"key": "9_CR49", "unstructured": "Haraldsdottir S, Hampel H, Tomsic J, Frankel WL, Pearlman R, de la Chapelle A, et al. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Gastroenterology. 2014;147(6):1308\u201316.e1 (Epub 10 Sep 2014)", "DOI": "10.1053/j.gastro.2014.08.041", "doi-asserted-by": "crossref"}, {"key": "9_CR50", "unstructured": "Mensenkamp AR, Vogelaar IP, van Zelst-Stams WA, Goossens M, Ouchene H, Hendriks-Cornelissen SJ, et al. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. Gastroenterology. 2014;146(3):643\u20136.e8 (Epub 18 Dec 2013)", "DOI": "10.1053/j.gastro.2013.12.002", "doi-asserted-by": "crossref"}, {"issue": "11", "key": "9_CR51", "doi-asserted-by": "crossref", "first-page": "828", "DOI": "10.1136/jmg.37.11.828", "volume": "37", "author": "C Eng", "year": "2000", "unstructured": "Eng C. Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet. 2000;37(11):828\u201330 (Epub 10 Nov 2000).", "journal-title": "J Med Genet"}, {"issue": "5", "key": "9_CR52", "doi-asserted-by": "crossref", "first-page": "705", "DOI": "10.1093/ajcp/97.5.705", "volume": "97", "author": "H Haibach", "year": "1992", "unstructured": "Haibach H, Burns TW, Carlson HE, Burman KD, Deftos LJ. Multiple hamartoma syndrome (Cowden\u2019s disease) associated with renal cell carcinoma and primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Am J Clin Pathol. 1992;97(5):705\u201312 (Epub 01 May 1992).", "journal-title": "Am J Clin Pathol"}, {"issue": "1", "key": "9_CR53", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/S0046-8177(98)90389-6", "volume": "29", "author": "CA Schrager", "year": "1998", "unstructured": "Schrager CA, Schneider D, Gruener AC, Tsou HC, Peacocke M. Clinical and pathological features of breast disease in Cowden\u2019s syndrome: an underrecognized syndrome with an increased risk of breast cancer. Hum Pathol. 1998;29(1):47\u201353 (Epub 28 Jan 1998).", "journal-title": "Hum Pathol"}, {"issue": "5", "key": "9_CR54", "doi-asserted-by": "crossref", "first-page": "644", "DOI": "10.1002/cncr.29107", "volume": "121", "author": "ZK Stadler", "year": "2015", "unstructured": "Stadler ZK, Robson ME. Inherited predisposition to endometrial cancer: moving beyond Lynch syndrome. Cancer. 2015;121(5):644\u20137 (Epub 08 Nov 2014).", "journal-title": "Cancer"}, {"key": "9_CR55", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1016/j.humpath.2015.10.002", "volume": "49", "author": "R Shaco-Levy", "year": "2016", "unstructured": "Shaco-Levy R, Jasperson KW, Martin K, Samadder NJ, Burt RW, Ying J, et al. Morphologic characterization of hamartomatous gastrointestinal polyps in Cowden syndrome, Peutz-Jeghers syndrome, and juvenile polyposis syndrome. Hum Pathol. 2016;49:39\u201348 (Epub 31 Jan 2016).", "journal-title": "Hum Pathol"}, {"issue": "5", "key": "9_CR56", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1136/jmg.2004.018036", "volume": "41", "author": "R Pilarski", "year": "2004", "unstructured": "Pilarski R, Eng C. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet. 2004;41(5):323\u20136 (Epub 04 May 2004).", "journal-title": "J Med Genet"}, {"issue": "2", "key": "9_CR57", "doi-asserted-by": "crossref", "first-page": "400", "DOI": "10.1158/1078-0432.CCR-11-2283", "volume": "18", "author": "MH Tan", "year": "2012", "unstructured": "Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res: Off J Am Assoc Cancer Res. 2012;18(2):400\u20137 (Epub 19 Jan 2012).", "journal-title": "Clin Cancer Res: Off J Am Assoc Cancer Res"}, {"issue": "1", "key": "9_CR58", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1038/ng0597-64", "volume": "16", "author": "D Liaw", "year": "1997", "unstructured": "Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997;16(1):64\u20137 (Epub 01 May 1997).", "journal-title": "Nat Genet"}, {"issue": "1", "key": "9_CR59", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1038/ng0596-114", "volume": "13", "author": "MR Nelen", "year": "1996", "unstructured": "Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet. 1996;13(1):114\u20136 (Epub 01 May 1996).", "journal-title": "Nat Genet"}, {"issue": "8", "key": "9_CR60", "doi-asserted-by": "crossref", "first-page": "1383", "DOI": "10.1093/hmg/6.8.1383", "volume": "6", "author": "MR Nelen", "year": "1997", "unstructured": "Nelen MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H, et al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet. 1997;6(8):1383\u20137 (Epub 01 Aug 1997).", "journal-title": "Hum Mol Genet"}, {"issue": "5", "key": "9_CR61", "doi-asserted-by": "crossref", "first-page": "688", "DOI": "10.1002/cncr.29106", "volume": "121", "author": "H Mahdi", "year": "2015", "unstructured": "Mahdi H, Mester JL, Nizialek EA, Ngeow J, Michener C, Eng C. Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study. Cancer. 2015;121(5):688\u201396 (Epub 08 Nov 2014).", "journal-title": "Cancer"}, {"issue": "7", "key": "9_CR62", "doi-asserted-by": "crossref", "first-page": "e268", "DOI": "10.1016/S1470-2045(13)70591-6", "volume": "15", "author": "R Murali", "year": "2014", "unstructured": "Murali R, Soslow RA, Weigelt B. Classification of endometrial carcinoma: more than two types. Lancet Oncol. 2014;15(7):e268\u201378 (Epub 30 May 2014).", "journal-title": "Lancet Oncol"}, {"issue": "10", "key": "9_CR63", "doi-asserted-by": "crossref", "first-page": "2796", "DOI": "10.1158/0008-5472.CAN-14-0108", "volume": "74", "author": "GL Mutter", "year": "2014", "unstructured": "Mutter GL, Monte NM, Neuberg D, Ferenczy A, Eng C. Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues. Can Res. 2014;74(10):2796\u2013802 (Epub 26 Mar 2014).", "journal-title": "Can Res"}, {"issue": "24", "key": "9_CR64", "doi-asserted-by": "crossref", "first-page": "2724", "DOI": "10.1001/jama.2010.1877", "volume": "304", "author": "KL Bennett", "year": "2010", "unstructured": "Bennett KL, Mester J, Eng C. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. JAMA. 2010;304(24):2724\u201331 (Epub 24 Dec 2010).", "journal-title": "JAMA"}, {"issue": "2", "key": "9_CR65", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/j.ajhg.2008.07.011", "volume": "83", "author": "Y Ni", "year": "2008", "unstructured": "Ni Y, Zbuk KM, Sadler T, Patocs A, Lobo G, Edelman E, et al. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Hum Genet. 2008;83(2):261\u20138 (Epub 06 Aug 2008).", "journal-title": "Am J Hum Genet"}, {"issue": "1", "key": "9_CR66", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1016/j.ygyno.2006.08.004", "volume": "104", "author": "ME Beiner", "year": "2007", "unstructured": "Beiner ME, Finch A, Rosen B, Lubinski J, Moller P, Ghadirian P, et al. The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations prospective study. Gynecol Oncol. 2007;104(1):7\u201310 Epub 12 Sep 2006).", "journal-title": "Gynecol Oncol"}, {"issue": "3", "key": "9_CR67", "doi-asserted-by": "crossref", "first-page": "395", "DOI": "10.1006/gyno.2000.6082", "volume": "80", "author": "DA Levine", "year": "2001", "unstructured": "Levine DA, Lin O, Barakat RR, Robson ME, McDermott D, Cohen L, et al. Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol. 2001;80(3):395\u20138 (Epub 27 Mar 2001).", "journal-title": "Gynecol Oncol"}, {"issue": "1", "key": "9_CR68", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.1016/j.ygyno.2013.03.027", "volume": "130", "author": "Y Segev", "year": "2013", "unstructured": "Segev Y, Iqbal J, Lubinski J, Gronwald J, Lynch HT, Moller P, et al. The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study. Gynecol Oncol. 2013;130(1):127\u201331 (Epub 09 Apr 2013).", "journal-title": "Gynecol Oncol"}, {"key": "9_CR69", "unstructured": "Su CA, Pike MC, Jotwani AR, Friebel TM, Soslow RA, Levine\u00a0 DA, et al. Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations. JAMA Oncol. 2016;2(11):1434\u20131440.", "DOI": "10.1001/jamaoncol.2016.1820", "doi-asserted-by": "crossref"}, {"key": "9_CR70", "unstructured": "Bellido F, Pineda M, Aiza G,\u00a0 Valdes-Mas R, Navarro M, Puente DA, et al.\u00a0 POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance. Genet Med 2015;18(4):325\u2013332.", "DOI": "10.1038/gim.2015.75", "doi-asserted-by": "crossref"}, {"key": "9_CR71", "unstructured": "Schneider K, Zelley K, Nichols KE, Garber J. Li-Fraumeni syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews\u00ae; 1993. Seattle, WA."}], "container-title": ["Molecular Pathology Library", "Precision Molecular Pathology of Uterine Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-57985-6_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 5]], "date-time": "2019-10-05T08:45:39Z", "timestamp": 1570265139000}, "score": 23.270538, "issued": {"date-parts": [[2017]]}, "ISBN": ["9783319579832", "9783319579856"], "references-count": 71, "URL": "http://dx.doi.org/10.1007/978-3-319-57985-6_9", "relation": {"cites": []}, "ISSN": ["1935-987X", "1935-9888"], "issn-type": [{"value": "1935-987X", "type": "print"}, {"value": "1935-9888", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T11:56:08Z", "timestamp": 1574423768023}, "reference-count": 4, "publisher": "Informa UK Limited", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pediatric Pathology & Molecular Medicine"], "published-print": {"date-parts": [[2000, 1]]}, "DOI": "10.1080/15513810009168641", "type": "journal-article", "created": {"date-parts": [[2010, 4, 16]], "date-time": "2010-04-16T13:50:26Z", "timestamp": 1271425826000}, "page": "303-304", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Foreword"], "prefix": "10.1080", "volume": "19", "author": [{"given": "Deborah A.", "family": "Belchis", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2010, 4, 16]]}, "reference": [{"key": "CIT0001", "author": "Link M P", "volume": "270", "first-page": "8", "year": "1991", "journal-title": "Clin Orthop"}, {"issue": "4", "key": "CIT0002", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1007/BF02785871", "volume": "16", "author": "Aparicio J", "year": "1999", "journal-title": "Med Oncol"}, {"issue": "5", "key": "CIT0003", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1093/oxfordjournals.jjco.a039576", "volume": "22", "author": "Tsuchiya H", "year": "1992", "journal-title": "Jpn J Clin Oncol"}, {"issue": "2", "key": "CIT0004", "first-page": "339", "volume": "7", "author": "Bacci G", "year": "2000", "journal-title": "Oncol Rep"}], "container-title": ["Pediatric Pathology & Molecular Medicine"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/15513810009168641", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 28]], "date-time": "2019-05-28T12:55:20Z", "timestamp": 1559048120000}, "score": 23.192225, "issued": {"date-parts": [[2000, 1]]}, "references-count": 4, "journal-issue": {"published-online": {"date-parts": [[2010, 4, 16]]}, "published-print": {"date-parts": [[2000, 1]]}, "issue": "5"}, "alternative-id": ["10.1080/15513810009168641"], "URL": "http://dx.doi.org/10.1080/15513810009168641", "relation": {"cites": []}, "ISSN": ["1522-7952"], "issn-type": [{"value": "1522-7952", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T20:17:30Z", "timestamp": 1576786650707}, "reference-count": 79, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T00:00:00Z", "timestamp": 1575158400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Social Science & Medicine"], "published-print": {"date-parts": [[2019, 12]]}, "DOI": "10.1016/j.socscimed.2019.112721", "type": "journal-article", "created": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T16:35:37Z", "timestamp": 1575477337000}, "page": "112721", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The global use of diverse medical systems"], "prefix": "10.1016", "author": [{"ORCID": "http://orcid.org/0000-0002-3690-5878", "authenticated-orcid": false, "given": "Bernice A.", "family": "Pescosolido", "sequence": "first", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0002-2152-8256", "authenticated-orcid": false, "given": "Bianca", "family": "Manago", "sequence": "additional", "affiliation": []}, {"given": "Sigrun", "family": "Olafsdottir", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Social Science & Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0277953619307166?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0277953619307166?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 12, 10]], "date-time": "2019-12-10T22:03:17Z", "timestamp": 1576015397000}, "score": 23.090683, "issued": {"date-parts": [[2019, 12]]}, "references-count": 79, "alternative-id": ["S0277953619307166"], "URL": "http://dx.doi.org/10.1016/j.socscimed.2019.112721", "ISSN": ["0277-9536"], "issn-type": [{"value": "0277-9536", "type": "print"}], "subject": ["History and Philosophy of Science", "Health(social science)"], "article-number": "112721"}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:10:19Z", "timestamp": 1574719819042}, "publisher-location": "New York, NY", "reference-count": 20, "publisher": "Springer New York", "isbn-type": [{"value": "9781493928859", "type": "print"}, {"value": "9781493928866", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2015]]}, "DOI": "10.1007/978-1-4939-2886-6_18", "type": "book-chapter", "created": {"date-parts": [[2015, 8, 12]], "date-time": "2015-08-12T08:51:12Z", "timestamp": 1439369472000}, "page": "309-315", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The Molecular Pathology of Male Breast Cancer"], "prefix": "10.1007", "author": [{"given": "Rebecca A.", "family": "Millican-Slater", "sequence": "first", "affiliation": []}, {"given": "Valerie", "family": "Speirs", "sequence": "additional", "affiliation": []}, {"given": "Thomas A.", "family": "Hughes", "sequence": "additional", "affiliation": []}, {"given": "Andrew M.", "family": "Hanby", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 8, 13]]}, "reference": [{"key": "18_CR1", "unstructured": "UK, C.R. Breast cancer incidence statistics. 2013. \n                  http://info.cancerresearchuk.org/cancerstats/types/breast/incidence/uk-breast-cancer-incidence-statistics\n                  \n                . 1 May 2013."}, {"issue": "2", "key": "18_CR2", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.1007/s10549-008-0053-y", "volume": "115", "author": "V Speirs", "year": "2009", "unstructured": "Speirs V, Shaaban AM. The rising incidence of male breast cancer. Breast Cancer Res Treat. 2009;115(2):429\u201330.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "6", "key": "18_CR3", "doi-asserted-by": "publisher", "first-page": "1145", "DOI": "10.1111/j.1365-2559.2012.04330.x", "volume": "61", "author": "R Kornegoor", "year": "2012", "unstructured": "Kornegoor R, et al. Immunophenotyping of male breast cancer. Histopathology. 2012;61(6):1145\u201355.", "journal-title": "Histopathology"}, {"issue": "1", "key": "18_CR4", "doi-asserted-by": "publisher", "first-page": "102", "DOI": "10.3109/0284186X.2012.711952", "volume": "52", "author": "C Nilsson", "year": "2013", "unstructured": "Nilsson C, et al. Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact. Acta Oncol. 2013;52(1):102\u20139.", "journal-title": "Acta Oncol"}, {"issue": "1", "key": "18_CR5", "doi-asserted-by": "publisher", "first-page": "411", "DOI": "10.1007/s10549-012-2062-0", "volume": "134", "author": "L Ottini", "year": "2012", "unstructured": "Ottini L, et al. Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy. Breast Cancer Res Treat. 2012;134(1):411\u20138.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "3", "key": "18_CR6", "doi-asserted-by": "publisher", "first-page": "949", "DOI": "10.1007/s10549-011-1856-9", "volume": "133", "author": "AM Shaaban", "year": "2012", "unstructured": "Shaaban AM, et al. A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Res Treat. 2012;133(3):949\u201358.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "21", "key": "18_CR7", "doi-asserted-by": "publisher", "first-page": "2492", "DOI": "10.1001/jama.295.21.2492", "volume": "295", "author": "LA Carey", "year": "2006", "unstructured": "Carey LA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, J Am Med Assoc. 2006;295(21):2492\u2013502.", "journal-title": "JAMA, J Am Med Assoc"}, {"key": "18_CR8", "unstructured": "Nilsson C, et al. High proliferation is associated with inferior outcome in male breast cancer patients. Mod Pathol An Official J US Can Acad Pathol Inc. 2013;26(1):87\u201394.", "DOI": "10.1038/modpathol.2012.145", "doi-asserted-by": "crossref"}, {"issue": "10", "key": "18_CR9", "doi-asserted-by": "publisher", "first-page": "2455", "DOI": "10.1002/ijc.21646", "volume": "118", "author": "C Rudlowski", "year": "2006", "unstructured": "Rudlowski C, et al. Comparative genomic hybridization analysis on male breast cancer. Int J Cancer. Journal international du cancer. 2006;118(10):2455\u201360.", "journal-title": "Int J Cancer. Journal international du cancer"}, {"issue": "1", "key": "18_CR10", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1007/s10549-012-2051-3", "volume": "135", "author": "R Kornegoor", "year": "2012", "unstructured": "Kornegoor R, et al. Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification. Breast Cancer Res Treat. 2012;135(1):49\u201358.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "3", "key": "18_CR11", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1007/s10549-010-1262-8", "volume": "129", "author": "I Johansson", "year": "2011", "unstructured": "Johansson I, et al. High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer. Breast Cancer Res Treat. 2011;129(3):747\u201360.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "11", "key": "18_CR12", "doi-asserted-by": "publisher", "first-page": "1182", "DOI": "10.1038/ng.2417", "volume": "44", "author": "N Orr", "year": "2012", "unstructured": "Orr N, et al. Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. Nat Genet. 2012;44(11):1182\u20134.", "journal-title": "Nat Genet"}, {"issue": "4", "key": "18_CR13", "doi-asserted-by": "publisher", "first-page": "R101", "DOI": "10.1186/bcr3220", "volume": "14", "author": "R Kornegoor", "year": "2012", "unstructured": "Kornegoor R, et al. Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification. Breast Cancer Res BCR. 2012;14(4):R101.", "journal-title": "Breast Cancer Res BCR"}, {"issue": "6", "key": "18_CR14", "doi-asserted-by": "publisher", "first-page": "1264", "DOI": "10.1002/jcp.24281", "volume": "228", "author": "R Pinto", "year": "2013", "unstructured": "Pinto R, et al. Different methylation and microRNA expression pattern in male and female familial breast cancer. J Cell Physiol. 2013;228(6):1264\u20139.", "journal-title": "J Cell Physiol"}, {"issue": "3", "key": "18_CR15", "doi-asserted-by": "publisher", "first-page": "601", "DOI": "10.1007/s10549-010-1015-8", "volume": "127", "author": "M Callari", "year": "2011", "unstructured": "Callari M, et al. Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer. Breast Cancer Res Treat. 2011;127(3):601\u201310.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "1", "key": "18_CR16", "doi-asserted-by": "publisher", "first-page": "R31", "DOI": "10.1186/bcr3116", "volume": "14", "author": "I Johansson", "year": "2012", "unstructured": "Johansson I, et al. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker. Breast Cancer Res BCR. 2012;14(1):R31.", "journal-title": "Breast Cancer Res BCR"}, {"issue": "10", "key": "18_CR17", "doi-asserted-by": "publisher", "first-page": "e78299", "DOI": "10.1371/journal.pone.0078299", "volume": "8", "author": "I Johansson", "year": "2013", "unstructured": "Johansson I, Ringner M, Hedenfalk I. The landscape of candidate driver genes differs between male and female breast cancer. PLoS ONE. 2013;8(10):e78299.", "journal-title": "PLoS ONE"}, {"issue": "5", "key": "18_CR18", "doi-asserted-by": "publisher", "first-page": "455", "DOI": "10.1586/erm.09.25", "volume": "9", "author": "CK Zoon", "year": "2009", "unstructured": "Zoon CK, et al. Current molecular diagnostics of breast cancer and the potential incorporation of microRNA. Expert Rev Mol Diagn. 2009;9(5):455\u201367.", "journal-title": "Expert Rev Mol Diagn"}, {"issue": "4", "key": "18_CR19", "doi-asserted-by": "publisher", "first-page": "R58", "DOI": "10.1186/bcr2348", "volume": "11", "author": "M Fassan", "year": "2009", "unstructured": "Fassan M, et al. MicroRNA expression profiling of male breast cancer. Breast Cancer Res BCR. 2009;11(4):R58.", "journal-title": "Breast Cancer Res BCR"}, {"key": "18_CR20", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.1186/1471-2407-10-109", "volume": "10", "author": "U Lehmann", "year": "2010", "unstructured": "Lehmann U, et al. Identification of differentially expressed microRNAs in human male breast cancer. BMC Cancer. 2010;10:109.", "journal-title": "BMC Cancer"}], "container-title": ["Molecular Pathology Library", "Precision Molecular Pathology of Breast Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4939-2886-6_18", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T16:37:56Z", "timestamp": 1559234276000}, "score": 22.902285, "issued": {"date-parts": [[2015]]}, "ISBN": ["9781493928859", "9781493928866"], "references-count": 20, "URL": "http://dx.doi.org/10.1007/978-1-4939-2886-6_18", "relation": {"cites": []}, "ISSN": ["1935-987X", "1935-9888"], "issn-type": [{"value": "1935-987X", "type": "print"}, {"value": "1935-9888", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T12:06:13Z", "timestamp": 1574510773334}, "reference-count": 11, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 1, 1]], "date-time": "2013-01-01T00:00:00Z", "timestamp": 1356998400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Social Science & Medicine"], "published-print": {"date-parts": [[2013, 1]]}, "DOI": "10.1016/j.socscimed.2012.09.038", "type": "journal-article", "created": {"date-parts": [[2012, 10, 18]], "date-time": "2012-10-18T08:05:15Z", "timestamp": 1350547515000}, "page": "12-15", "source": "Crossref", "is-referenced-by-count": 10, "title": ["A United Nations Global Health Panel for Global Health Governance"], "prefix": "10.1016", "volume": "76", "author": [{"given": "Tim K.", "family": "Mackey", "sequence": "first", "affiliation": []}, {"given": "Bryan A.", "family": "Liang", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Social Science & Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0277953612007022?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0277953612007022?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 20]], "date-time": "2018-11-20T03:22:49Z", "timestamp": 1542684169000}, "score": 22.665462, "issued": {"date-parts": [[2013, 1]]}, "references-count": 11, "alternative-id": ["S0277953612007022"], "URL": "http://dx.doi.org/10.1016/j.socscimed.2012.09.038", "ISSN": ["0277-9536"], "issn-type": [{"value": "0277-9536", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T12:40:55Z", "timestamp": 1574512855440}, "reference-count": 12, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 1, 1]], "date-time": "2013-01-01T00:00:00Z", "timestamp": 1356998400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Social Science & Medicine"], "published-print": {"date-parts": [[2013, 1]]}, "DOI": "10.1016/j.socscimed.2012.09.036", "type": "journal-article", "created": {"date-parts": [[2012, 10, 31]], "date-time": "2012-10-31T08:02:40Z", "timestamp": 1351670560000}, "page": "24-27", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Response to comments on \u201cA United Nations Global Health Panel for Global Health Governance\u201d"], "prefix": "10.1016", "volume": "76", "author": [{"given": "Tim K.", "family": "Mackey", "sequence": "first", "affiliation": []}, {"given": "Bryan A.", "family": "Liang", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Social Science & Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0277953612007009?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0277953612007009?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 19]], "date-time": "2018-11-19T18:27:50Z", "timestamp": 1542652070000}, "score": 22.665462, "issued": {"date-parts": [[2013, 1]]}, "references-count": 12, "alternative-id": ["S0277953612007009"], "URL": "http://dx.doi.org/10.1016/j.socscimed.2012.09.036", "ISSN": ["0277-9536"], "issn-type": [{"value": "0277-9536", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T04:39:02Z", "timestamp": 1574397542358}, "reference-count": 0, "publisher": "Informa UK Limited", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pediatric Pathology & Molecular Medicine"], "published-print": {"date-parts": [[2003, 1]]}, "DOI": "10.1080/pdp.22.2.175.179", "type": "journal-article", "created": {"date-parts": [[2009, 12, 8]], "date-time": "2009-12-08T20:49:34Z", "timestamp": 1260305374000}, "page": "175-179", "source": "Crossref", "is-referenced-by-count": 2, "title": ["PATHOLOGY TEACH AND TELL: NEONATAL ELS"], "prefix": "10.1080", "volume": "22", "author": [{"given": "Pratibha A.", "family": "Ankola", "sequence": "first", "affiliation": []}, {"given": "Ashraf", "family": "Morkos", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 7, 9]]}, "container-title": ["Pediatric Pathology & Molecular Medicine"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/pdp.22.2.175.179", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 17]], "date-time": "2016-12-17T04:19:57Z", "timestamp": 1481948397000}, "score": 22.64099, "issued": {"date-parts": [[2003, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2009, 7, 9]]}, "published-print": {"date-parts": [[2003, 1]]}, "issue": "2"}, "alternative-id": ["10.1080/pdp.22.2.175.179"], "URL": "http://dx.doi.org/10.1080/pdp.22.2.175.179", "ISSN": ["1522-7952"], "issn-type": [{"value": "1522-7952", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:10:19Z", "timestamp": 1574719819128}, "publisher-location": "New York, NY", "reference-count": 53, "publisher": "Springer New York", "isbn-type": [{"value": "9781493928859", "type": "print"}, {"value": "9781493928866", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2015]]}, "DOI": "10.1007/978-1-4939-2886-6_4", "type": "book-chapter", "created": {"date-parts": [[2015, 8, 12]], "date-time": "2015-08-12T08:51:12Z", "timestamp": 1439369472000}, "page": "51-62", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Molecular Pathology of Precancerous Lesions of the Breast"], "prefix": "10.1007", "author": [{"given": "Abhik", "family": "Mukherjee", "sequence": "first", "affiliation": []}, {"given": "Ian O.", "family": "Ellis", "sequence": "additional", "affiliation": []}, {"given": "Emad A.", "family": "Rakha", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 8, 13]]}, "reference": [{"issue": "1", "key": "4_CR1", "doi-asserted-by": "publisher", "first-page": "32", "DOI": "10.1002/path.1006", "volume": "196", "author": "R Roylance", "year": "2002", "unstructured": "Roylance R, et al. Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways. J Pathol. 2002;196(1):32\u20136.", "journal-title": "J Pathol"}, {"issue": "7", "key": "4_CR2", "first-page": "1433", "volume": "59", "author": "R Roylance", "year": "1999", "unstructured": "Roylance R, et al. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res. 1999;59(7):1433\u20136.", "journal-title": "Cancer Res"}, {"issue": "2", "key": "4_CR3", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.1002/gcc.20070", "volume": "41", "author": "AM Cleton-Jansen", "year": "2004", "unstructured": "Cleton-Jansen AM, et al. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer. Genes Chromosomes Cancer. 2004;41(2):109\u201316.", "journal-title": "Genes Chromosomes Cancer"}, {"issue": "4", "key": "4_CR4", "doi-asserted-by": "publisher", "first-page": "351", "DOI": "10.1002/gcc.20646", "volume": "48", "author": "R Natrajan", "year": "2009", "unstructured": "Natrajan R, et al. Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype? Genes Chromosomes Cancer. 2009;48(4):351\u201365.", "journal-title": "Genes Chromosomes Cancer"}, {"issue": "3", "key": "4_CR5", "doi-asserted-by": "publisher", "first-page": "417", "DOI": "10.1097/01.pas.0000213368.41251.b9", "volume": "31", "author": "TM Abdel-Fatah", "year": "2007", "unstructured": "Abdel-Fatah TM, et al. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol. 2007;31(3):417\u201326.", "journal-title": "Am J Surg Pathol"}, {"issue": "4", "key": "4_CR6", "doi-asserted-by": "publisher", "first-page": "513", "DOI": "10.1097/PAS.0b013e318161d1a5", "volume": "32", "author": "TM Abdel-Fatah", "year": "2008", "unstructured": "Abdel-Fatah TM, et al. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol. 2008;32(4):513\u201323.", "journal-title": "Am J Surg Pathol"}, {"issue": "9", "key": "4_CR7", "doi-asserted-by": "publisher", "first-page": "2072", "DOI": "10.1002/(SICI)1097-0142(20000501)88:9<2072::AID-CNCR13>3.0.CO;2-H", "volume": "88", "author": "F Moinfar", "year": "2000", "unstructured": "Moinfar F, et al. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (\u201cclinging ductal carcinoma in situ\u201d): a simulator of normal mammary epithelium. Cancer. 2000;88(9):2072\u201381.", "journal-title": "Cancer"}, {"issue": "4", "key": "4_CR8", "doi-asserted-by": "publisher", "first-page": "326", "DOI": "10.1007/BF02966399", "volume": "7", "author": "T Oyama", "year": "2000", "unstructured": "Oyama T, et al. Atypical cystic lobule of the breast: an early stage of low-grade ductal carcinoma in-situ. Breast Cancer. 2000;7(4):326\u201331.", "journal-title": "Breast Cancer"}, {"issue": "6", "key": "4_CR9", "doi-asserted-by": "publisher", "first-page": "734", "DOI": "10.1097/01.pas.0000157295.93914.3b", "volume": "29", "author": "PT Simpson", "year": "2005", "unstructured": "Simpson PT, et al. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol. 2005;29(6):734\u201346.", "journal-title": "Am J Surg Pathol"}, {"key": "4_CR10", "unstructured": "Pathology Reporting of Breast Disease. A Joint document incorporating the third edition of the NHS breast screening programme\u2019s guidelines for pathology reporting in breast cancer screening and the second edition of The Royal College of Pathologists\u2019 minimum dataset for breast cancer histopathology. NHSBSP Publication No 58, January 2005. p. 50\u201359. Available from: \n                  http://www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/P/PathologyReportingOfBreastDisease-CORRECTED-lowres.pdf\n                  \n                ."}, {"issue": "3", "key": "4_CR11", "doi-asserted-by": "publisher", "first-page": "124", "DOI": "10.1016/j.mpdhp.2011.12.004", "volume": "18", "author": "EA Rakha", "year": "2012", "unstructured": "Rakha EA. The low nuclear grade breast neoplasia family. Diagnostic Histopathology. 2012;18(3):124\u201332.", "journal-title": "Diagnostic Histopathology"}, {"issue": "11", "key": "4_CR12", "doi-asserted-by": "publisher", "first-page": "1001", "DOI": "10.1136/jclinpath-2011-200176", "volume": "64", "author": "S Rajan", "year": "2011", "unstructured": "Rajan S, et al. What is the significance of flat epithelial atypia and what are the management implications? J Clin Pathol. 2011;64(11):1001\u20134.", "journal-title": "J Clin Pathol"}, {"issue": "1", "key": "4_CR13", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1200/JCO.2009.23.5051", "volume": "28", "author": "EA Rakha", "year": "2010", "unstructured": "Rakha EA, et al. Tubular carcinoma of the breast: further evidence to support its excellent prognosis. J Clin Oncol. 2010;28(1):99\u2013104.", "journal-title": "J Clin Oncol"}, {"issue": "6", "key": "4_CR14", "doi-asserted-by": "publisher", "first-page": "1417", "DOI": "10.1002/ijc.25801", "volume": "129", "author": "EA Rakha", "year": "2011", "unstructured": "Rakha EA, et al. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Int J Cancer. 2011;129(6):1417\u201324.", "journal-title": "Int J Cancer"}, {"issue": "9", "key": "4_CR15", "doi-asserted-by": "publisher", "first-page": "697", "DOI": "10.1093/jnci/90.9.697", "volume": "90", "author": "P O\u2019Connell", "year": "1998", "unstructured": "O\u2019Connell P, et al. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst. 1998;90(9):697\u2013703.", "journal-title": "J Natl Cancer Inst"}, {"issue": "4", "key": "4_CR16", "doi-asserted-by": "publisher", "first-page": "396", "DOI": "10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L", "volume": "187", "author": "H Buerger", "year": "1999", "unstructured": "Buerger H, et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol. 1999;187(4):396\u2013402.", "journal-title": "J Pathol"}, {"issue": "2", "key": "4_CR17", "doi-asserted-by": "publisher", "first-page": "165", "DOI": "10.1002/path.875", "volume": "194", "author": "H Buerger", "year": "2001", "unstructured": "Buerger H, et al. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol. 2001;194(2):165\u201370.", "journal-title": "J Pathol"}, {"issue": "11", "key": "4_CR18", "doi-asserted-by": "publisher", "first-page": "1007", "DOI": "10.1002/gcc.20368", "volume": "45", "author": "TL Mastracci", "year": "2006", "unstructured": "Mastracci TL, et al. Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast. Genes Chromosomes Cancer. 2006;45(11):1007\u201317.", "journal-title": "Genes Chromosomes Cancer"}, {"issue": "2", "key": "4_CR19", "doi-asserted-by": "publisher", "first-page": "207", "DOI": "10.1016/S0304-3835(00)00467-5", "volume": "156", "author": "Y Ando", "year": "2000", "unstructured": "Ando Y, et al. Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breast. Cancer Lett. 2000;156(2):207\u201314.", "journal-title": "Cancer Lett"}, {"issue": "6797", "key": "4_CR20", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1038/35021093", "volume": "406", "author": "CM Perou", "year": "2000", "unstructured": "Perou CM, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747\u201352.", "journal-title": "Nature"}, {"issue": "19", "key": "4_CR21", "doi-asserted-by": "publisher", "first-page": "10869", "DOI": "10.1073/pnas.191367098", "volume": "98", "author": "T Sorlie", "year": "2001", "unstructured": "Sorlie T, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U.S.A. 2001;98(19):10869\u201374.", "journal-title": "Proc Natl Acad Sci U.S.A"}, {"issue": "7", "key": "4_CR22", "doi-asserted-by": "publisher", "first-page": "1956", "DOI": "10.1158/1078-0432.CCR-07-1465", "volume": "14", "author": "A Vincent-Salomon", "year": "2008", "unstructured": "Vincent-Salomon A, et al. Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast. Clin Cancer Res. 2008;14(7):1956\u201365.", "journal-title": "Clin Cancer Res"}, {"key": "4_CR23", "unstructured": "Williams KE, et al. Molecular Phenotypes of DCIS predict overall and invasive recurrence. Ann Oncol. 2015;26:1019\u20131025.", "DOI": "10.1093/annonc/mdv062", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "4_CR24", "doi-asserted-by": "publisher", "first-page": "82", "DOI": "10.1002/(SICI)1097-0215(20000101)85:1<82::AID-IJC15>3.0.CO;2-S", "volume": "85", "author": "M Aubele", "year": "2000", "unstructured": "Aubele M, et al. Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH. Int J Cancer. 2000;85(1):82\u20136.", "journal-title": "Int J Cancer"}, {"issue": "1", "key": "4_CR25", "doi-asserted-by": "publisher", "first-page": "14", "DOI": "10.1097/00019606-200003000-00003", "volume": "9", "author": "MM Aubele", "year": "2000", "unstructured": "Aubele MM, et al. Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer. Diagn Mol Pathol. 2000;9(1):14\u20139.", "journal-title": "Diagn Mol Pathol"}, {"issue": "2", "key": "4_CR26", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1002/path.2808", "volume": "223", "author": "A Bombonati", "year": "2011", "unstructured": "Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression. J Pathol. 2011;223(2):307\u201317.", "journal-title": "J Pathol"}, {"issue": "10", "key": "4_CR27", "doi-asserted-by": "publisher", "first-page": "5974", "DOI": "10.1073/pnas.0931261100", "volume": "100", "author": "XJ Ma", "year": "2003", "unstructured": "Ma XJ, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A. 2003;100(10):5974\u20139.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "22", "key": "4_CR28", "first-page": "5260", "volume": "56", "author": "H Fujii", "year": "1996", "unstructured": "Fujii H, et al. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Cancer Res. 1996;56(22):5260\u20135.", "journal-title": "Cancer Res"}, {"issue": "1", "key": "4_CR29", "first-page": "297", "volume": "150", "author": "RF Chuaqui", "year": "1997", "unstructured": "Chuaqui RF, et al. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol. 1997;150(1):297\u2013303.", "journal-title": "Am J Pathol"}, {"issue": "12", "key": "4_CR30", "first-page": "3788", "volume": "8", "author": "A Adeyinka", "year": "2002", "unstructured": "Adeyinka A, et al. Analysis of gene expression in ductal carcinoma in situ of the breast. Clin Cancer Res. 2002;8(12):3788\u201395.", "journal-title": "Clin Cancer Res"}, {"issue": "6", "key": "4_CR31", "doi-asserted-by": "publisher", "first-page": "2005", "DOI": "10.1016/S0002-9440(10)64672-X", "volume": "158", "author": "V Luzzi", "year": "2001", "unstructured": "Luzzi V, Holtschlag V, Watson MA. Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays. Am J Pathol. 2001;158(6):2005\u201310.", "journal-title": "Am J Pathol"}, {"issue": "3", "key": "4_CR32", "first-page": "261", "volume": "1", "author": "H Tsuda", "year": "1995", "unstructured": "Tsuda H, Fukutomi T, Hirohashi S. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade. Clin Cancer Res. 1995;1(3):261\u20137.", "journal-title": "Clin Cancer Res"}, {"key": "4_CR33", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1007/978-3-642-45769-2_11", "volume": "152", "author": "MJ Vijver van de", "year": "1998", "unstructured": "van de Vijver MJ. Ductal carcinoma in situ of the breast: histological classification and genetic alterations. Recent Results Cancer Res. 1998;152:123\u201334.", "journal-title": "Recent Results Cancer Res"}, {"issue": "1", "key": "4_CR34", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1097/PAS.0b013e31829fc47b", "volume": "38", "author": "TM D\u2019Alfonso", "year": "2014", "unstructured": "D\u2019Alfonso TM, et al. Cystic hypersecretory (in situ) carcinoma of the breast: a clinicopathologic and immunohistochemical characterization of 10 cases with clinical follow-up. Am J Surg Pathol. 2014;38(1):45\u201353.", "journal-title": "Am J Surg Pathol"}, {"issue": "5", "key": "4_CR35", "doi-asserted-by": "publisher", "first-page": "674", "DOI": "10.6061/clinics/2013(05)15", "volume": "68", "author": "AA Perez", "year": "2013", "unstructured": "Perez AA, et al. Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast. Clinics (Sao Paulo). 2013;68(5):674\u20138.", "journal-title": "Clinics (Sao Paulo)"}, {"issue": "2", "key": "4_CR36", "first-page": "127", "volume": "37", "author": "S Steinman", "year": "2007", "unstructured": "Steinman S, et al. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. Ann Clin Lab Sci. 2007;37(2):127\u201334.", "journal-title": "Ann Clin Lab Sci"}, {"issue": "4", "key": "4_CR37", "doi-asserted-by": "publisher", "first-page": "R67", "DOI": "10.1186/bcr2128", "volume": "10", "author": "RM Tamimi", "year": "2008", "unstructured": "Tamimi RM, et al. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res. 2008;10(4):R67.", "journal-title": "Breast Cancer Res"}, {"issue": "5", "key": "4_CR38", "doi-asserted-by": "publisher", "first-page": "638", "DOI": "10.6061/clinics/2013(05)010", "volume": "68", "author": "FN Aguiar", "year": "2013", "unstructured": "Aguiar FN, et al. Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ. Clinics (Sao Paulo). 2013;68(5):638\u201343.", "journal-title": "Clinics (Sao Paulo)"}, {"issue": "2", "key": "4_CR39", "doi-asserted-by": "publisher", "first-page": "e205", "DOI": "10.1016/j.jss.2009.07.030", "volume": "167", "author": "Y Horimoto", "year": "2011", "unstructured": "Horimoto Y, et al. Significance of HER2 protein examination in ductal carcinoma in situ. J Surg Res. 2011;167(2):e205\u201310.", "journal-title": "J Surg Res"}, {"issue": "1", "key": "4_CR40", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/j.prp.2010.08.005", "volume": "207", "author": "N Liao", "year": "2011", "unstructured": "Liao N, et al. HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component. Pathol Res Pract. 2011;207(1):1\u20137.", "journal-title": "Pathol Res Pract"}, {"issue": "10", "key": "4_CR41", "doi-asserted-by": "publisher", "first-page": "926", "DOI": "10.1136/jcp.2009.065524", "volume": "62", "author": "P Groep van der", "year": "2009", "unstructured": "van der Groep P, et al. Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers. J Clin Pathol. 2009;62(10):926\u201330.", "journal-title": "J Clin Pathol"}, {"issue": "2", "key": "4_CR42", "doi-asserted-by": "publisher", "first-page": "e56055", "DOI": "10.1371/journal.pone.0056055", "volume": "8", "author": "P Groep van der", "year": "2013", "unstructured": "van der Groep P, et al. HIF-1alpha overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers. PLoS ONE. 2013;8(2):e56055.", "journal-title": "PLoS ONE"}, {"issue": "4", "key": "4_CR43", "doi-asserted-by": "publisher", "first-page": "357", "DOI": "10.1016/j.molonc.2010.06.007", "volume": "4", "author": "AA Muggerud", "year": "2010", "unstructured": "Muggerud AA, et al. Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. Mol Oncol. 2010;4(4):357\u201368.", "journal-title": "Mol Oncol"}, {"issue": "5", "key": "4_CR44", "doi-asserted-by": "publisher", "first-page": "R61", "DOI": "10.1186/bcr1613", "volume": "8", "author": "J Hannemann", "year": "2006", "unstructured": "Hannemann J, et al. Classification of ductal carcinoma in situ by gene expression profiling. Breast Cancer Res. 2006;8(5):R61.", "journal-title": "Breast Cancer Res"}, {"issue": "5", "key": "4_CR45", "doi-asserted-by": "publisher", "first-page": "423", "DOI": "10.1186/s13058-014-0423-9", "volume": "16", "author": "JM Pang", "year": "2014", "unstructured": "Pang JM, et al. Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features. Breast Cancer Res. 2014;16(5):423.", "journal-title": "Breast Cancer Res"}, {"issue": "6", "key": "4_CR46", "doi-asserted-by": "publisher", "first-page": "1269", "DOI": "10.1016/j.humpath.2014.02.007", "volume": "45", "author": "O Saglam", "year": "2014", "unstructured": "Saglam O, et al. Matricellular protein CCN1 (CYR61) expression is associated with high-grade ductal carcinoma in situ. Hum Pathol. 2014;45(6):1269\u201375.", "journal-title": "Hum Pathol"}, {"issue": "1", "key": "4_CR47", "first-page": "48", "volume": "81", "author": "GR Sue", "year": "2015", "unstructured": "Sue GR, Chagpar AB. Predictors of recurrence in patients diagnosed with ductal carcinoma in situ. Am Surg. 2015;81(1):48\u201351.", "journal-title": "Am Surg"}, {"issue": "3", "key": "4_CR48", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1016/j.clon.2011.09.008", "volume": "24", "author": "K Han", "year": "2012", "unstructured": "Han K, et al. Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence. Clin Oncol (R Coll Radiol). 2012;24(3):183\u20139.", "journal-title": "Clin Oncol (R Coll Radiol)"}, {"issue": "9", "key": "4_CR49", "doi-asserted-by": "publisher", "first-page": "627", "DOI": "10.1093/jnci/djq101", "volume": "102", "author": "K Kerlikowske", "year": "2010", "unstructured": "Kerlikowske K, et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst. 2010;102(9):627\u201337.", "journal-title": "J Natl Cancer Inst"}, {"issue": "2", "key": "4_CR50", "doi-asserted-by": "publisher", "first-page": "415", "DOI": "10.1007/s10549-013-2755-z", "volume": "142", "author": "KP Siziopikou", "year": "2013", "unstructured": "Siziopikou KP, et al. Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43. Breast Cancer Res Treat. 2013;142(2):415\u201321.", "journal-title": "Breast Cancer Res Treat"}, {"key": "4_CR51", "doi-asserted-by": "publisher", "first-page": "512", "DOI": "10.1186/1471-2407-13-512", "volume": "13", "author": "W Zhou", "year": "2013", "unstructured": "Zhou W, et al. Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study. BMC Cancer. 2013;13:512.", "journal-title": "BMC Cancer"}, {"issue": "4", "key": "4_CR52", "doi-asserted-by": "publisher", "first-page": "343", "DOI": "10.1111/j.1524-4741.2011.01091.x", "volume": "17", "author": "S Altintas", "year": "2011", "unstructured": "Altintas S, et al. Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS). Breast J. 2011;17(4):343\u201351.", "journal-title": "Breast J"}, {"issue": "1", "key": "4_CR53", "doi-asserted-by": "publisher", "first-page": "2", "DOI": "10.1111/his.12336", "volume": "65", "author": "MA Quintayo", "year": "2014", "unstructured": "Quintayo MA, et al. Virtual tissue microarrays: a novel and viable approach to optimizing tissue microarrays for biomarker research applied to ductal carcinoma in situ. Histopathology. 2014;65(1):2\u20138.", "journal-title": "Histopathology"}], "container-title": ["Molecular Pathology Library", "Precision Molecular Pathology of Breast Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4939-2886-6_4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T16:15:19Z", "timestamp": 1559232919000}, "score": 22.530127, "issued": {"date-parts": [[2015]]}, "ISBN": ["9781493928859", "9781493928866"], "references-count": 53, "URL": "http://dx.doi.org/10.1007/978-1-4939-2886-6_4", "relation": {"cites": []}, "ISSN": ["1935-987X", "1935-9888"], "issn-type": [{"value": "1935-987X", "type": "print"}, {"value": "1935-9888", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:10:19Z", "timestamp": 1574719819233}, "publisher-location": "New York, NY", "reference-count": 103, "publisher": "Springer New York", "isbn-type": [{"value": "9781493928859", "type": "print"}, {"value": "9781493928866", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2015]]}, "DOI": "10.1007/978-1-4939-2886-6_17", "type": "book-chapter", "created": {"date-parts": [[2015, 8, 12]], "date-time": "2015-08-12T08:51:12Z", "timestamp": 1439369472000}, "page": "291-307", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The Molecular Pathology of Chemoresistance During the Therapeutic Response in Breast Cancer"], "prefix": "10.1007", "author": [{"given": "James L.", "family": "Thorne", "sequence": "first", "affiliation": []}, {"given": "Andrew M.", "family": "Hanby", "sequence": "additional", "affiliation": []}, {"given": "Thomas A.", "family": "Hughes", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 8, 13]]}, "reference": [{"issue": "3", "key": "17_CR1", "doi-asserted-by": "publisher", "first-page": "151", "DOI": "10.1016/j.anndiagpath.2009.02.003", "volume": "13", "author": "I Alvarado-Cabrero", "year": "2009", "unstructured": "Alvarado-Cabrero I, Alderete-Vazquez G, Quintal-Ramirez M, Patino M, Ruiz E. Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer: correlation of histology, hormone receptor status, Her2/Neu, and gross pathologic findings. Ann Diagn Pathol. 2009;13(3):151\u20137.", "journal-title": "Ann Diagn Pathol"}, {"issue": "4", "key": "17_CR2", "doi-asserted-by": "publisher", "first-page": "409", "DOI": "10.1111/j.1365-2559.2006.02419.x", "volume": "50", "author": "SE Pinder", "year": "2007", "unstructured": "Pinder SE, Provenzano E, Earl H, Ellis IO. Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy. Histopathology. 2007;50(4):409\u201317.", "journal-title": "Histopathology"}, {"key": "17_CR3", "unstructured": "Garcia-Closas M, Couch FJ, Lindstrom S, et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 2013;45(4):392\u20138, 398e1\u20132."}, {"issue": "15 Pt 1", "key": "17_CR4", "doi-asserted-by": "publisher", "first-page": "4429", "DOI": "10.1158/1078-0432.CCR-06-3045", "volume": "13", "author": "R Dent", "year": "2007", "unstructured": "Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15 Pt 1):4429\u201334.", "journal-title": "Clin Cancer Res"}, {"issue": "3", "key": "17_CR5", "doi-asserted-by": "publisher", "first-page": "545", "DOI": "10.1002/cncr.11083", "volume": "97", "author": "J Chang", "year": "2003", "unstructured": "Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer. 2003;97(3):545\u201353.", "journal-title": "Cancer"}, {"issue": "13", "key": "17_CR6", "doi-asserted-by": "publisher", "first-page": "978", "DOI": "10.1093/jnci/djt134", "volume": "105", "author": "E Copson", "year": "2013", "unstructured": "Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Lawrence G, Jones L, Bliss J, Eccles D. Prospective observational study of breast cancer treatment outcomes for UK women aged 18\u201340 years at diagnosis: the POSH study. J Natl Cancer Inst. 2013;105(13):978\u201388.", "journal-title": "J Natl Cancer Inst"}, {"issue": "3", "key": "17_CR7", "doi-asserted-by": "publisher", "first-page": "249", "DOI": "10.1007/BF02977789", "volume": "28", "author": "C Xu", "year": "2005", "unstructured": "Xu C, Li CY, Kong AN. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharmacal Res. 2005;28(3):249\u201368.", "journal-title": "Arch Pharmacal Res"}, {"issue": "6", "key": "17_CR8", "doi-asserted-by": "publisher", "first-page": "1497", "DOI": "10.1111/bcp.12021", "volume": "75", "author": "PJ Voon", "year": "2013", "unstructured": "Voon PJ, Yap HL, Ma CY, Lu F, Wong AL, Sapari NS, Soong R, Soh TI, Goh BC, Lee HS, Lee SC. Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients. Br J Clin Pharmacol. 2013;75(6):1497\u2013505.", "journal-title": "Br J Clin Pharmacol"}, {"issue": "2A", "key": "17_CR9", "first-page": "1159", "volume": "18", "author": "A Serafino", "year": "1998", "unstructured": "Serafino A, Sinibaldi-Vallebona P, Gaudiano G, Koch TH, Rasi G, Garaci E, Ravagnan G. Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms. Anticancer Res. 1998;18(2A):1159\u201366.", "journal-title": "Anticancer Res"}, {"issue": "3", "key": "17_CR10", "doi-asserted-by": "publisher", "first-page": "859", "DOI": "10.1006/bbrc.1998.8887", "volume": "247", "author": "W Priebe", "year": "1998", "unstructured": "Priebe W, Krawczyk M, Kuo MT, Yamane Y, Savaraj N, Ishikawa T. Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C-4 transport mediated by MRP/GS-X pump. Biochem Bioph Res Co. 1998;247(3):859\u201363.", "journal-title": "Biochem Bioph Res Co"}, {"issue": "10", "key": "17_CR11", "first-page": "2594", "volume": "47", "author": "SE Mirski", "year": "1987", "unstructured": "Mirski SE, Gerlach JH, Cole SP. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res. 1987;47(10):2594\u20138.", "journal-title": "Cancer Res"}, {"issue": "4", "key": "17_CR12", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1016/0145-2126(94)00159-8", "volume": "19", "author": "RA Davey", "year": "1995", "unstructured": "Davey RA, Longhurst TJ, Davey MW, Belov L, Harvie RM, Hancox D, Wheeler H. Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukaemia cell line. Leuk Res. 1995;19(4):275\u201382.", "journal-title": "Leuk Res"}, {"issue": "12", "key": "17_CR13", "doi-asserted-by": "publisher", "first-page": "752", "DOI": "10.1080/15216540701736285", "volume": "59", "author": "M Munoz", "year": "2007", "unstructured": "Munoz M, Henderson M, Haber M, Norris M. Role of the MRP1/ABCC1 multidrug transporter protein in cancer. IUBMB Life. 2007;59(12):752\u20137.", "journal-title": "IUBMB Life"}, {"issue": "12", "key": "17_CR14", "doi-asserted-by": "publisher", "first-page": "1915", "DOI": "10.1016/S0006-2952(00)00521-9", "volume": "60", "author": "G Gaudiano", "year": "2000", "unstructured": "Gaudiano G, Koch TH, Lo Bello M, Nuccetelli M, Ravagnan G, Serafino A, Sinibaldi-Vallebona P. Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells\u2014inhibition of glutathione S-transferase P1-1 by glutathione conjugates from anthracyclines. Biochem Pharmacol. 2000;60(12):1915\u201323.", "journal-title": "Biochem Pharmacol"}, {"issue": "10", "key": "17_CR15", "doi-asserted-by": "publisher", "first-page": "1333", "DOI": "10.1038/bjc.1997.557", "volume": "76", "author": "T Asakura", "year": "1997", "unstructured": "Asakura T, Ohkawa K, Takahashi N, Takada K, Inoue T, Yokoyama S. Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells. Brit J Cancer. 1997;76(10):1333\u20137.", "journal-title": "Brit J Cancer"}, {"issue": "1", "key": "17_CR16", "doi-asserted-by": "publisher", "first-page": "190", "DOI": "10.1093/carcin/bgs318", "volume": "34", "author": "I Goldstein", "year": "2013", "unstructured": "Goldstein I, Rivlin N, Shoshana OY, Ezra O, Madar S, Goldfinger N, Rotter V. Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53. Carcinogenesis. 2013;34(1):190\u20138.", "journal-title": "Carcinogenesis"}, {"issue": "6", "key": "17_CR17", "doi-asserted-by": "publisher", "first-page": "1053", "DOI": "10.1200/JCO.2005.09.927", "volume": "23", "author": "EC Dees", "year": "2005", "unstructured": "Dees EC, Watkins PB. Role of cytochrome P450 phenotyping in cancer treatment. J Clin Oncol. 2005;23(6):1053\u20135 (official journal of the American Society of Clinical Oncology).", "journal-title": "J Clin Oncol"}, {"issue": "4", "key": "17_CR18", "doi-asserted-by": "publisher", "first-page": "710", "DOI": "10.1124/dmd.108.024398", "volume": "37", "author": "D Zhang", "year": "2009", "unstructured": "Zhang D, Ly VT, Lago M, Tian Y, Gan J, Humphreys WG, Comezoglu SN. CYP3A4-mediated ester cleavage as the major metabolic pathway of the oral taxane 3\u2032-tert-butyl-3\u2032-N-tert-butyloxycarbonyl-4-deacetyl-3\u2032-dephenyl-3\u2032-N-debenzoyl-4-O-methoxycarbonyl-paclitaxel (BMS-275183). Drug Metab Dispos. 2009;37(4):710\u20138.", "journal-title": "Drug Metab Dispos"}, {"issue": "1", "key": "17_CR19", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1007/s00280-008-0842-3", "volume": "64", "author": "S Harmsen", "year": "2009", "unstructured": "Harmsen S, Meijerman I, Beijnen JH, Schellens JH. Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor. Cancer Chemother Pharmacol. 2009;64(1):35\u201343.", "journal-title": "Cancer Chemother Pharmacol"}, {"issue": "8", "key": "17_CR20", "doi-asserted-by": "publisher", "first-page": "1083", "DOI": "10.1124/dmd.105.004374", "volume": "33", "author": "DS Riddick", "year": "2005", "unstructured": "Riddick DS, Lee C, Ramji S, Chinje EC, Cowen RL, Williams KJ, Patterson AV, Stratford IJ, Morrow CS, Townsend AJ, Jounaidi Y, Chen CS, Su T, Lu H, Schwartz PS, Waxman DJ. Cancer chemotherapy and drug metabolism. Drug Metab Dispos. 2005;33(8):1083\u201396.", "journal-title": "Drug Metab Dispos"}, {"issue": "1", "key": "17_CR21", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1093/mutage/18.1.25", "volume": "18", "author": "A Buschini", "year": "2003", "unstructured": "Buschini A, Poli P, Rossi C. Saccharomyces cerevisiae as an eukaryotic cell model to assess cytotoxicity and genotoxicity of three anticancer anthraquinones. Mutagenesis. 2003;18(1):25\u201336.", "journal-title": "Mutagenesis"}, {"issue": "1", "key": "17_CR22", "first-page": "387", "volume": "294", "author": "D Yao", "year": "2000", "unstructured": "Yao D, Ding S, Burchell B, Wolf CR, Friedberg T. Detoxication of vinca alkaloids by human P450 CYP3A4-mediated metabolism: implications for the development of drug resistance. J Pharmacol Exp Ther. 2000;294(1):387\u201395.", "journal-title": "J Pharmacol Exp Ther"}, {"issue": "4", "key": "17_CR23", "doi-asserted-by": "publisher", "first-page": "213", "DOI": "10.1016/j.ygeno.2012.11.009", "volume": "101", "author": "S AbuHammad", "year": "2013", "unstructured": "AbuHammad S, Zihlif M. Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line. Genomics. 2013;101(4):213\u201320.", "journal-title": "Genomics"}, {"key": "17_CR24", "unstructured": "Choi CH. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int. 2005;5:30.", "DOI": "10.1186/1475-2867-5-30", "doi-asserted-by": "crossref"}, {"issue": "5", "key": "17_CR25", "doi-asserted-by": "publisher", "first-page": "e62766", "DOI": "10.1371/journal.pone.0062766", "volume": "8", "author": "B Kim", "year": "2013", "unstructured": "Kim B, Fatayer H, Hanby AM, Horgan K, Perry SL, Valleley EM, Verghese ET, Williams BJ, Thorne JL, Hughes TA. Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancer. PLoS ONE. 2013;8(5):e62766.", "journal-title": "PLoS ONE"}, {"issue": "3", "key": "17_CR26", "first-page": "334", "volume": "59", "author": "NV Litviakov", "year": "2013", "unstructured": "Litviakov NV, Garbukov E, Slonimskaia EM, Tsyganov MM, Denisov EV, Vtorushin SV, Khristenko K, Zav\u2019ialova MV, Cherdyntseva NV. Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy. Vopr Onkol. 2013;59(3):334\u201340.", "journal-title": "Vopr Onkol"}, {"issue": "9", "key": "17_CR27", "first-page": "681", "volume": "83", "author": "A Maciejczyk", "year": "2012", "unstructured": "Maciejczyk A, Szelachowska J, Ekiert M, Matkowski R, Halon A, Surowiak P. Analysis of BCRP expression in breast cancer patients. Ginekol Pol. 2012;83(9):681\u20137.", "journal-title": "Ginekol Pol"}, {"issue": "1", "key": "17_CR28", "doi-asserted-by": "publisher", "first-page": "46", "DOI": "10.5414/CPP47046", "volume": "47", "author": "W Jaeger", "year": "2009", "unstructured": "Jaeger W. Classical resistance mechanisms. Int J Clin Pharmacol Ther. 2009;47(1):46\u20138.", "journal-title": "Int J Clin Pharmacol Ther"}, {"issue": "25", "key": "17_CR29", "doi-asserted-by": "publisher", "first-page": "19532", "DOI": "10.1074/jbc.M109.078584", "volume": "285", "author": "A Porro", "year": "2010", "unstructured": "Porro A, Haber M, Diolaiti D, et al. Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells. J Biol Chem. 2010;285(25):19532\u201343.", "journal-title": "J Biol Chem"}, {"issue": "2", "key": "17_CR30", "doi-asserted-by": "publisher", "first-page": "210", "DOI": "10.1002/stem.1002", "volume": "30", "author": "S Fatima", "year": "2012", "unstructured": "Fatima S, Zhou S, Sorrentino BP. Abcg2 expression marks tissue-specific stem cells in multiple organs in a mouse progeny tracking model. Stem Cells. 2012;30(2):210\u201321.", "journal-title": "Stem Cells"}, {"issue": "12", "key": "17_CR31", "doi-asserted-by": "publisher", "first-page": "979", "DOI": "10.1097/FPC.0b013e3283335277", "volume": "19", "author": "C Oshiro", "year": "2009", "unstructured": "Oshiro C, Marsh S, McLeod H, Carrillo MW, Klein T, Altman R. Taxane pathway. Pharmacogenet Genomics. 2009;19(12):979\u201383.", "journal-title": "Pharmacogenet Genomics"}, {"issue": "5", "key": "17_CR32", "doi-asserted-by": "publisher", "first-page": "1170", "DOI": "10.1210/me.2004-0434", "volume": "19", "author": "H Masuyama", "year": "2005", "unstructured": "Masuyama H, Suwaki N, Tateishi Y, Nakatsukasa H, Segawa T, Hiramatsu Y. The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. Mol Endocrinol. 2005;19(5):1170\u201380.", "journal-title": "Mol Endocrinol"}, {"issue": "2", "key": "17_CR33", "doi-asserted-by": "publisher", "first-page": "272", "DOI": "10.1093/annonc/mdn624", "volume": "20", "author": "H Chang", "year": "2009", "unstructured": "Chang H, Rha SY, Jeung HC, Im CK, Ahn JB, Kwon WS, Yoo NC, Roh JK, Chung HC. Association of the ABCB1 gene polymorphisms 2677G> T/A and 3435C> T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients. Ann Oncol. 2009;20(2):272\u20137 (official journal of the European Society for Medical Oncology/ESMO).", "journal-title": "Ann Oncol"}, {"issue": "7", "key": "17_CR34", "doi-asserted-by": "publisher", "first-page": "3983", "DOI": "10.1073/pnas.0530291100", "volume": "100", "author": "M Al-Hajj", "year": "2003", "unstructured": "Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983\u20138.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "8B", "key": "17_CR35", "doi-asserted-by": "publisher", "first-page": "2236", "DOI": "10.1111/j.1582-4934.2008.00455.x", "volume": "13", "author": "AK Croker", "year": "2009", "unstructured": "Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA, Allan AL. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med. 2009;13(8B):2236\u201352.", "journal-title": "J Cell Mol Med"}, {"issue": "5", "key": "17_CR36", "doi-asserted-by": "publisher", "first-page": "555", "DOI": "10.1016/j.stem.2007.08.014", "volume": "1", "author": "C Ginestier", "year": "2007", "unstructured": "Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1(5):555\u201367.", "journal-title": "Cell Stem Cell"}, {"issue": "14", "key": "17_CR37", "doi-asserted-by": "publisher", "first-page": "6207", "DOI": "10.1158/0008-5472.CAN-05-0592", "volume": "65", "author": "L Patrawala", "year": "2005", "unstructured": "Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2\u2212 cancer cells are similarly tumorigenic. Cancer Res. 2005;65(14):6207\u201319.", "journal-title": "Cancer Res"}, {"issue": "11", "key": "17_CR38", "doi-asserted-by": "publisher", "first-page": "1730", "DOI": "10.1038/bjc.2011.159", "volume": "104", "author": "HE Lee", "year": "2011", "unstructured": "Lee HE, Kim JH, Kim YJ, Choi SY, Kim SW, Kang E, Chung IY, Kim IA, Kim EJ, Choi Y, Ryu HS, Park SY. An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer. Brit J Cancer. 2011;104(11):1730\u20138.", "journal-title": "Brit J Cancer"}, {"issue": "3", "key": "17_CR39", "doi-asserted-by": "publisher", "first-page": "252", "DOI": "10.1111/j.1524-4741.2009.00896.x", "volume": "16", "author": "E Rivera", "year": "2010", "unstructured": "Rivera E. Implications of anthracycline-resistant and taxane-resistant metastatic breast cancer and new therapeutic options. Breast J. 2010;16(3):252\u201363.", "journal-title": "Breast J"}, {"issue": "3", "key": "17_CR40", "first-page": "1097", "volume": "87", "author": "M Magni", "year": "1996", "unstructured": "Magni M, Shammah S, Schiro R, Mellado W, Dalla-Favera R, Gianni AM. Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood. 1996;87(3):1097\u2013103.", "journal-title": "Blood"}, {"key": "17_CR41", "doi-asserted-by": "publisher", "first-page": "12", "DOI": "10.1186/1471-2210-10-12", "volume": "10", "author": "L Tang", "year": "2010", "unstructured": "Tang L, Bergevoet SM, Gilissen C, de Witte T, Jansen JH, van der Reijden BA, Raymakers RA. Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells. BMC Pharmacol. 2010;10:12.", "journal-title": "BMC Pharmacol"}, {"issue": "17\u201318", "key": "17_CR42", "doi-asserted-by": "publisher", "first-page": "631", "DOI": "10.1016/j.lfs.2010.02.012", "volume": "86", "author": "XW Ding", "year": "2010", "unstructured": "Ding XW, Wu JH, Jiang CP. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci. 2010;86(17\u201318):631\u20137.", "journal-title": "Life Sci"}, {"issue": "12", "key": "17_CR43", "doi-asserted-by": "publisher", "first-page": "1529", "DOI": "10.1517/17425250903228834", "volume": "5", "author": "Y An", "year": "2009", "unstructured": "An Y, Ongkeko WM. ABCG2: the key to chemoresistance in cancer stem cells? Expert Opin Drug Metab Toxicol. 2009;5(12):1529\u201342.", "journal-title": "Expert Opin Drug Metab Toxicol"}, {"issue": "9", "key": "17_CR44", "doi-asserted-by": "publisher", "first-page": "1028", "DOI": "10.1038/nm0901-1028", "volume": "7", "author": "S Zhou", "year": "2001", "unstructured": "Zhou S, Schuetz JD, Bunting KD, Colapietro AM, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001;7(9):1028\u201334.", "journal-title": "Nat Med"}, {"issue": "39", "key": "17_CR45", "doi-asserted-by": "publisher", "first-page": "14228", "DOI": "10.1073/pnas.0400067101", "volume": "101", "author": "C Hirschmann-Jax", "year": "2004", "unstructured": "Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA, Brenner MK. A distinct \u201cside population\u201d of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A. 2004;101(39):14228\u201333.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "5", "key": "17_CR46", "doi-asserted-by": "publisher", "first-page": "1750", "DOI": "10.2353/ajpath.2007.060798", "volume": "170", "author": "Y Zen", "year": "2007", "unstructured": "Zen Y, Fujii T, Yoshikawa S, Takamura H, Tani T, Ohta T, Nakanuma Y. Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am J Pathol. 2007;170(5):1750\u201362.", "journal-title": "Am J Pathol"}, {"issue": "4", "key": "17_CR47", "doi-asserted-by": "publisher", "first-page": "574", "DOI": "10.1016/j.humpath.2009.08.023", "volume": "41", "author": "S Aulmann", "year": "2010", "unstructured": "Aulmann S, Waldburger N, Penzel R, Andrulis M, Schirmacher P, Sinn HP. Reduction of CD44(+)/CD24(\u2212) breast cancer cells by conventional cytotoxic chemotherapy. Hum Pathol. 2010;41(4):574\u201381.", "journal-title": "Hum Pathol"}, {"issue": "2", "key": "17_CR48", "doi-asserted-by": "publisher", "first-page": "421", "DOI": "10.1002/jcp.22764", "volume": "227", "author": "CI Kobayashi", "year": "2012", "unstructured": "Kobayashi CI, Suda T. Regulation of reactive oxygen species in stem cells and cancer stem cells. J Cell Physiol. 2012;227(2):421\u201330.", "journal-title": "J Cell Physiol"}, {"key": "17_CR49", "doi-asserted-by": "publisher", "first-page": "265", "DOI": "10.1038/nrc2620", "volume": "4", "author": "K Polyak", "year": "2009", "unstructured": "Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;4:265\u201373.", "journal-title": "Nat Rev Cancer"}, {"issue": "1", "key": "17_CR50", "doi-asserted-by": "publisher", "first-page": "61", "DOI": "10.1016/j.cell.2013.06.005", "volume": "154", "author": "CL Chaffer", "year": "2013", "unstructured": "Chaffer CL, Marjanovic ND, Lee T, Bell G, Kleer CG, Reinhardt F, D\u2019Alessio AC, Young RA, Weinberg RA. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell. 2013;154(1):61\u201374.", "journal-title": "Cell"}, {"key": "17_CR51", "unstructured": "Smalley M, Piggott L, Clarkson R. Breast cancer stem cells: obstacles to therapy. Cancer Lett. 2013;338(1):57\u201362.", "DOI": "10.1016/j.canlet.2012.04.023", "doi-asserted-by": "crossref"}, {"issue": "10", "key": "17_CR52", "doi-asserted-by": "publisher", "first-page": "1512", "DOI": "10.1111/j.1349-7006.2007.00550.x", "volume": "98", "author": "A Moustakas", "year": "2007", "unstructured": "Moustakas A, Heldin CH. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007;98(10):1512\u201320.", "journal-title": "Cancer Sci"}, {"issue": "3", "key": "17_CR53", "doi-asserted-by": "publisher", "first-page": "1348", "DOI": "10.1172/JCI65416", "volume": "123", "author": "NE Bhola", "year": "2013", "unstructured": "Bhola NE, Balko JM, Dugger TC, Kuba MG, Sanchez V, Sanders M, Stanford J, Cook RS, Arteaga CL. TGF-beta inhibition enhances chemotherapy action against triple-negative breast cancer. J Clin Investig. 2013;123(3):1348\u201358.", "journal-title": "J Clin Investig"}, {"issue": "81", "key": "17_CR54", "first-page": "62", "volume": "55", "author": "FY Wang", "year": "2008", "unstructured": "Wang FY, Arisawa T, Tahara T, Takahama K, Watanabe M, Hirata I, Nakano H. Aberrant DNA methylation in ulcerative colitis without neoplasia. Hepatogastroenterology. 2008;55(81):62\u20135.", "journal-title": "Hepatogastroenterology"}, {"issue": "5", "key": "17_CR55", "doi-asserted-by": "publisher", "first-page": "1544", "DOI": "10.1158/1535-7163.MCT-06-0673", "volume": "6", "author": "KM Rogers", "year": "2007", "unstructured": "Rogers KM, Thomas M, Galligan L, Wilson TR, Allen WL, Sakai H, Johnston PG, Longley DB. Cellular FLICE-inhibitory protein regulates chemotherapy-induced apoptosis in breast cancer cells. Mol Cancer Ther. 2007;6(5):1544\u201351.", "journal-title": "Mol Cancer Ther"}, {"issue": "9055", "key": "17_CR56", "doi-asserted-by": "publisher", "first-page": "849", "DOI": "10.1016/S0140-6736(05)61752-7", "volume": "349", "author": "PA Ellis", "year": "1997", "unstructured": "Ellis PA, Smith IE, McCarthy K, Detre S, Salter J, Dowsett M. Preoperative chemotherapy induces apoptosis in early breast cancer. Lancet. 1997;349(9055):849.", "journal-title": "Lancet"}, {"issue": "1", "key": "17_CR57", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1097/00130404-200301000-00007", "volume": "9", "author": "TA Buchholz", "year": "2003", "unstructured": "Buchholz TA, Davis DW, McConkey DJ, Symmans WF, Valero V, Jhingran A, Tucker SL, Pusztai L, Cristofanilli M, Esteva FJ, Hortobagyi GN, Sahin AA. Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy. Cancer J. 2003;9(1):33\u201341.", "journal-title": "Cancer J"}, {"issue": "1", "key": "17_CR58", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1080/00313020500465315", "volume": "38", "author": "DG Tiezzi", "year": "2006", "unstructured": "Tiezzi DG, De Andrade JM, Candido dos Reis FJ, Marana HR, Ribeiro-Silva A, Tiezzi MG, Pereira AP. Apoptosis induced by neoadjuvant chemotherapy in breast cancer. Pathology. 2006;38(1):21\u20137.", "journal-title": "Pathology"}, {"issue": "17", "key": "17_CR59", "first-page": "3902", "volume": "55", "author": "C Teixeira", "year": "1995", "unstructured": "Teixeira C, Reed JC, Pratt MA. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 1995;55(17):3902\u20137.", "journal-title": "Cancer Res"}, {"issue": "6", "key": "17_CR60", "doi-asserted-by": "crossref", "first-page": "2280", "DOI": "10.1200/JCO.1998.16.6.2280", "volume": "16", "author": "HA Hahm", "year": "1998", "unstructured": "Hahm HA, Davidson NE, Giguere JK, DiBernardo C, O\u2019Reilly S. Breast cancer metastatic to the choroid. J Clin Oncol. 1998;16(6):2280\u20132 (official journal of the American Society of Clinical Oncology).", "journal-title": "J Clin Oncol"}, {"issue": "4", "key": "17_CR61", "doi-asserted-by": "publisher", "first-page": "462", "DOI": "10.1016/S0959-8049(02)00600-7", "volume": "39", "author": "WR Miller", "year": "2003", "unstructured": "Miller WR, Dixon JM, Macfarlane L, Cameron D, Anderson TJ. Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen. Eur J Cancer. 2003;39(4):462\u20138.", "journal-title": "Eur J Cancer"}, {"issue": "24", "key": "17_CR62", "doi-asserted-by": "publisher", "first-page": "25535", "DOI": "10.1074/jbc.M400944200", "volume": "279", "author": "S Wang", "year": "2004", "unstructured": "Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms intermediacy of H(2)O(2)\u2212 and p53-dependent pathways. J Biol Chem. 2004;279(24):25535\u201343.", "journal-title": "J Biol Chem"}, {"issue": "6", "key": "17_CR63", "doi-asserted-by": "publisher", "first-page": "1185", "DOI": "10.1083/jcb.128.6.1185", "volume": "128", "author": "GR Merlo", "year": "1995", "unstructured": "Merlo GR, Basolo F, Fiore L, Duboc L, Hynes NE. p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J Cell Biol. 1995;128(6):1185\u201396.", "journal-title": "J Cell Biol"}, {"issue": "44", "key": "17_CR64", "doi-asserted-by": "publisher", "first-page": "18060", "DOI": "10.1073/pnas.1018858109", "volume": "109", "author": "ST Bailey", "year": "2012", "unstructured": "Bailey ST, Shin HJ, Westerling T, Liu XS, Brown M. Estrogen receptor prevents p53-dependent apoptosis in breast cancer. P Natl Acad Sci USA. 2012;109(44):18060\u20135.", "journal-title": "P Natl Acad Sci USA"}, {"issue": "3 Pt 2", "key": "17_CR65", "doi-asserted-by": "publisher", "first-page": "1024s", "DOI": "10.1158/1078-0432.CCR-05-2127", "volume": "12", "author": "M Dowsett", "year": "2006", "unstructured": "Dowsett M, Smith IE, Ebbs SR, Dixon JM, Skene A, Griffith C, Boeddinghaus I, Salter J, Detre S, Hills M, Ashley S, Francis S, Walsh G, A\u2019Hern R. Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer. Clin Cancer Res. 2006;12(3 Pt 2):1024s\u201330s (an official journal of the American Association for Cancer Research).", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "17_CR66", "first-page": "155", "volume": "37", "author": "T Tanei", "year": "2011", "unstructured": "Tanei T, Shimomura A, Shimazu K, Nakayama T, Kim SJ, Iwamoto T, Tamaki Y, Noguchi S. Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer. Euro J Surg Oncol J Euro Soc Surg Oncol Br Assoc Surg Oncol. 2011;37(2):155\u201361.", "journal-title": "Euro J Surg Oncol J Euro Soc Surg Oncol Br Assoc Surg Oncol"}, {"issue": "16", "key": "17_CR67", "doi-asserted-by": "publisher", "first-page": "7746", "DOI": "10.1158/0008-5472.CAN-06-3724", "volume": "67", "author": "A Sayeed", "year": "2007", "unstructured": "Sayeed A, Konduri SD, Liu W, Bansal S, Li F, Das GM. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis. Cancer Res. 2007;67(16):7746\u201355.", "journal-title": "Cancer Res"}, {"issue": "7", "key": "17_CR68", "doi-asserted-by": "publisher", "first-page": "811", "DOI": "10.1038/nm0796-811", "volume": "2", "author": "T Aas", "year": "1996", "unstructured": "Aas T, Borresen AL, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug JE, Akslen LA, Lonning PE. Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med. 1996;2(7):811\u20134.", "journal-title": "Nat Med"}, {"issue": "16", "key": "17_CR69", "doi-asserted-by": "publisher", "first-page": "1254", "DOI": "10.1093/jnci/87.16.1254", "volume": "87", "author": "RM Elledge", "year": "1995", "unstructured": "Elledge RM, Gray R, Mansour E, Yu Y, Clark GM, Ravdin P, Osborne CK, Gilchrist K, Davidson NE, Robert N, et al. Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer. J Natl Cancer Inst. 1995;87(16):1254\u20136.", "journal-title": "J Natl Cancer Inst"}, {"issue": "10", "key": "17_CR70", "first-page": "1203", "volume": "1", "author": "RM Elledge", "year": "1995", "unstructured": "Elledge RM, Lock-Lim S, Allred DC, Hilsenbeck SG, Cordner L. p53 mutation and tamoxifen resistance in breast cancer. Clin Cancer Res. 1995;1(10):1203\u20138 (an official journal of the American Association for Cancer Research).", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "17_CR71", "doi-asserted-by": "publisher", "first-page": "510", "DOI": "10.1093/humrep/dep421", "volume": "25", "author": "AE King", "year": "2010", "unstructured": "King AE, Collins F, Klonisch T, Sallenave JM, Critchley HO, Saunders PT. An additive interaction between the NFkappaB and estrogen receptor signalling pathways in human endometrial epithelial cells. Hum Reprod. 2010;25(2):510\u20138.", "journal-title": "Hum Reprod"}, {"issue": "2", "key": "17_CR72", "doi-asserted-by": "publisher", "first-page": "262", "DOI": "10.1093/carcin/bgt334", "volume": "35", "author": "MD Long", "year": "2014", "unstructured": "Long MD, Thorne JL, Russell J, Battaglia S, Singh PK, Sucheston-Campbell LE, Campbell MJ. Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer. Carcinogenesis. 2014;35(2):262\u201371.", "journal-title": "Carcinogenesis"}, {"issue": "13", "key": "17_CR73", "doi-asserted-by": "publisher", "first-page": "5226", "DOI": "10.1158/0008-5472.CAN-07-5744", "volume": "68", "author": "P Rizzo", "year": "2008", "unstructured": "Rizzo P, Miao H, D\u2019Souza G, Osipo C, Song LL, Yun J, Zhao H, Mascarenhas J, Wyatt D, Antico G, Hao L, Yao K, Rajan P, Hicks C, Siziopikou K, Selvaggi S, Bashir A, Bhandari D, Marchese A, Lendahl U, Qin JZ, Tonetti DA, Albain K, Nickoloff BJ, Miele L. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res. 2008;68(13):5226\u201335.", "journal-title": "Cancer Res"}, {"issue": "21", "key": "17_CR74", "doi-asserted-by": "publisher", "first-page": "3405", "DOI": "10.4161/cc.26421", "volume": "12", "author": "D Sisci", "year": "2013", "unstructured": "Sisci D, Maris P, Cesario MG, Anselmo W, Coroniti R, Trombino GE, Romeo F, Ferraro A, Lanzino M, Aquila S, Maggiolini M, Mauro L, Morelli C, Ando S. The estrogen receptor alpha is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness. Cell Cycle. 2013;12(21):3405\u201320.", "journal-title": "Cell Cycle"}, {"key": "17_CR75", "doi-asserted-by": "publisher", "first-page": "276", "DOI": "10.1186/1471-2407-6-276", "volume": "6", "author": "MA Troester", "year": "2006", "unstructured": "Troester MA, Herschkowitz JI, Oh DS, He X, Hoadley KA, Barbier CS, Perou CM. Gene expression patterns associated with p53 status in breast cancer. BMC Cancer. 2006;6:276.", "journal-title": "BMC Cancer"}, {"issue": "1", "key": "17_CR76", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1016/j.ydbio.2011.09.018", "volume": "360", "author": "JW Cave", "year": "2011", "unstructured": "Cave JW. Selective repression of Notch pathway target gene transcription. Developmental biology. 2011;360(1):123\u201331.", "journal-title": "Developmental biology"}, {"issue": "4", "key": "17_CR77", "doi-asserted-by": "publisher", "first-page": "465", "DOI": "10.1016/j.semcdb.2012.01.016", "volume": "23", "author": "C Groth", "year": "2012", "unstructured": "Groth C, Fortini ME. Therapeutic approaches to modulating Notch signaling. Semin Cell Dev Biol. 2012;23(4):465\u201372.", "journal-title": "Semin Cell Dev Biol"}, {"issue": "1", "key": "17_CR78", "doi-asserted-by": "publisher", "first-page": "23", "DOI": "10.1023/A:1009512414430", "volume": "6", "author": "Raafat Callahan", "year": "2001", "unstructured": "Callahan Raafat. Notch signaling in mammary gland tumorigenesis. Journal of mammary gland biology and neoplasia. 2001;6(1):23\u201336.", "journal-title": "Journal of mammary gland biology and neoplasia"}, {"key": "17_CR79", "unstructured": "Landor SKJ, Mutvei AP, Mamaeva V, Jin S, Busk M, Borra R, Gronroos TJ, Kronqvist P, Lendahl U, Sahlgren CM. Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms. PNAS USA 2011;108(46):18814\u20139.", "DOI": "10.1073/pnas.1104943108", "doi-asserted-by": "crossref"}, {"issue": "18", "key": "17_CR80", "doi-asserted-by": "publisher", "first-page": "8530", "DOI": "10.1158/0008-5472.CAN-05-1069", "volume": "65", "author": "M Reedijk", "year": "2005", "unstructured": "Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, Lockwood G, Egan SE. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005;65(18):8530\u20137.", "journal-title": "Cancer Res"}, {"issue": "3", "key": "17_CR81", "doi-asserted-by": "publisher", "first-page": "439", "DOI": "10.1007/s10549-007-9805-3", "volume": "111", "author": "M Reedijk", "year": "2008", "unstructured": "Reedijk M, Pinnaduwage D, Dickson BC, Mulligan AM, Zhang H, Bull SB, O\u2019Malley FP, Egan SE, Andrulis IL. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Res Treat. 2008;111(3):439\u201348.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "6", "key": "17_CR82", "doi-asserted-by": "publisher", "first-page": "R605", "DOI": "10.1186/bcr920", "volume": "6", "author": "G Dontu", "year": "2004", "unstructured": "Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res (BCR). 2004;6(6):R605\u201315.", "journal-title": "Breast Cancer Res (BCR)"}, {"issue": "25", "key": "17_CR83", "doi-asserted-by": "publisher", "first-page": "4006", "DOI": "10.1200/JCO.2009.27.5388", "volume": "28", "author": "S Liu", "year": "2010", "unstructured": "Liu S, Wicha MS. Targeting breast cancer stem cells. J Clin Oncol. 2010;28(25):4006\u201312 (official journal of the American Society of Clinical Oncology).", "journal-title": "J Clin Oncol"}, {"issue": "4", "key": "17_CR84", "doi-asserted-by": "publisher", "first-page": "1109", "DOI": "10.1158/1078-0432.CCR-11-2762", "volume": "18", "author": "AM Gonzalez-Angulo", "year": "2012", "unstructured": "Gonzalez-Angulo AM, Iwamoto T, Liu S, Chen H, Do KA, Hortobagyi GN, Mills GB, Meric-Bernstam F, Symmans WF, Pusztai L. Gene expression, molecular class changes, and pathway analysis after NACT for breast cancer. Clinical Cancer Res. 2012;18(4):1109\u201319 (an official journal of the American Association for Cancer Research).", "journal-title": "Clinical Cancer Res"}, {"key": "17_CR85", "unstructured": "Cho S, Lu M, He X, Ee PL, Bhat U, Schneider E, Miele L, Beck WT. Notch1 regulates the expression of ABCC1/MRP1 in cultured cancer cells. PNAS USA 2011;108(51):20778\u201383.", "DOI": "10.1073/pnas.1019452108", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "17_CR86", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.1677/erc.0.0100043", "volume": "10", "author": "C Leonessa", "year": "2003", "unstructured": "Leonessa C. ABC transporters and drug resistance in breast cancer. Endocr-Relat Cancer. 2003;10(1):43\u201373.", "journal-title": "Endocr-Relat Cancer"}, {"issue": "6", "key": "17_CR87", "doi-asserted-by": "publisher", "first-page": "1064", "DOI": "10.1016/j.biocel.2013.02.022", "volume": "45", "author": "J Mao", "year": "2013", "unstructured": "Mao J, Song B, Shi Y, Wang B, Fan S, Yu X, Tang J, Li L. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel. Int J Biochem Cell Biol. 2013;45(6):1064\u201373.", "journal-title": "Int J Biochem Cell Biol"}, {"issue": "2", "key": "17_CR88", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1016/j.canlet.2012.09.023", "volume": "328", "author": "M Qiu", "year": "2013", "unstructured": "Qiu M, Peng Q, Jiang I, Carroll C, Han G, Rymer I, Lippincott J, Zachwieja J, Gajiwala K, Kraynov E, Thibault S, Stone D, Gao Y, Sofia S, Gallo J, Li G, Yang J, Li K, Wei P. Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells. Cancer Lett. 2013;328(2):261\u201370.", "journal-title": "Cancer Lett"}, {"issue": "21", "key": "17_CR89", "doi-asserted-by": "publisher", "first-page": "7678", "DOI": "10.1158/0008-5472.CAN-04-2933", "volume": "64", "author": "IG Campbell", "year": "2004", "unstructured": "Campbell IG, Russell SE, Choong DYH, Montgomery KG, Ciavarella ML, Hooi CSF, Cristiano BE, Pearson RB, Phillips WA. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res. 2004;64(21):7678\u201381.", "journal-title": "Cancer Res"}, {"issue": "1", "key": "17_CR90", "doi-asserted-by": "publisher", "first-page": "150", "DOI": "10.1016/j.bbapap.2007.09.008", "volume": "1784", "author": "BH Jiang", "year": "2008", "unstructured": "Jiang BH, Liu LZ. PI3\u00a0K/PTEN signaling in tumorigenesis and angiogenesis. Bba-Proteins Proteom. 2008;1784(1):150\u20138.", "journal-title": "Bba-Proteins Proteom"}, {"issue": "56", "key": "17_CR91", "doi-asserted-by": "publisher", "first-page": "7381", "DOI": "10.1038/sj.onc.1209737", "volume": "25", "author": "SE Winograd-Katz", "year": "2006", "unstructured": "Winograd-Katz SE, Levitzki A. Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor. Oncogene. 2006;25(56):7381\u201390.", "journal-title": "Oncogene"}, {"issue": "3", "key": "17_CR92", "doi-asserted-by": "publisher", "first-page": "150", "DOI": "10.1016/S0014-5793(99)00631-6", "volume": "452", "author": "I Plo", "year": "1999", "unstructured": "Plo I, Bettaieb A, Payrastre B, Mansat-De Mas V, Bordier C, Rousse A, Kowalski-Chauvel A, Laurent G, Lautier D. The phosphoinositide 3-kinase/Akt pathway is activated by daunorubicin in human acute myeloid leukemia cell lines. FEBS Lett. 1999;452(3):150\u20134.", "journal-title": "FEBS Lett"}, {"issue": "9", "key": "17_CR93", "first-page": "707", "volume": "1", "author": "AS Clark", "year": "2002", "unstructured": "Clark AS, West K, Streicher S, Dennis PA. Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther. 2002;1(9):707\u201317.", "journal-title": "Mol Cancer Ther"}, {"issue": "36", "key": "17_CR94", "doi-asserted-by": "publisher", "first-page": "33490", "DOI": "10.1074/jbc.M204042200", "volume": "277", "author": "S Mabuchi", "year": "2002", "unstructured": "Mabuchi S, Ohmichi M, Kimura A, Hisamoto K, Hayakawa J, Nishio Y, Adachi K, Takahashi K, Arimoto-Ishida E, Nakatsuji Y, Tasaka K, Murata Y. Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel. J Biol Chem. 2002;277(36):33490\u2013500.", "journal-title": "J Biol Chem"}, {"issue": "2", "key": "17_CR95", "doi-asserted-by": "publisher", "first-page": "231", "DOI": "10.1016/S0092-8674(00)80405-5", "volume": "91", "author": "SR Datta", "year": "1997", "unstructured": "Datta SR, Dudek H, Tao X, Masters S, Fu HA, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997;91(2):231\u201341.", "journal-title": "Cell"}, {"key": "17_CR96", "unstructured": "delPeso L, GonzalezGarcia M, Page C, Herrera R, Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997;278(5338):687\u20139.", "DOI": "10.1126/science.278.5338.687", "doi-asserted-by": "crossref"}, {"issue": "20", "key": "17_CR97", "doi-asserted-by": "publisher", "first-page": "21085", "DOI": "10.1074/jbc.M400063200", "volume": "279", "author": "SJ Gardai", "year": "2004", "unstructured": "Gardai SJ, Hildeman DA, Frankel SK, Whitlock BB, Frasch SC, Borregaard N, Marrack P, Bratton DL, Henson PM. Phosphorylation of Bax Ser(184) by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem. 2004;279(20):21085\u201395.", "journal-title": "J Biol Chem"}, {"issue": "11", "key": "17_CR98", "doi-asserted-by": "publisher", "first-page": "973", "DOI": "10.1038/ncb1101-973", "volume": "3", "author": "BHP Zhou", "year": "2001", "unstructured": "Zhou BHP, Liao Y, Xia WY, Zou YY, Spohn B, Hung MC. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol. 2001;3(11):973\u201382.", "journal-title": "Nat Cell Biol"}, {"issue": "2", "key": "17_CR99", "doi-asserted-by": "publisher", "first-page": "288", "DOI": "10.1016/j.leukres.2008.06.010", "volume": "33", "author": "MG Garcia", "year": "2009", "unstructured": "Garcia MG, Alaniz LD, Russo RIC, Alvarez E, Hajos SE. PI3K/Akt inhibition modulates multidrug resistance and activates NF-kappa B in murine lymphoma cell lines. Leukemia Res. 2009;33(2):288\u201396.", "journal-title": "Leukemia Res"}, {"issue": "7", "key": "17_CR100", "doi-asserted-by": "publisher", "first-page": "905", "DOI": "10.1124/dmd.104.003228", "volume": "33", "author": "T Takada", "year": "2005", "unstructured": "Takada T, Suzuki H, Gotoh Y, Sugiyama Y. Regulation of the cell surface expression of human BCRP/ABCG2 by the phosphorylation state of Akt in polarized cells. Drug Metab Dispos. 2005;33(7):905\u20139.", "journal-title": "Drug Metab Dispos"}, {"issue": "40", "key": "17_CR101", "doi-asserted-by": "publisher", "first-page": "39068", "DOI": "10.1074/jbc.M306362200", "volume": "278", "author": "M Mogi", "year": "2003", "unstructured": "Mogi M, Yang J, Lambert JF, Colvin GA, Shiojima I, Skurk C, Summer R, Fine A, Quesenberry PJ, Walsh K. Akt signaling regulates side population cell phenotype via Bcrp1 translocation. J Biol Chem. 2003;278(40):39068\u201375.", "journal-title": "J Biol Chem"}, {"issue": "5", "key": "17_CR102", "doi-asserted-by": "publisher", "first-page": "815", "DOI": "10.1038/sj.bjc.6605553", "volume": "102", "author": "T Nakanishi", "year": "2010", "unstructured": "Nakanishi T, Chumsri S, Khakpour N, Brodie AH, Leyland-Jones B, Hamburger AW, Ross DD, Burger AM. Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling. Brit J Cancer. 2010;102(5):815\u201326.", "journal-title": "Brit J Cancer"}, {"issue": "3", "key": "17_CR103", "doi-asserted-by": "publisher", "first-page": "226", "DOI": "10.1016/j.stem.2009.01.007", "volume": "4", "author": "AM Bleau", "year": "2009", "unstructured": "Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW, Holland EC. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell. 2009;4(3):226\u201335.", "journal-title": "Cell Stem Cell"}], "container-title": ["Molecular Pathology Library", "Precision Molecular Pathology of Breast Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4939-2886-6_17", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T16:08:25Z", "timestamp": 1559232505000}, "score": 22.530127, "issued": {"date-parts": [[2015]]}, "ISBN": ["9781493928859", "9781493928866"], "references-count": 103, "URL": "http://dx.doi.org/10.1007/978-1-4939-2886-6_17", "relation": {"cites": []}, "ISSN": ["1935-987X", "1935-9888"], "issn-type": [{"value": "1935-987X", "type": "print"}, {"value": "1935-9888", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T20:57:51Z", "timestamp": 1575406671598}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Epidemiology"], "published-print": {"date-parts": [[2019, 2]]}, "DOI": "10.1097/00001648-900000000-98587", "type": "journal-article", "created": {"date-parts": [[2019, 2, 21]], "date-time": "2019-02-21T12:57:21Z", "timestamp": 1550753841000}, "page": "1", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Defining evidence for precision medicine"], "prefix": "10.1097", "author": [{"given": "A. Cecile J.W.", "family": "Janssens", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Epidemiology"], "language": "en", "link": [{"URL": "http://journals.lww.com/epidem/Fulltext/9000/00000/.98587.aspx", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T12:04:13Z", "timestamp": 1552824253000}, "score": 22.521835, "subtitle": ["a patient is more than a set of covariates"], "issued": {"date-parts": [[2019, 2]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1097/00001648-900000000-98587", "ISSN": ["1044-3983"], "issn-type": [{"value": "1044-3983", "type": "print"}], "subject": ["Epidemiology"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}